data_1azk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1azk _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 . . . . . 0 CA--C 1.553 1.065 0 CA-C-O 121.838 0.828 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.8 m -59.71 -55.65 31.73 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -171.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -115.17 140.77 48.8 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.939 1.296 . . . . 0.0 114.028 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 62.9 41.92 8.16 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 125.564 1.546 . . . . 0.0 113.17 -171.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.09 109.91 3.68 Favored Glycine 0 CA--C 1.54 1.64 0 C-N-CA 126.113 1.815 . . . . 0.0 114.588 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -52.41 124.36 13.23 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.362 1.465 . . . . 0.0 114.09 176.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 m -118.51 -0.37 11.41 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.58 114.64 0.33 Allowed Glycine 0 CA--C 1.546 2.005 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -175.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.63 -160.28 30.15 Favored Glycine 0 CA--C 1.552 2.384 0 C-N-CA 126.391 1.948 . . . . 0.0 115.023 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -45.64 124.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.7 -13.13 49.43 Favored Glycine 0 CA--C 1.544 1.894 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -89.69 167.43 12.91 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 119.08 1.44 . . . . 0.0 114.856 -172.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 94.2 p -131.49 -92.42 0.4 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.635 1.574 . . . . 0.0 110.881 166.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.2 38.61 0.52 Allowed Glycine 0 CA--C 1.548 2.147 0 N-CA-C 118.294 2.078 . . . . 0.0 118.294 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -76.1 50.58 2.88 Favored 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 123.384 2.723 . . . . 0.0 112.198 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.2 p -77.67 66.6 3.4 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.212 -1.555 . . . . 0.0 113.119 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 t -76.46 51.87 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 O-C-N 120.874 -1.141 . . . . 0.0 112.088 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.1 t -98.59 169.4 9.54 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 129.722 3.209 . . . . 0.0 111.915 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.4 159.37 16.44 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.691 -1.256 . . . . 0.0 112.238 169.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.8 t -72.89 -177.13 2.26 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 161.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.68 -57.02 5.03 Favored Glycine 0 CA--C 1.542 1.742 0 O-C-N 120.857 -1.152 . . . . 0.0 111.688 -165.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.1 p -76.8 177.79 7.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.233 1.013 . . . . 0.0 111.224 153.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -129.11 -128.71 0.21 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -159.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.4 m 179.85 62.51 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 128.645 2.778 . . . . 0.0 111.835 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -128.82 157.83 40.4 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -165.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.39 132.77 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -167.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.1 -113.09 0.16 Allowed 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.745 1.218 . . . . 0.0 112.762 151.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.35 157.45 71.42 Favored Pre-proline 0 CA--C 1.562 1.409 0 O-C-N 119.566 -1.959 . . . . 0.0 114.51 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.79 -17.35 0.71 Allowed 'Trans proline' 0 CA--C 1.554 1.506 0 C-N-CA 124.622 3.548 . . . . 0.0 117.969 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -74.15 -25.52 59.79 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.96 105.31 2.73 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -154.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -71.78 117.3 13.19 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 121.465 -0.772 . . . . 0.0 109.422 130.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -138.97 151.32 46.77 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -160.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.7 m -57.97 76.33 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.527 1.931 . . . . 0.0 113.028 169.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 C--O 1.257 1.483 0 C-N-CA 125.161 1.384 . . . . 0.0 111.237 153.593 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? . . . . . 0 CA--C 1.56 1.354 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.8 m -77.01 154.37 33.55 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -168.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -41.13 146.77 0.16 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.134 1.774 . . . . 0.0 114.112 162.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 60.66 12.67 3.8 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.39 140.4 33.67 Favored Glycine 0 CA--C 1.545 1.937 0 O-C-N 119.807 -1.808 . . . . 0.0 115.254 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -64.95 119.31 10.48 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.572 -1.546 . . . . 0.0 112.78 173.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.5 38.28 3.79 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.453 1.479 . . . . 0.0 113.093 166.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.03 159.85 22.76 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 125.088 1.328 . . . . 0.0 114.685 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.87 -49.85 51.7 Favored Glycine 0 CA--C 1.545 1.955 0 N-CA-C 119.066 2.386 . . . . 0.0 119.066 -158.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.3 mt -58.32 119.72 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 O-C-N 120.724 -1.456 . . . . 0.0 112.983 -168.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.23 25.4 75.61 Favored Glycine 0 CA--C 1.543 1.838 0 C-N-CA 124.755 1.169 . . . . 0.0 115.548 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.22 -170.59 3.53 Favored 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 115.734 1.754 . . . . 0.0 115.734 -166.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.8 p -146.34 -69.29 0.26 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.993 2.117 . . . . 0.0 110.702 175.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.1 64.99 0.52 Allowed Glycine 0 CA--C 1.541 1.699 0 N-CA-C 117.584 1.794 . . . . 0.0 117.584 156.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.54 34.73 0.38 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 C-N-CA 122.663 2.242 . . . . 0.0 112.757 166.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.0 p -84.09 66.36 9.21 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 119.814 -1.804 . . . . 0.0 113.393 -170.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 t -65.35 78.45 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.996 0.919 . . . . 0.0 109.762 163.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 174.27 7.68 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 -168.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.54 73.08 0.06 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.329 1.451 . . . . 0.0 113.721 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.8 t -37.8 109.21 0.09 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.549 1.94 . . . . 0.0 114.74 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.78 -55.56 0.72 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.11 1.814 . . . . 0.0 108.69 -158.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.7 p -70.66 168.49 16.39 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.299 -0.451 . . . . 0.0 111.714 141.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -126.03 -114.04 0.28 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.852 1.661 . . . . 0.0 114.616 -166.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.0 m 162.3 65.35 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.806 0 C-N-CA 131.448 3.899 . . . . 0.0 111.504 -169.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -135.79 165.28 25.97 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 -171.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -68.1 136.52 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 118.178 2.659 . . . . 0.0 118.178 -159.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.39 -46.37 0.51 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.321 1.449 . . . . 0.0 114.532 155.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -130.22 161.18 61.77 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.996 1.319 . . . . 0.0 112.914 -176.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.81 50.05 2.01 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 123.43 2.753 . . . . 0.0 113.865 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -152.82 -49.49 0.1 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.467 2.307 . . . . 0.0 110.437 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.35 100.86 9.39 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.387 2.275 . . . . 0.0 113.374 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.0 t -70.26 88.56 0.63 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 140.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -88.32 148.92 24.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.281 1.832 . . . . 0.0 114.093 -158.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 m -63.81 75.53 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.712 -1.243 . . . . 0.0 112.501 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.208 -1.377 . . . . 0.0 110.806 163.712 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.5 t -66.72 -111.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 157.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -62.99 110.88 1.94 Allowed 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.901 -1.124 . . . . 0.0 112.622 170.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.255 27.4 m-85 89.67 94.26 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 129.424 3.09 . . . . 0.0 115.835 177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.88 129.45 3.08 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 126.532 2.015 . . . . 0.0 113.533 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -71.39 133.97 46.32 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 125.126 1.37 . . . . 0.0 113.561 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 m -140.4 20.11 2.39 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.83 129.69 2.54 Favored Glycine 0 CA--C 1.544 1.854 0 O-C-N 120.406 -1.433 . . . . 0.0 115.178 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.36 -158.12 28.68 Favored Glycine 0 CA--C 1.545 1.965 0 C-N-CA 126.124 1.821 . . . . 0.0 112.437 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.1 mt -43.39 105.63 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-N 119.274 1.537 . . . . 0.0 112.352 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.45 -32.84 2.31 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -73.19 56.49 0.46 Allowed 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -167.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.9 m -73.52 60.78 0.67 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.95 1.3 . . . . 0.0 109.389 155.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.7 -173.45 13.31 Favored Glycine 0 CA--C 1.544 1.903 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 -150.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.35 89.63 1.31 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.955 3.103 . . . . 0.0 112.015 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.5 p -72.61 62.75 0.57 Allowed 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.354 -1.467 . . . . 0.0 113.714 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.69 56.37 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 125.332 1.453 . . . . 0.0 112.254 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.3 t -101.55 151.61 21.77 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.725 2.01 . . . . 0.0 113.933 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.5 90.06 6.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.636 1.574 . . . . 0.0 112.641 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -42.72 115.63 0.75 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.424 1.09 . . . . 0.0 112.946 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.74 -51.84 0.75 Allowed Glycine 0 CA--C 1.539 1.533 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -152.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.5 p -82.98 166.8 18.53 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.634 0.373 . . . . 0.0 111.854 140.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.5 p -99.64 -88.41 0.34 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -158.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.3 m 124.78 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 131.507 3.923 . . . . 0.0 111.508 -163.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -119.12 152.94 35.63 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 126.416 1.887 . . . . 0.0 114.067 -172.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.4 m -57.2 123.91 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -171.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.98 -38.71 3.19 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 156.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -160.86 167.81 12.88 Favored Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -165.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.97 -29.01 25.83 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 124.013 3.142 . . . . 0.0 117.347 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -81.54 -19.8 41.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.231 1.013 . . . . 0.0 113.729 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.28 113.48 3.45 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -165.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 t -67.44 140.86 57.14 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.441 118.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -160.39 135.44 7.83 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -145.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.4 m -67.17 76.64 0.14 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.0 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.463 -1.256 . . . . 0.0 111.264 141.657 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 . . . . . 0 CA--C 1.554 1.1 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.0 t -77.93 -102.21 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.257 -0.902 . . . . 0.0 113.034 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.44 127.91 34.69 Favored 'General case' 0 CA--C 1.553 1.091 0 O-C-N 121.034 -1.041 . . . . 0.0 113.459 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.261 37.2 m-85 77.7 47.7 0.05 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 126.931 2.092 . . . . 0.0 115.429 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.62 120.35 6.85 Favored Glycine 0 CA--C 1.545 1.917 0 C-N-CA 125.884 1.707 . . . . 0.0 115.832 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -68.21 103.46 1.58 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.844 1.322 . . . . 0.0 114.312 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -104.04 57.72 0.72 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.944 1.298 . . . . 0.0 110.826 167.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.14 162.81 36.6 Favored Glycine 0 CA--C 1.544 1.881 0 O-C-N 120.467 -1.396 . . . . 0.0 116.472 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.15 -76.21 0.19 Allowed Glycine 0 CA--C 1.544 1.906 0 N-CA-C 119.043 2.377 . . . . 0.0 119.043 -157.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.5 108.25 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 O-C-N 120.981 -1.305 . . . . 0.0 112.075 -164.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.08 -26.97 11.4 Favored Glycine 0 CA--C 1.546 2.025 0 C-N-CA 125.805 1.669 . . . . 0.0 116.446 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -109.73 65.19 0.61 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 -148.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.3 p -70.06 49.39 0.1 Allowed 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.369 -1.457 . . . . 0.0 112.339 162.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.01 156.42 22.15 Favored Glycine 0 CA--C 1.547 2.05 0 N-CA-C 116.33 1.292 . . . . 0.0 116.33 -158.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -82.52 116.93 2.66 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.361 2.708 . . . . 0.0 110.811 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.3 p -71.19 65.66 0.4 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 120.451 -1.406 . . . . 0.0 113.227 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -73.63 61.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 125.248 1.419 . . . . 0.0 112.015 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.2 t -95.06 153.76 17.49 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 127.012 2.125 . . . . 0.0 114.297 -173.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.03 100.37 13.2 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.305 1.042 . . . . 0.0 113.01 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.9 p -49.99 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.954 1.702 . . . . 0.0 114.112 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.83 -48.87 0.32 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.957 1.265 . . . . 0.0 110.235 -159.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.8 p -84.98 158.12 20.59 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 120.873 0.368 . . . . 0.0 111.349 138.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.2 p -101.4 -84.83 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -150.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.5 m 126.03 62.08 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 131.574 3.949 . . . . 0.0 111.049 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -126.91 137.59 53.17 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.3 t -50.52 115.59 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 127.076 2.151 . . . . 0.0 115.101 -170.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.0 mt -101.6 -42.16 6.33 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.907 0.883 . . . . 0.0 113.006 163.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -158.1 166.14 17.16 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 126.905 2.082 . . . . 0.0 110.315 -163.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.93 25.65 0.18 Allowed 'Trans proline' 0 CA--C 1.557 1.65 0 C-N-CA 122.768 2.312 . . . . 0.0 115.005 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -122.29 -66.87 1.0 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.795 2.038 . . . . 0.0 109.902 171.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.43 109.59 22.31 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.549 2.34 . . . . 0.0 113.42 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -76.56 102.35 6.05 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 136.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -97.85 137.91 36.0 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.969 1.708 . . . . 0.0 113.327 -156.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.7 m -64.95 75.84 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.742 -1.224 . . . . 0.0 112.842 166.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.246 0.897 0 C-N-CA 125.41 1.484 . . . . 0.0 111.304 157.878 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 . . . . . 0 CA--C 1.551 0.989 0 N-CA-C 110.819 -0.067 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 t -74.11 178.51 4.99 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -57.68 139.54 53.5 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.035 1.334 . . . . 0.0 114.219 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 73.64 26.65 1.88 Allowed 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 127.6 2.36 . . . . 0.0 115.451 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.43 136.03 12.59 Favored Glycine 0 CA--C 1.549 2.216 0 O-C-N 119.45 -2.031 . . . . 0.0 116.228 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -58.58 126.74 28.88 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 119.747 -2.031 . . . . 0.0 113.732 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.54 45.32 2.06 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 127.317 2.247 . . . . 0.0 110.991 165.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.99 164.32 27.91 Favored Glycine 0 CA--C 1.541 1.694 0 O-C-N 120.615 -1.303 . . . . 0.0 115.06 -169.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.37 -45.4 9.92 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 119.101 2.4 . . . . 0.0 119.101 -149.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.9 mt -53.36 118.48 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 O-C-N 120.693 -1.475 . . . . 0.0 112.919 -170.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.08 33.89 76.68 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 124.645 1.117 . . . . 0.0 115.509 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.1 -179.74 5.96 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -166.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -165.55 -57.21 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.192 2.197 . . . . 0.0 110.59 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 55.15 87.84 0.01 OUTLIER Glycine 0 CA--C 1.548 2.154 0 N-CA-C 118.701 2.241 . . . . 0.0 118.701 155.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -66.92 71.16 0.5 Allowed 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.449 2.766 . . . . 0.0 111.391 166.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -90.08 61.49 5.22 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.672 1.989 . . . . 0.0 113.771 -160.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.26 79.57 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 O-C-N 121.145 -0.972 . . . . 0.0 110.96 171.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.1 t -50.19 153.48 1.44 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.283 2.233 . . . . 0.0 113.907 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.13 74.21 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 O-C-N 120.709 -1.244 . . . . 0.0 113.275 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.9 t -33.45 98.79 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 127.721 2.408 . . . . 0.0 114.804 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.27 -53.97 0.58 Allowed Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.555 1.55 . . . . 0.0 109.396 -156.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.5 p -82.93 166.93 18.47 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.246 0.618 . . . . 0.0 110.78 143.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -117.95 -92.21 0.53 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.161 2.652 . . . . 0.0 118.161 -152.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.3 m 131.14 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 1 C-N-CA 131.797 4.039 . . . . 0.0 113.429 -166.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -134.22 157.72 45.54 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.7 t -54.45 112.52 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -164.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.6 mt -85.85 -55.68 3.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.456 1.102 . . . . 0.0 112.629 153.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -167.55 176.49 1.64 Allowed Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 125.588 1.555 . . . . 0.0 112.185 -159.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.9 -41.81 38.75 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.202 3.268 . . . . 0.0 115.983 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -67.21 -45.06 77.98 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.319 -0.863 . . . . 0.0 113.07 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.58 95.73 4.2 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -151.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -77.28 102.06 6.54 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 144.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -105.21 142.06 35.64 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.114 1.765 . . . . 0.0 113.949 -159.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.4 t -56.31 71.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 127.926 2.49 . . . . 0.0 112.321 167.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 mt . . . . . 0 C--O 1.248 1.0 0 C-N-CA 129.789 3.236 . . . . 0.0 112.838 174.644 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? . . . . . 0 CA--C 1.554 1.121 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.7 t -112.27 -102.42 0.41 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.546 1.138 . . . . 0.0 112.823 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -68.63 122.17 17.96 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.937 1.295 . . . . 0.0 112.874 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 86.4 61.82 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 128.021 2.529 . . . . 0.0 115.588 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.14 139.49 13.83 Favored Glycine 0 CA--C 1.549 2.184 0 C-N-CA 125.863 1.697 . . . . 0.0 114.48 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -82.39 116.29 21.8 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 118.998 1.399 . . . . 0.0 114.081 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.66 55.59 0.91 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.054 1.742 . . . . 0.0 111.001 171.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.21 163.74 35.1 Favored Glycine 0 CA--C 1.54 1.652 0 O-C-N 120.671 -1.268 . . . . 0.0 114.435 -173.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.99 -64.15 4.31 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 118.697 2.239 . . . . 0.0 118.697 -160.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.3 mt -60.07 116.1 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 O-C-N 120.738 -1.448 . . . . 0.0 112.775 -164.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.01 -12.43 69.54 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 126.153 1.835 . . . . 0.0 116.557 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -111.91 75.21 0.91 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -153.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.2 p -74.42 26.62 0.08 Allowed 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.427 -1.421 . . . . 0.0 113.605 154.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.93 160.35 17.87 Favored Glycine 0 CA--C 1.545 1.939 0 C-N-CA 124.89 1.233 . . . . 0.0 116.008 -165.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.63 124.55 4.08 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 123.292 2.662 . . . . 0.0 111.472 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.7 p -73.84 62.99 0.87 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.964 1.306 . . . . 0.0 113.717 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 t -74.42 53.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 O-C-N 120.184 -1.573 . . . . 0.0 113.477 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.9 t -100.26 159.52 15.05 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 128.161 2.585 . . . . 0.0 114.455 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.35 104.65 16.56 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.616 1.966 . . . . 0.0 113.655 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.0 t -47.15 117.34 1.69 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.181 1.393 . . . . 0.0 112.728 169.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.83 -52.17 0.72 Allowed Glycine 0 CA--C 1.538 1.497 0 C-N-CA 126.144 1.83 . . . . 0.0 109.211 -160.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.9 p -74.42 162.03 29.24 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.198 -0.501 . . . . 0.0 111.11 140.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.0 p -98.57 -90.17 0.29 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -166.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.1 m 125.84 57.26 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 131.628 3.971 . . . . 0.0 110.805 -162.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -118.93 142.23 47.95 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.701 1.601 . . . . 0.0 115.013 -164.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.1 t -51.16 102.04 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 126.449 1.9 . . . . 0.0 114.319 -170.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.3 mt -107.41 -50.12 3.13 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.759 1.224 . . . . 0.0 114.04 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -153.37 166.84 14.71 Favored Pre-proline 0 CA--C 1.557 1.225 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -163.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.51 -35.27 65.84 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.285 2.657 . . . . 0.0 114.982 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -72.17 -54.32 10.04 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.093 1.357 . . . . 0.0 112.513 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.19 120.13 34.32 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.557 1.543 . . . . 0.0 114.354 -166.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -71.97 119.53 16.28 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 126.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -126.43 143.41 51.19 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.115 -0.99 . . . . 0.0 113.393 -151.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.8 m -67.68 81.56 0.18 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.266 -0.896 . . . . 0.0 112.523 171.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 C--O 1.255 1.364 0 CA-C-O 117.286 -1.34 . . . . 0.0 109.645 146.489 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.9 t -64.37 168.44 5.7 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -48.52 131.4 17.31 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.904 0.882 . . . . 0.0 112.165 167.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 69.72 74.07 0.23 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.405 1.482 . . . . 0.0 113.338 -173.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.89 145.02 12.7 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 125.128 1.347 . . . . 0.0 114.187 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -70.83 131.63 44.08 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.708 -1.466 . . . . 0.0 114.891 -173.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.17 57.32 1.79 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.263 1.825 . . . . 0.0 110.687 170.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.24 168.59 41.16 Favored Glycine 0 CA--C 1.545 1.963 0 O-C-N 120.47 -1.394 . . . . 0.0 115.502 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.62 -76.1 0.14 Allowed Glycine 0 CA--C 1.545 1.934 0 C-N-CA 127.468 2.461 . . . . 0.0 119.201 -162.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.5 mt -61.24 96.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.055 -1.262 . . . . 0.0 112.564 -164.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.6 13.93 31.2 Favored Glycine 0 CA--C 1.544 1.895 0 C-N-CA 126.279 1.895 . . . . 0.0 116.409 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.05 164.87 28.87 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 120.022 1.911 . . . . 0.0 116.147 -173.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 t -127.08 -65.13 0.96 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.084 2.154 . . . . 0.0 110.406 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.92 75.9 0.07 OUTLIER Glycine 0 CA--C 1.545 1.968 0 N-CA-C 119.407 2.523 . . . . 0.0 119.407 151.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.81 52.55 0.54 Allowed 'Trans proline' 0 CA--C 1.554 1.481 0 C-N-CA 123.514 2.809 . . . . 0.0 112.114 157.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.4 p -73.24 29.75 0.07 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 -162.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.5 t -75.5 66.78 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 O-C-N 119.967 -1.708 . . . . 0.0 111.72 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 52.5 t -59.57 158.88 9.16 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.844 2.057 . . . . 0.0 113.95 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.74 61.77 0.17 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.521 1.529 . . . . 0.0 114.596 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -6.06 75.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 130.12 3.368 . . . . 0.0 116.52 176.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.46 -51.71 0.48 Allowed Glycine 0 CA--C 1.535 1.327 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -158.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.6 p -80.5 160.09 25.34 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.473 0.309 . . . . 0.0 110.393 140.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.1 p -116.21 -84.83 0.63 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -156.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.8 m 127.33 61.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 131.571 3.948 . . . . 0.0 112.102 -167.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -123.54 146.52 48.05 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 125.848 1.659 . . . . 0.0 115.253 -166.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.93 113.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.546 1.939 . . . . 0.0 114.932 -169.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.7 mt -116.45 -46.59 2.77 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -152.63 165.02 18.46 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 120.856 -1.153 . . . . 0.0 113.28 -161.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.79 43.02 0.75 Allowed 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 123.251 2.634 . . . . 0.0 114.204 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -143.41 -54.66 0.38 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.773 2.429 . . . . 0.0 108.552 172.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.26 124.05 48.1 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 128.02 2.528 . . . . 0.0 113.838 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -68.09 134.79 51.18 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.69 120.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -136.82 132.55 34.8 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.977 -1.077 . . . . 0.0 111.618 -144.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.3 t -66.6 67.17 0.06 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.055 1.742 . . . . 0.0 112.293 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--O 1.247 0.974 0 C-N-CA 126.733 2.013 . . . . 0.0 112.242 167.441 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.5 t -106.31 -162.71 0.87 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.211 1.804 . . . . 0.0 112.037 166.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -52.05 143.49 13.86 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 57.68 8.87 0.73 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 126.712 2.005 . . . . 0.0 116.051 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.8 150.35 35.65 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.248 -1.533 . . . . 0.0 115.933 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -89.28 114.07 25.4 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.273 1.429 . . . . 0.0 113.285 -171.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.35 62.61 0.77 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.965 1.306 . . . . 0.0 112.927 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.88 -128.69 5.93 Favored Glycine 0 CA--C 1.547 2.048 0 N-CA-C 116.444 1.338 . . . . 0.0 116.444 168.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.5 -150.37 26.27 Favored Glycine 0 CA--C 1.549 2.17 0 O-C-N 120.926 -1.338 . . . . 0.0 115.654 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.0 mt -53.79 110.77 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 O-C-N 120.756 -1.438 . . . . 0.0 113.115 175.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.74 -37.54 3.17 Favored Glycine 0 CA--C 1.546 2.018 0 N-CA-C 117.005 1.562 . . . . 0.0 117.005 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.68 81.83 1.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -158.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.7 p -72.75 5.22 3.31 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 166.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 142.85 35.25 Favored Glycine 0 CA--C 1.552 2.356 0 O-C-N 120.375 -1.453 . . . . 0.0 115.286 -173.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -80.31 66.22 8.83 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.664 2.91 . . . . 0.0 112.574 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.9 p -84.36 48.12 1.45 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 119.797 -1.814 . . . . 0.0 115.311 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -51.94 108.45 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 O-C-N 121.063 -1.023 . . . . 0.0 110.515 162.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.72 -178.69 4.77 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -160.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.69 71.27 0.08 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.68 1.592 . . . . 0.0 112.846 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -37.39 107.21 0.06 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.62 1.968 . . . . 0.0 114.483 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.31 -54.94 0.74 Allowed Glycine 0 CA--C 1.536 1.347 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -158.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.6 p -72.37 170.24 14.62 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.485 0.314 . . . . 0.0 111.484 142.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.3 p -119.74 -113.34 0.33 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -168.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 m 154.13 60.4 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 129.887 3.275 . . . . 0.0 110.474 -166.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -129.69 147.01 51.43 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 126.756 2.023 . . . . 0.0 115.742 -166.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.7 m -51.48 131.8 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -168.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.22 -76.1 0.17 Allowed 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 155.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -81.48 153.24 70.96 Favored Pre-proline 0 CA--C 1.561 1.396 0 O-C-N 120.191 -1.568 . . . . 0.0 112.886 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -58.81 -11.59 12.41 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.458 2.772 . . . . 0.0 116.033 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -91.55 -10.86 39.08 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.993 1.317 . . . . 0.0 113.881 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.96 113.62 5.02 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -166.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -74.21 95.75 2.66 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 137.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -101.21 145.95 28.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.774 1.63 . . . . 0.0 113.816 -154.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.7 m -65.57 75.25 0.07 Allowed 'General case' 0 CA--C 1.551 0.992 0 O-C-N 120.767 -1.208 . . . . 0.0 114.084 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.571 -1.204 . . . . 0.0 112.464 165.45 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 . . . . . 0 CA--C 1.556 1.182 0 CA-C-O 121.519 0.676 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -79.71 -117.1 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.337 1.455 . . . . 0.0 113.009 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -63.66 123.18 18.18 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 121.175 -0.953 . . . . 0.0 112.463 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 79.19 39.75 0.11 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 127.806 2.443 . . . . 0.0 115.11 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.28 122.41 7.56 Favored Glycine 0 CA--C 1.551 2.341 0 N-CA-C 116.607 1.403 . . . . 0.0 116.607 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -66.98 112.12 4.17 Favored 'General case' 0 CA--C 1.556 1.21 0 O-C-N 119.872 -1.957 . . . . 0.0 115.773 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -109.77 50.16 0.81 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.849 1.66 . . . . 0.0 111.588 164.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.37 158.55 29.04 Favored Glycine 0 CA--C 1.54 1.617 0 O-C-N 120.202 -1.561 . . . . 0.0 116.353 -171.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.88 -68.14 1.52 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 119.024 2.369 . . . . 0.0 119.024 -161.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.8 mt -60.68 101.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 120.988 -1.301 . . . . 0.0 112.401 -165.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.19 -28.28 10.58 Favored Glycine 0 CA--C 1.546 1.992 0 C-N-CA 126.242 1.877 . . . . 0.0 115.7 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -106.07 62.27 0.66 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -150.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.2 p -68.69 58.77 0.09 Allowed 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.235 -1.541 . . . . 0.0 111.64 159.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.52 161.56 27.98 Favored Glycine 0 CA--C 1.547 2.042 0 N-CA-C 116.214 1.245 . . . . 0.0 116.214 -158.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -83.88 130.15 4.91 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.092 3.195 . . . . 0.0 112.225 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.5 p -79.56 69.34 5.83 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.302 -1.499 . . . . 0.0 112.31 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.3 t -77.19 57.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.983 1.313 . . . . 0.0 112.525 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.1 t -105.53 149.5 26.18 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.829 2.052 . . . . 0.0 115.121 -158.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.07 62.87 6.82 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -171.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -19.76 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.567 2.347 . . . . 0.0 115.397 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.88 -54.38 0.55 Allowed Glycine 0 CA--C 1.54 1.637 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -151.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.7 p -70.79 154.3 41.97 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 122.807 -0.231 . . . . 0.0 111.319 137.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.7 p -101.08 -117.75 0.17 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -162.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.3 m 162.51 51.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 131.058 3.743 . . . . 0.0 111.102 -172.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -121.47 149.88 42.4 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 119.99 -1.694 . . . . 0.0 115.314 -167.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 m -57.4 137.62 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -171.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -152.73 -59.84 0.15 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.859 1.264 . . . . 0.0 113.675 161.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -92.3 150.66 40.53 Favored Pre-proline 0 CA--C 1.561 1.371 0 O-C-N 120.554 -1.341 . . . . 0.0 112.777 168.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.88 -26.32 57.26 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.702 2.935 . . . . 0.0 115.101 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -45.04 70.53 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.217 -0.927 . . . . 0.0 112.989 175.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.21 113.47 19.51 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.413 1.885 . . . . 0.0 114.106 -167.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.7 t -70.36 113.85 7.92 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 136.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -127.2 137.03 52.83 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -147.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -59.82 79.9 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.415 1.086 . . . . 0.0 112.749 167.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.105 146.903 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -85.74 175.68 8.57 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -49.85 135.76 19.12 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.681 1.193 . . . . 0.0 112.658 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 69.15 -2.28 1.86 Allowed 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -169.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.73 144.88 49.7 Favored Glycine 0 CA--C 1.549 2.178 0 O-C-N 119.906 -1.746 . . . . 0.0 115.185 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.77 136.51 36.76 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -167.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.67 35.54 4.82 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 126.316 1.846 . . . . 0.0 113.241 161.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.26 168.96 21.32 Favored Glycine 0 CA--C 1.54 1.632 0 O-C-N 120.472 -1.392 . . . . 0.0 114.712 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.97 -45.41 83.39 Favored Glycine 0 CA--C 1.544 1.896 0 N-CA-C 117.855 1.902 . . . . 0.0 117.855 -158.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.7 mm -56.92 109.22 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 O-C-N 121.175 -1.191 . . . . 0.0 113.113 -170.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.46 39.11 96.61 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 125.758 1.647 . . . . 0.0 115.418 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.1 178.98 6.78 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 -168.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 91.3 p -136.73 -84.92 0.34 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.805 1.642 . . . . 0.0 111.046 172.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.5 53.04 0.05 OUTLIER Glycine 0 CA--C 1.545 1.95 0 N-CA-C 117.979 1.952 . . . . 0.0 117.979 169.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.1 46.57 1.14 Allowed 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 123.39 2.727 . . . . 0.0 112.674 169.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.3 p -70.94 23.38 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -164.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 t -77.34 63.28 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 O-C-N 119.798 -1.814 . . . . 0.0 112.181 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.1 t -55.43 154.93 5.73 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.564 1.545 . . . . 0.0 114.682 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.17 73.35 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 O-C-N 120.608 -1.308 . . . . 0.0 112.621 165.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.1 t -38.3 109.16 0.09 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.344 1.858 . . . . 0.0 114.687 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.82 -53.24 0.71 Allowed Glycine 0 CA--C 1.537 1.469 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -156.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.3 p -82.05 163.4 22.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.299 0.64 . . . . 0.0 110.736 146.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.8 p -113.44 -120.17 0.3 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -161.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.4 t 171.42 51.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 127.79 2.436 . . . . 0.0 111.315 -169.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -129.54 146.67 51.33 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.676 1.59 . . . . 0.0 115.197 -154.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 m -51.12 127.84 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.3 0.0 OUTLIER -148.76 -99.56 0.08 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 125.112 1.365 . . . . 0.0 113.64 158.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -53.64 146.38 25.85 Favored Pre-proline 0 CA--C 1.565 1.535 0 O-C-N 119.553 -1.967 . . . . 0.0 113.994 169.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -58.23 -28.68 85.14 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.808 3.005 . . . . 0.0 115.045 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -66.22 -33.26 75.34 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 121.035 -1.04 . . . . 0.0 113.77 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.58 115.9 9.97 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.621 1.568 . . . . 0.0 114.917 -166.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -66.43 121.24 14.86 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.842 -1.161 . . . . 0.0 108.525 136.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -129.97 142.8 50.59 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -149.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.7 t -69.19 66.51 0.16 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.832 2.053 . . . . 0.0 112.744 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.9 2.08 . . . . 0.0 112.846 170.872 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -89.53 -166.86 1.7 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 125.072 1.349 . . . . 0.0 114.504 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -59.44 149.96 27.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.282 1.433 . . . . 0.0 114.829 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 61.36 5.12 1.07 Allowed 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.17 130.97 51.79 Favored Glycine 0 CA--C 1.546 1.987 0 O-C-N 119.494 -2.004 . . . . 0.0 115.019 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -66.63 125.7 26.62 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 120.693 -1.475 . . . . 0.0 111.965 175.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -119.32 40.58 3.31 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 125.424 1.489 . . . . 0.0 110.971 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.03 158.77 27.84 Favored Glycine 0 CA--C 1.544 1.904 0 C-N-CA 125.181 1.372 . . . . 0.0 115.195 -170.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.67 -58.77 11.92 Favored Glycine 0 CA--C 1.549 2.187 0 N-CA-C 120.324 2.89 . . . . 0.0 120.324 -158.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.9 mt -57.08 107.34 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 O-C-N 120.643 -1.504 . . . . 0.0 113.22 -165.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.04 19.47 62.87 Favored Glycine 0 CA--C 1.544 1.866 0 C-N-CA 126.254 1.883 . . . . 0.0 115.786 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -140.92 117.02 10.55 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.6 p -120.26 42.85 2.86 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.165 1.386 . . . . 0.0 112.466 163.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.52 122.84 7.17 Favored Glycine 0 CA--C 1.547 2.084 0 C-N-CA 125.083 1.325 . . . . 0.0 114.745 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.46 63.11 7.16 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.588 2.859 . . . . 0.0 111.823 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.8 p -77.56 66.3 3.25 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.273 -1.517 . . . . 0.0 114.28 -176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.26 89.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.905 0.882 . . . . 0.0 109.365 155.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.28 177.44 7.26 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -166.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.43 68.92 0.14 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.878 1.271 . . . . 0.0 113.782 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.2 t -28.75 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 127.156 2.182 . . . . 0.0 114.535 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.63 -54.45 0.62 Allowed Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.283 1.42 . . . . 0.0 109.638 -155.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -77.24 176.3 8.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.287 0.635 . . . . 0.0 111.16 142.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 p -127.92 -124.06 0.23 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.367 1.467 . . . . 0.0 114.582 -167.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 m 167.85 55.08 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 128.867 2.867 . . . . 0.0 111.383 -168.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . 0.266 2.8 pp0? -139.25 169.2 18.2 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -168.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.79 139.88 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -148.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.32 -67.97 0.12 Allowed 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 160.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -88.98 147.64 39.24 Favored Pre-proline 0 CA--C 1.555 1.139 0 O-C-N 120.395 -1.44 . . . . 0.0 112.705 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -54.82 -28.63 58.96 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.531 2.821 . . . . 0.0 115.026 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.85 -44.7 72.85 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 121.077 -1.015 . . . . 0.0 112.698 174.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.21 109.7 15.28 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.042 1.737 . . . . 0.0 115.27 -167.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -64.37 103.59 0.66 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 134.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -111.05 148.8 31.81 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.672 1.589 . . . . 0.0 114.192 -155.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.0 m -68.21 70.58 0.16 Allowed 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.254 1.294 0 CA-C-O 117.65 -1.167 . . . . 0.0 111.304 157.875 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.4 t -86.85 -117.47 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.875 0.87 . . . . 0.0 111.347 167.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -47.83 159.99 0.15 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 172.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 73.38 58.43 0.1 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.303 1.841 . . . . 0.0 115.392 162.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.24 135.86 7.74 Favored Glycine 0 CA--C 1.545 1.958 0 C-N-CA 126.168 1.842 . . . . 0.0 112.653 171.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -76.21 128.85 35.75 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.009 -1.289 . . . . 0.0 113.933 -173.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -111.78 57.66 0.64 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 126.59 1.956 . . . . 0.0 110.892 170.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.12 156.39 27.47 Favored Glycine 0 CA--C 1.544 1.85 0 O-C-N 120.889 -1.132 . . . . 0.0 115.333 -169.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.96 -48.75 5.94 Favored Glycine 0 CA--C 1.546 2.024 0 N-CA-C 118.147 2.019 . . . . 0.0 118.147 -159.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.66 122.97 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.595 -1.533 . . . . 0.0 112.828 -171.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.41 34.96 91.32 Favored Glycine 0 CA--C 1.544 1.855 0 C-N-CA 124.85 1.214 . . . . 0.0 115.089 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.38 -172.6 3.99 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -166.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.1 p -160.52 -87.75 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.659 1.984 . . . . 0.0 110.416 168.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.76 36.66 1.6 Allowed Glycine 0 CA--C 1.552 2.386 0 N-CA-C 119.773 2.669 . . . . 0.0 119.773 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -62.9 37.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.637 0 CA-C-N 122.145 2.972 . . . . 0.0 116.809 165.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.5 p -75.43 57.93 0.96 Allowed 'General case' 0 N--CA 1.481 1.083 0 O-C-N 119.432 -2.043 . . . . 0.0 113.575 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.0 t -73.51 28.8 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.44 0 O-C-N 119.922 -1.736 . . . . 0.0 114.347 -176.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.2 t -95.75 157.68 15.79 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 129.303 3.041 . . . . 0.0 113.549 -173.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.43 108.06 19.38 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.254 1.422 . . . . 0.0 112.766 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -56.11 150.67 13.53 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.31 -47.69 1.02 Allowed Glycine 0 CA--C 1.541 1.703 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -145.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.1 p -77.16 171.21 15.19 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.945 0.898 . . . . 0.0 111.991 147.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 p -107.99 -146.32 0.4 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.886 1.674 . . . . 0.0 114.08 -168.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 m -162.24 68.61 0.26 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 127.459 2.304 . . . . 0.0 109.787 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -124.29 148.58 47.31 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 126.138 1.775 . . . . 0.0 115.668 -158.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.1 m -57.83 118.98 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -168.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.38 -48.88 3.71 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.109 1.363 . . . . 0.0 113.091 162.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -150.82 168.65 10.6 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 127.831 2.452 . . . . 0.0 110.748 -170.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -55.5 -15.77 12.71 Favored 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.095 2.53 . . . . 0.0 117.741 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.76 -45.36 9.35 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.934 1.243 . . . . 0.0 111.942 173.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.77 94.32 5.01 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.474 1.91 . . . . 0.0 112.84 -157.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 t -89.31 99.28 12.31 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 151.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.87 156.36 38.01 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.875 2.07 . . . . 0.0 113.872 -154.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.5 m -64.91 82.66 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 127.192 2.197 . . . . 0.0 112.967 157.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 . . . . . 0 CA--C 1.554 1.1 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 m -85.18 -89.28 0.11 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.255 1.022 . . . . 0.0 112.241 -161.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -73.57 92.24 1.9 Allowed 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.456 -0.778 . . . . 0.0 109.623 168.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.254 13.6 m-85 98.93 106.46 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 130.22 3.408 . . . . 0.0 112.442 -174.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.83 109.32 0.39 Allowed Glycine 0 CA--C 1.541 1.671 0 C-N-CA 127.184 2.326 . . . . 0.0 111.625 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -72.62 119.39 16.78 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.748 1.219 . . . . 0.0 112.895 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 p -137.29 56.93 1.76 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.948 1.699 . . . . 0.0 111.189 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.5 34.81 1.47 Allowed Glycine 0 CA--C 1.545 1.915 0 N-CA-C 117.607 1.803 . . . . 0.0 117.607 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.23 -70.66 1.55 Allowed Glycine 0 CA--C 1.545 1.911 0 N-CA-C 117.046 1.578 . . . . 0.0 117.046 165.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.9 mt -54.4 112.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 119.015 1.408 . . . . 0.0 113.841 -168.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.18 -11.55 48.86 Favored Glycine 0 CA--C 1.548 2.145 0 C-N-CA 125.651 1.596 . . . . 0.0 115.332 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -110.85 62.62 0.61 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -155.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 t -70.11 64.09 0.23 Allowed 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.701 -1.25 . . . . 0.0 111.039 156.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.74 176.14 20.12 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 -164.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.16 143.48 25.58 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.615 3.543 . . . . 0.0 112.45 -174.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.8 p -123.94 41.33 3.51 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.992 1.317 . . . . 0.0 113.265 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 t -79.35 51.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 O-C-N 120.323 -1.485 . . . . 0.0 112.335 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.6 t -82.4 164.02 21.29 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 128.73 2.812 . . . . 0.0 113.122 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.58 93.71 4.09 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 t -36.84 111.04 0.13 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.838 1.655 . . . . 0.0 114.218 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.74 -50.3 0.89 Allowed Glycine 0 CA--C 1.541 1.704 0 C-N-CA 125.844 1.688 . . . . 0.0 109.536 -158.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.6 p -82.62 152.87 25.72 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.661 1.185 . . . . 0.0 110.695 143.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.1 p -101.44 -107.25 0.24 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -159.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t 146.09 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 131.547 3.939 . . . . 0.0 110.206 -170.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -118.31 127.12 53.4 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 127.536 2.334 . . . . 0.0 114.214 -157.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.9 t -65.17 86.86 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 C-N-CA 125.431 1.492 . . . . 0.0 114.586 -170.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.69 -44.73 8.4 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -152.91 160.21 31.3 Favored Pre-proline 0 CA--C 1.557 1.246 0 O-C-N 121.029 -1.044 . . . . 0.0 113.497 -164.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.67 53.64 3.25 Favored 'Trans proline' 0 CA--C 1.554 1.48 0 C-N-CA 124.268 3.312 . . . . 0.0 113.58 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -159.75 -53.76 0.06 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 129.534 3.133 . . . . 0.0 109.084 176.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.91 119.16 36.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.028 2.131 . . . . 0.0 113.175 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 t -66.55 123.41 19.98 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 120.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -113.67 129.22 56.6 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.94 1.696 . . . . 0.0 111.38 -160.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.0 m -64.43 83.88 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.357 -0.84 . . . . 0.0 111.909 165.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 C--O 1.256 1.432 0 CA-C-O 116.694 -1.622 . . . . 0.0 109.678 153.385 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 . . . . . 0 CA--C 1.553 1.075 0 CA-C-O 120.944 0.402 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 m -82.79 -131.65 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.499 1.52 . . . . 0.0 113.243 -166.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -47.7 121.32 3.96 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.998 1.319 . . . . 0.0 113.682 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 72.48 50.02 0.19 Allowed 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 127.377 2.271 . . . . 0.0 114.336 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.01 133.76 10.11 Favored Glycine 0 CA--C 1.547 2.038 0 C-N-CA 126.111 1.815 . . . . 0.0 115.317 -174.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -73.66 130.39 39.91 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 120.221 2.011 . . . . 0.0 115.023 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.3 m -112.01 -47.28 3.14 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.588 1.555 . . . . 0.0 111.88 166.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 165.49 10.08 Favored Glycine 0 CA--C 1.548 2.107 0 N-CA-C 117.239 1.656 . . . . 0.0 117.239 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.57 -52.64 24.64 Favored Glycine 0 CA--C 1.548 2.113 0 N-CA-C 119.471 2.549 . . . . 0.0 119.471 -157.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.6 114.35 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 120.094 -1.827 . . . . 0.0 112.033 -166.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.67 -16.83 60.44 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 126.031 1.777 . . . . 0.0 116.391 -172.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -111.37 76.22 0.96 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -153.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 p -72.28 24.27 0.05 Allowed 'General case' 0 CA--C 1.554 1.123 0 O-C-N 120.138 -1.601 . . . . 0.0 114.297 158.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.76 157.73 22.38 Favored Glycine 0 CA--C 1.546 1.984 0 O-C-N 120.735 -1.228 . . . . 0.0 116.036 -168.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -83.68 122.47 3.1 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.336 2.69 . . . . 0.0 110.614 172.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -73.76 60.55 0.71 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.638 -1.288 . . . . 0.0 113.853 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 t -72.39 57.21 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 O-C-N 120.168 -1.583 . . . . 0.0 112.045 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.9 t -93.04 154.59 18.03 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.94 2.096 . . . . 0.0 113.726 -171.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.39 83.78 7.38 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.765 -1.209 . . . . 0.0 112.339 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.3 t -44.24 109.71 0.17 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.785 1.234 . . . . 0.0 113.213 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.26 -50.79 0.81 Allowed Glycine 0 CA--C 1.537 1.455 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -156.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.1 p -74.45 155.09 38.4 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.6 0.36 . . . . 0.0 110.892 139.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.3 p -98.59 -106.46 0.2 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -163.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 m 158.42 30.76 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 130.994 3.718 . . . . 0.0 112.584 -172.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -95.02 151.32 19.28 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.361 -2.087 . . . . 0.0 116.369 -164.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.4 t -55.89 115.2 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 126.481 1.912 . . . . 0.0 114.427 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -122.58 -49.51 2.01 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -139.65 162.1 52.93 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.856 1.263 . . . . 0.0 112.558 -167.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.97 49.99 1.7 Allowed 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 123.833 3.022 . . . . 0.0 113.471 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -154.17 -67.75 0.14 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 129.626 3.17 . . . . 0.0 107.746 172.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.87 111.24 23.69 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 127.046 2.138 . . . . 0.0 113.049 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.1 p -58.79 124.14 18.78 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.573 115.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -138.65 140.56 38.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.085 1.354 . . . . 0.0 114.444 -147.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.1 m -67.75 83.07 0.19 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.794 1.238 . . . . 0.0 112.7 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt . . . . . 0 C--O 1.254 1.312 0 CA-C-O 117.405 -1.283 . . . . 0.0 110.467 152.359 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 . . . . . 0 CA--C 1.546 0.802 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.0 t -98.38 -145.46 0.32 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.83 1.252 . . . . 0.0 110.46 164.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -47.84 144.7 3.28 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 169.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 81.34 4.19 1.45 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.146 2.178 . . . . 0.0 116.391 172.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.07 153.78 41.49 Favored Glycine 0 CA--C 1.55 2.268 0 O-C-N 120.426 -1.421 . . . . 0.0 115.285 173.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -84.2 135.78 34.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.605 1.562 . . . . 0.0 113.563 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.5 m -131.54 -6.91 3.7 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.24 111.44 0.3 Allowed Glycine 0 CA--C 1.546 1.975 0 CA-C-N 119.975 1.261 . . . . 0.0 115.237 -177.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.55 24.23 0.06 OUTLIER Glycine 0 CA--C 1.541 1.718 0 O-C-N 118.952 -2.499 . . . . 0.0 117.477 -6.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.9 mt -64.12 129.44 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 120.345 2.073 . . . . 0.0 110.683 169.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.5 -39.43 0.74 Allowed Glycine 0 CA--C 1.547 2.084 0 C-N-CA 124.589 1.09 . . . . 0.0 115.648 -174.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -64.93 178.43 0.82 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 126.858 2.063 . . . . 0.0 115.217 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.6 p -134.39 -86.0 0.41 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.916 1.287 . . . . 0.0 110.953 165.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.95 38.56 0.5 Allowed Glycine 0 CA--C 1.546 2.005 0 N-CA-C 118.103 2.001 . . . . 0.0 118.103 169.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -77.82 58.55 6.51 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 CA-C-N 121.086 2.443 . . . . 0.0 111.181 172.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -74.61 57.59 0.74 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.756 1.222 . . . . 0.0 113.923 -171.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 t -78.78 62.52 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 O-C-N 120.429 -1.419 . . . . 0.0 111.28 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.07 -177.96 4.32 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.138 2.175 . . . . 0.0 112.603 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.33 165.88 24.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.749 0.82 . . . . 0.0 112.801 166.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.4 t -106.4 171.93 7.09 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.567 1.147 . . . . 0.0 112.172 171.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.06 -53.68 1.4 Allowed Glycine 0 CA--C 1.546 1.975 0 O-C-N 120.928 -1.108 . . . . 0.0 111.821 -159.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -58.89 147.44 33.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.809 1.243 . . . . 0.0 113.502 157.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.6 p -108.44 -128.4 0.27 Allowed 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -173.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m 179.86 55.88 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 128.2 2.6 . . . . 0.0 111.73 -162.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -124.03 147.47 47.8 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 126.345 1.858 . . . . 0.0 115.215 -159.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.3 m -44.68 110.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 127.459 2.304 . . . . 0.0 116.439 -170.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.83 -49.67 2.21 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.15 1.38 . . . . 0.0 114.378 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -153.45 163.51 23.47 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 125.626 1.57 . . . . 0.0 112.325 -169.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.96 48.77 2.07 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.74 2.96 . . . . 0.0 113.94 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -155.51 -46.16 0.08 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.511 2.724 . . . . 0.0 108.826 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.43 113.46 17.54 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 127.669 2.387 . . . . 0.0 114.015 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -59.08 122.78 14.6 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.36 117.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -139.58 148.3 42.34 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.14 1.376 . . . . 0.0 113.276 -145.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 m -65.35 91.09 0.11 Allowed 'General case' 0 CA--C 1.555 1.168 0 O-C-N 120.687 -1.258 . . . . 0.0 113.574 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.129 1.372 . . . . 0.0 110.208 154.999 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 CA--C 1.55 0.952 0 N-CA-C 110.86 -0.052 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -90.59 176.79 6.55 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -173.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -49.45 140.71 10.1 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.652 1.581 . . . . 0.0 112.932 -174.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 69.48 -20.34 0.17 Allowed 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -44.94 141.31 3.97 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 116.722 1.449 . . . . 0.0 116.722 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -70.22 138.41 51.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.911 2.084 . . . . 0.0 115.182 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 p -150.26 63.71 0.96 Allowed 'General case' 0 CA--C 1.553 1.075 0 O-C-N 121.078 -1.014 . . . . 0.0 111.851 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.2 -155.23 26.26 Favored Glycine 0 CA--C 1.55 2.278 0 C-N-CA 126.163 1.839 . . . . 0.0 115.071 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.95 -144.94 5.82 Favored Glycine 0 CA--C 1.547 2.063 0 C-N-CA 126.368 1.937 . . . . 0.0 117.446 172.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -55.28 107.01 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 O-C-N 120.887 -1.36 . . . . 0.0 112.424 174.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.74 -44.16 2.57 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 116.93 1.532 . . . . 0.0 116.93 159.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -73.93 69.21 1.4 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 119.407 1.603 . . . . 0.0 114.906 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.5 m -80.06 73.89 6.85 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.017 -1.052 . . . . 0.0 109.102 151.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.78 -170.03 12.62 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 -162.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.13 83.56 0.15 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.618 2.879 . . . . 0.0 114.332 -174.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 p -62.45 15.24 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.05 62.46 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 O-C-N 120.088 -1.632 . . . . 0.0 112.385 -162.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.6 t -57.83 162.6 3.1 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 127.282 2.233 . . . . 0.0 113.968 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.22 69.86 0.09 Allowed 'General case' 0 CA--C 1.555 1.158 0 O-C-N 120.155 -1.591 . . . . 0.0 113.781 172.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.4 t -14.28 80.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 129.06 2.944 . . . . 0.0 116.29 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.16 -55.08 0.47 Allowed Glycine 0 CA--C 1.537 1.432 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -158.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.4 p -81.59 158.18 24.47 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 120.704 0.288 . . . . 0.0 110.481 145.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.4 p -122.94 -115.58 0.3 Allowed 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -154.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.9 t 179.9 74.67 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 128.904 2.881 . . . . 0.0 110.631 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.95 131.06 55.4 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 128.233 2.613 . . . . 0.0 113.797 -162.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.6 t -63.85 103.79 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 125.405 1.482 . . . . 0.0 113.836 -173.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 mt -111.77 -51.77 2.83 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -148.05 158.38 41.89 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -161.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -51.57 -18.26 5.68 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 124.009 3.139 . . . . 0.0 117.106 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -90.0 -45.49 9.15 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.916 -1.115 . . . . 0.0 113.209 168.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.3 119.64 34.61 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.047 1.339 . . . . 0.0 114.101 -170.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -68.41 132.7 47.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 117.144 -1.822 . . . . 0.0 108.933 114.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -131.67 136.45 47.7 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -149.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.3 t -68.18 64.51 0.1 Allowed 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.723 1.209 . . . . 0.0 112.279 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.251 1.153 0 C-N-CA 126.311 1.844 . . . . 0.0 111.856 167.103 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 CA--C 1.558 1.273 0 CA-C-O 120.451 0.167 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.6 t -121.88 -145.35 0.35 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.345 1.458 . . . . 0.0 111.725 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -50.38 134.37 23.37 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.878 1.271 . . . . 0.0 113.896 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 57.99 25.1 11.84 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 126.612 1.965 . . . . 0.0 115.987 -171.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.36 134.29 20.94 Favored Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.306 1.282 . . . . 0.0 116.306 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -72.95 130.97 41.56 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.271 1.428 . . . . 0.0 113.48 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.78 66.84 1.41 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 127.96 2.504 . . . . 0.0 109.234 160.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.96 170.93 33.22 Favored Glycine 0 CA--C 1.543 1.801 0 C-N-CA 126.479 1.99 . . . . 0.0 113.427 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.75 -54.58 27.4 Favored Glycine 0 CA--C 1.545 1.965 0 N-CA-C 119.325 2.49 . . . . 0.0 119.325 -159.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 mt -53.97 114.58 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 O-C-N 121.229 -1.159 . . . . 0.0 113.784 -165.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.76 36.02 70.33 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 125.84 1.686 . . . . 0.0 115.698 -176.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.07 175.12 9.89 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -160.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 m -158.04 -44.73 0.06 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.337 2.255 . . . . 0.0 111.866 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.18 68.31 1.21 Allowed Glycine 0 CA--C 1.547 2.056 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 164.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -61.37 66.64 0.1 OUTLIER 'Trans proline' 0 CA--C 1.551 1.325 0 C-N-CA 123.432 2.755 . . . . 0.0 111.977 152.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 p -141.57 49.99 1.59 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -157.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.97 91.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 O-C-N 121.174 -0.954 . . . . 0.0 109.307 155.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 171.18 5.46 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -166.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.69 78.95 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.9 t -36.21 123.37 0.75 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.407 1.883 . . . . 0.0 114.588 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.2 -45.73 1.25 Allowed Glycine 0 CA--C 1.543 1.801 0 C-N-CA 124.727 1.156 . . . . 0.0 110.585 -149.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.5 p -103.83 148.87 25.62 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.163 2.185 . . . . 0.0 111.771 161.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.4 p -134.75 113.27 11.48 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.413 1.485 . . . . 0.0 114.653 -158.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.0 t -63.58 88.44 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 126.041 1.736 . . . . 0.0 114.622 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -122.59 146.14 47.7 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.76 114.85 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.8 mt -125.04 -58.81 1.45 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.484 1.514 . . . . 0.0 114.97 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -135.94 162.03 59.15 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 124.222 1.009 . . . . 0.0 112.928 -155.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.66 32.95 0.29 Allowed 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.198 2.598 . . . . 0.0 114.963 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -133.74 -48.59 0.81 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.039 2.136 . . . . 0.0 110.649 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.05 135.31 51.61 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 127.746 2.418 . . . . 0.0 114.742 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.4 t -72.43 124.34 24.96 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.483 127.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -122.1 130.19 53.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.787 1.635 . . . . 0.0 112.641 -151.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.8 m -66.24 92.04 0.18 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 C--O 1.246 0.909 0 C-N-CA 124.11 0.964 . . . . 0.0 111.471 165.298 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? . . . . . 0 CA--C 1.556 1.209 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.1 t -116.5 -91.44 0.54 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 119.318 0.963 . . . . 0.0 113.173 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -72.14 120.28 17.52 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.545 1.538 . . . . 0.0 112.837 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 90.56 50.44 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 127.548 2.339 . . . . 0.0 116.406 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.06 132.49 10.71 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 125.732 1.634 . . . . 0.0 114.715 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -68.73 132.51 46.95 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 119.101 1.45 . . . . 0.0 113.658 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.9 m -123.43 0.76 8.91 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.68 1.992 . . . . 0.0 115.097 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.62 -146.19 6.71 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.611 1.577 . . . . 0.0 111.719 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.56 -164.52 20.45 Favored Glycine 0 CA--C 1.545 1.945 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -54.18 134.4 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 O-C-N 121.155 -1.203 . . . . 0.0 114.141 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.64 -42.73 3.13 Favored Glycine 0 CA--C 1.543 1.823 0 C-N-CA 124.927 1.251 . . . . 0.0 115.033 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -67.18 171.48 5.68 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 126.167 1.787 . . . . 0.0 114.681 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.0 p -59.47 156.45 13.09 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 130.856 3.662 . . . . 0.0 116.664 6.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.5 -163.67 26.71 Favored Glycine 0 CA--C 1.549 2.159 0 O-C-N 121.351 -0.843 . . . . 0.0 114.968 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.46 82.32 2.11 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 123.69 2.927 . . . . 0.0 113.977 -168.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.8 p -67.73 56.98 0.06 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 126.242 1.817 . . . . 0.0 114.259 172.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.92 52.38 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 O-C-N 119.88 -1.763 . . . . 0.0 112.132 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.75 157.31 17.04 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 128.105 2.562 . . . . 0.0 113.936 -170.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -101.19 127.22 47.86 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.207 1.803 . . . . 0.0 112.299 172.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.0 t -65.44 122.11 16.41 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 171.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.21 -66.99 0.29 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.488 1.994 . . . . 0.0 109.139 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.4 p -60.53 151.58 28.19 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.559 0.743 . . . . 0.0 111.583 137.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.9 p -93.96 -105.86 0.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -169.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 167.98 3.42 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 128.41 2.684 . . . . 0.0 116.184 -170.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -90.73 172.81 8.39 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 -157.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.0 m -54.05 123.25 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 127.469 2.307 . . . . 0.0 116.602 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -163.54 -55.97 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 157.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -84.52 140.48 38.57 Favored Pre-proline 0 CA--C 1.561 1.4 0 O-C-N 119.604 -1.935 . . . . 0.0 112.333 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -39.32 -52.37 2.42 Favored 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 125.264 3.976 . . . . 0.0 115.93 171.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -69.89 -42.9 72.81 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.83 -1.169 . . . . 0.0 113.079 169.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.04 104.98 9.56 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -168.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t -55.23 116.39 2.79 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.648 124.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -129.87 146.79 51.59 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -155.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.0 m -64.17 80.39 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 O-C-N 120.95 -1.094 . . . . 0.0 112.515 166.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 124.256 1.022 . . . . 0.0 110.138 151.598 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 . . . . . 0 CA--C 1.552 1.031 0 CA-C-O 122.032 0.92 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 t -75.0 -143.54 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.661 -0.649 . . . . 0.0 111.088 160.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -44.7 103.59 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.356 1.463 . . . . 0.0 113.583 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 87.08 84.62 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 129.563 3.145 . . . . 0.0 114.255 -171.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.53 117.26 1.25 Allowed Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.315 1.436 . . . . 0.0 114.732 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -65.42 122.13 16.46 Favored 'General case' 0 CA--C 1.556 1.195 0 O-C-N 119.751 -2.029 . . . . 0.0 112.49 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.4 m -104.9 -52.53 2.84 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.919 1.288 . . . . 0.0 114.387 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.16 132.55 3.58 Favored Glycine 0 CA--C 1.543 1.837 0 C-N-CA 124.185 0.898 . . . . 0.0 114.26 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.27 -157.97 27.46 Favored Glycine 0 CA--C 1.546 2.017 0 C-N-CA 126.424 1.964 . . . . 0.0 113.029 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.0 mt -40.83 110.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 119.333 1.566 . . . . 0.0 112.764 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.37 -33.39 3.2 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 116.296 1.279 . . . . 0.0 116.296 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -82.01 55.56 2.83 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -156.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.2 t -74.53 71.56 1.85 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.357 -1.464 . . . . 0.0 108.612 147.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.0 -172.68 14.88 Favored Glycine 0 CA--C 1.546 2.008 0 N-CA-C 117.82 1.888 . . . . 0.0 117.82 -154.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.41 80.21 2.79 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.152 3.235 . . . . 0.0 112.45 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.5 p -68.9 51.12 0.08 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.856 1.662 . . . . 0.0 114.868 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -78.45 52.54 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 O-C-N 119.728 -1.857 . . . . 0.0 111.704 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 44.5 t -85.59 166.07 16.53 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.915 2.486 . . . . 0.0 115.269 -165.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.28 83.61 1.8 Allowed 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 t -43.29 109.91 0.17 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.834 1.253 . . . . 0.0 113.686 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.98 -52.37 0.79 Allowed Glycine 0 CA--C 1.539 1.584 0 C-N-CA 125.614 1.578 . . . . 0.0 110.158 -160.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.4 p -76.91 163.98 26.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.079 0.552 . . . . 0.0 109.958 140.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.7 p -114.26 -124.19 0.29 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -163.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 m -173.69 32.76 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 128.957 2.903 . . . . 0.0 111.808 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -65.08 141.98 58.54 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 119.867 -1.771 . . . . 0.0 114.676 -162.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 m -64.58 93.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.18 1.392 . . . . 0.0 113.905 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.2 mt -96.59 -48.01 5.7 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -162.86 176.14 2.52 Favored Pre-proline 0 CA--C 1.559 1.326 0 O-C-N 120.832 -1.168 . . . . 0.0 113.94 -165.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.95 -39.15 92.06 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.482 2.788 . . . . 0.0 115.106 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -67.3 -39.55 85.94 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.61 116.73 8.93 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 117.768 2.507 . . . . 0.0 117.768 -164.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.11 125.58 19.54 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.59 111.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -144.04 127.32 16.73 Favored 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -154.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.0 m -63.46 78.58 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.66 1.584 . . . . 0.0 113.043 174.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.6 mt . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.187 151.273 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -74.92 61.11 1.01 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.841 1.657 . . . . 0.0 111.704 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.8 m -59.71 -55.65 31.73 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -171.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -115.17 140.77 48.8 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.939 1.296 . . . . 0.0 114.028 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 62.9 41.92 8.16 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 125.564 1.546 . . . . 0.0 113.17 -171.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.09 109.91 3.68 Favored Glycine 0 CA--C 1.54 1.64 0 C-N-CA 126.113 1.815 . . . . 0.0 114.588 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -52.41 124.36 13.23 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.362 1.465 . . . . 0.0 114.09 176.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 m -118.51 -0.37 11.41 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.58 114.64 0.33 Allowed Glycine 0 CA--C 1.546 2.005 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -175.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.63 -160.28 30.15 Favored Glycine 0 CA--C 1.552 2.384 0 C-N-CA 126.391 1.948 . . . . 0.0 115.023 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -45.64 124.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.7 -13.13 49.43 Favored Glycine 0 CA--C 1.544 1.894 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -89.69 167.43 12.91 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 119.08 1.44 . . . . 0.0 114.856 -172.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 94.2 p -131.49 -92.42 0.4 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.635 1.574 . . . . 0.0 110.881 166.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.2 38.61 0.52 Allowed Glycine 0 CA--C 1.548 2.147 0 N-CA-C 118.294 2.078 . . . . 0.0 118.294 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -76.1 50.58 2.88 Favored 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 123.384 2.723 . . . . 0.0 112.198 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.2 p -77.67 66.6 3.4 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.212 -1.555 . . . . 0.0 113.119 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 t -76.46 51.87 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 O-C-N 120.874 -1.141 . . . . 0.0 112.088 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.1 t -98.59 169.4 9.54 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 129.722 3.209 . . . . 0.0 111.915 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.4 159.37 16.44 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.691 -1.256 . . . . 0.0 112.238 169.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.8 t -72.89 -177.13 2.26 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 161.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.68 -57.02 5.03 Favored Glycine 0 CA--C 1.542 1.742 0 O-C-N 120.857 -1.152 . . . . 0.0 111.688 -165.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.1 p -76.8 177.79 7.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.233 1.013 . . . . 0.0 111.224 153.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -129.11 -128.71 0.21 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -159.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.4 m 179.85 62.51 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 128.645 2.778 . . . . 0.0 111.835 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -128.82 157.83 40.4 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -165.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.39 132.77 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -167.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.1 -113.09 0.16 Allowed 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.745 1.218 . . . . 0.0 112.762 151.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.35 157.45 71.42 Favored Pre-proline 0 CA--C 1.562 1.409 0 O-C-N 119.566 -1.959 . . . . 0.0 114.51 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.79 -17.35 0.71 Allowed 'Trans proline' 0 CA--C 1.554 1.506 0 C-N-CA 124.622 3.548 . . . . 0.0 117.969 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -74.15 -25.52 59.79 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.96 105.31 2.73 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -154.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -71.78 117.3 13.19 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 121.465 -0.772 . . . . 0.0 109.422 130.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -138.97 151.32 46.77 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -160.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.7 m -57.97 76.33 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.527 1.931 . . . . 0.0 113.028 169.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 C--O 1.257 1.483 0 C-N-CA 125.161 1.384 . . . . 0.0 111.237 153.593 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 26.9 p . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 118.449 -0.786 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -106.55 156.02 19.01 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 125.974 1.71 . . . . 0.0 112.882 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.8 m -77.01 154.37 33.55 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -168.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -41.13 146.77 0.16 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.134 1.774 . . . . 0.0 114.112 162.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 60.66 12.67 3.8 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.39 140.4 33.67 Favored Glycine 0 CA--C 1.545 1.937 0 O-C-N 119.807 -1.808 . . . . 0.0 115.254 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -64.95 119.31 10.48 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.572 -1.546 . . . . 0.0 112.78 173.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.5 38.28 3.79 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.453 1.479 . . . . 0.0 113.093 166.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.03 159.85 22.76 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 125.088 1.328 . . . . 0.0 114.685 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.87 -49.85 51.7 Favored Glycine 0 CA--C 1.545 1.955 0 N-CA-C 119.066 2.386 . . . . 0.0 119.066 -158.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.3 mt -58.32 119.72 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 O-C-N 120.724 -1.456 . . . . 0.0 112.983 -168.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.23 25.4 75.61 Favored Glycine 0 CA--C 1.543 1.838 0 C-N-CA 124.755 1.169 . . . . 0.0 115.548 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.22 -170.59 3.53 Favored 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 115.734 1.754 . . . . 0.0 115.734 -166.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.8 p -146.34 -69.29 0.26 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.993 2.117 . . . . 0.0 110.702 175.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.1 64.99 0.52 Allowed Glycine 0 CA--C 1.541 1.699 0 N-CA-C 117.584 1.794 . . . . 0.0 117.584 156.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.54 34.73 0.38 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 C-N-CA 122.663 2.242 . . . . 0.0 112.757 166.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.0 p -84.09 66.36 9.21 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 119.814 -1.804 . . . . 0.0 113.393 -170.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 t -65.35 78.45 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.996 0.919 . . . . 0.0 109.762 163.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 174.27 7.68 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 -168.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.54 73.08 0.06 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.329 1.451 . . . . 0.0 113.721 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.8 t -37.8 109.21 0.09 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.549 1.94 . . . . 0.0 114.74 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.78 -55.56 0.72 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.11 1.814 . . . . 0.0 108.69 -158.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.7 p -70.66 168.49 16.39 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.299 -0.451 . . . . 0.0 111.714 141.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -126.03 -114.04 0.28 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.852 1.661 . . . . 0.0 114.616 -166.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.0 m 162.3 65.35 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.806 0 C-N-CA 131.448 3.899 . . . . 0.0 111.504 -169.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -135.79 165.28 25.97 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 -171.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -68.1 136.52 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 118.178 2.659 . . . . 0.0 118.178 -159.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.39 -46.37 0.51 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.321 1.449 . . . . 0.0 114.532 155.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -130.22 161.18 61.77 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.996 1.319 . . . . 0.0 112.914 -176.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.81 50.05 2.01 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 123.43 2.753 . . . . 0.0 113.865 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -152.82 -49.49 0.1 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.467 2.307 . . . . 0.0 110.437 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.35 100.86 9.39 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.387 2.275 . . . . 0.0 113.374 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.0 t -70.26 88.56 0.63 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 140.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -88.32 148.92 24.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.281 1.832 . . . . 0.0 114.093 -158.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 m -63.81 75.53 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.712 -1.243 . . . . 0.0 112.501 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.208 -1.377 . . . . 0.0 110.806 163.712 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.857 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -80.85 94.19 6.41 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.297 0.953 . . . . 0.0 112.073 -177.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.5 t -66.72 -111.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 157.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -62.99 110.88 1.94 Allowed 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.901 -1.124 . . . . 0.0 112.622 170.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.255 27.4 m-85 89.67 94.26 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 129.424 3.09 . . . . 0.0 115.835 177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.88 129.45 3.08 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 126.532 2.015 . . . . 0.0 113.533 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -71.39 133.97 46.32 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 125.126 1.37 . . . . 0.0 113.561 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 m -140.4 20.11 2.39 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.83 129.69 2.54 Favored Glycine 0 CA--C 1.544 1.854 0 O-C-N 120.406 -1.433 . . . . 0.0 115.178 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.36 -158.12 28.68 Favored Glycine 0 CA--C 1.545 1.965 0 C-N-CA 126.124 1.821 . . . . 0.0 112.437 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.1 mt -43.39 105.63 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-N 119.274 1.537 . . . . 0.0 112.352 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.45 -32.84 2.31 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -73.19 56.49 0.46 Allowed 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -167.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.9 m -73.52 60.78 0.67 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.95 1.3 . . . . 0.0 109.389 155.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.7 -173.45 13.31 Favored Glycine 0 CA--C 1.544 1.903 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 -150.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.35 89.63 1.31 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.955 3.103 . . . . 0.0 112.015 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.5 p -72.61 62.75 0.57 Allowed 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.354 -1.467 . . . . 0.0 113.714 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.69 56.37 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 125.332 1.453 . . . . 0.0 112.254 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.3 t -101.55 151.61 21.77 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.725 2.01 . . . . 0.0 113.933 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.5 90.06 6.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.636 1.574 . . . . 0.0 112.641 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -42.72 115.63 0.75 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.424 1.09 . . . . 0.0 112.946 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.74 -51.84 0.75 Allowed Glycine 0 CA--C 1.539 1.533 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -152.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.5 p -82.98 166.8 18.53 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.634 0.373 . . . . 0.0 111.854 140.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.5 p -99.64 -88.41 0.34 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -158.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.3 m 124.78 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 131.507 3.923 . . . . 0.0 111.508 -163.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -119.12 152.94 35.63 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 126.416 1.887 . . . . 0.0 114.067 -172.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.4 m -57.2 123.91 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -171.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.98 -38.71 3.19 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 156.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -160.86 167.81 12.88 Favored Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -165.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.97 -29.01 25.83 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 124.013 3.142 . . . . 0.0 117.347 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -81.54 -19.8 41.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.231 1.013 . . . . 0.0 113.729 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.28 113.48 3.45 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -165.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 t -67.44 140.86 57.14 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.441 118.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -160.39 135.44 7.83 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -145.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.4 m -67.17 76.64 0.14 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.0 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.463 -1.256 . . . . 0.0 111.264 141.657 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -76.52 100.28 5.23 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 119.696 1.135 . . . . 0.0 112.021 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.0 t -77.93 -102.21 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.257 -0.902 . . . . 0.0 113.034 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.44 127.91 34.69 Favored 'General case' 0 CA--C 1.553 1.091 0 O-C-N 121.034 -1.041 . . . . 0.0 113.459 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.261 37.2 m-85 77.7 47.7 0.05 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 126.931 2.092 . . . . 0.0 115.429 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.62 120.35 6.85 Favored Glycine 0 CA--C 1.545 1.917 0 C-N-CA 125.884 1.707 . . . . 0.0 115.832 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -68.21 103.46 1.58 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.844 1.322 . . . . 0.0 114.312 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -104.04 57.72 0.72 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.944 1.298 . . . . 0.0 110.826 167.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.14 162.81 36.6 Favored Glycine 0 CA--C 1.544 1.881 0 O-C-N 120.467 -1.396 . . . . 0.0 116.472 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.15 -76.21 0.19 Allowed Glycine 0 CA--C 1.544 1.906 0 N-CA-C 119.043 2.377 . . . . 0.0 119.043 -157.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.5 108.25 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 O-C-N 120.981 -1.305 . . . . 0.0 112.075 -164.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.08 -26.97 11.4 Favored Glycine 0 CA--C 1.546 2.025 0 C-N-CA 125.805 1.669 . . . . 0.0 116.446 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -109.73 65.19 0.61 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 -148.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.3 p -70.06 49.39 0.1 Allowed 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.369 -1.457 . . . . 0.0 112.339 162.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.01 156.42 22.15 Favored Glycine 0 CA--C 1.547 2.05 0 N-CA-C 116.33 1.292 . . . . 0.0 116.33 -158.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -82.52 116.93 2.66 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.361 2.708 . . . . 0.0 110.811 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.3 p -71.19 65.66 0.4 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 120.451 -1.406 . . . . 0.0 113.227 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -73.63 61.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 125.248 1.419 . . . . 0.0 112.015 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.2 t -95.06 153.76 17.49 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 127.012 2.125 . . . . 0.0 114.297 -173.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.03 100.37 13.2 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.305 1.042 . . . . 0.0 113.01 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.9 p -49.99 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.954 1.702 . . . . 0.0 114.112 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.83 -48.87 0.32 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.957 1.265 . . . . 0.0 110.235 -159.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.8 p -84.98 158.12 20.59 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 120.873 0.368 . . . . 0.0 111.349 138.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.2 p -101.4 -84.83 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -150.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.5 m 126.03 62.08 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 131.574 3.949 . . . . 0.0 111.049 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -126.91 137.59 53.17 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.3 t -50.52 115.59 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 127.076 2.151 . . . . 0.0 115.101 -170.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.0 mt -101.6 -42.16 6.33 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.907 0.883 . . . . 0.0 113.006 163.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -158.1 166.14 17.16 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 126.905 2.082 . . . . 0.0 110.315 -163.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.93 25.65 0.18 Allowed 'Trans proline' 0 CA--C 1.557 1.65 0 C-N-CA 122.768 2.312 . . . . 0.0 115.005 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -122.29 -66.87 1.0 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.795 2.038 . . . . 0.0 109.902 171.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.43 109.59 22.31 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.549 2.34 . . . . 0.0 113.42 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -76.56 102.35 6.05 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 136.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -97.85 137.91 36.0 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.969 1.708 . . . . 0.0 113.327 -156.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.7 m -64.95 75.84 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.742 -1.224 . . . . 0.0 112.842 166.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.246 0.897 0 C-N-CA 125.41 1.484 . . . . 0.0 111.304 157.878 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -86.45 125.73 33.91 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.686 1.194 . . . . 0.0 110.819 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 t -74.11 178.51 4.99 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -57.68 139.54 53.5 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.035 1.334 . . . . 0.0 114.219 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 73.64 26.65 1.88 Allowed 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 127.6 2.36 . . . . 0.0 115.451 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.43 136.03 12.59 Favored Glycine 0 CA--C 1.549 2.216 0 O-C-N 119.45 -2.031 . . . . 0.0 116.228 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -58.58 126.74 28.88 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 119.747 -2.031 . . . . 0.0 113.732 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.54 45.32 2.06 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 127.317 2.247 . . . . 0.0 110.991 165.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.99 164.32 27.91 Favored Glycine 0 CA--C 1.541 1.694 0 O-C-N 120.615 -1.303 . . . . 0.0 115.06 -169.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.37 -45.4 9.92 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 119.101 2.4 . . . . 0.0 119.101 -149.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.9 mt -53.36 118.48 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 O-C-N 120.693 -1.475 . . . . 0.0 112.919 -170.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.08 33.89 76.68 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 124.645 1.117 . . . . 0.0 115.509 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.1 -179.74 5.96 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -166.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -165.55 -57.21 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.192 2.197 . . . . 0.0 110.59 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 55.15 87.84 0.01 OUTLIER Glycine 0 CA--C 1.548 2.154 0 N-CA-C 118.701 2.241 . . . . 0.0 118.701 155.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -66.92 71.16 0.5 Allowed 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.449 2.766 . . . . 0.0 111.391 166.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -90.08 61.49 5.22 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.672 1.989 . . . . 0.0 113.771 -160.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.26 79.57 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 O-C-N 121.145 -0.972 . . . . 0.0 110.96 171.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.1 t -50.19 153.48 1.44 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.283 2.233 . . . . 0.0 113.907 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.13 74.21 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 O-C-N 120.709 -1.244 . . . . 0.0 113.275 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.9 t -33.45 98.79 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 127.721 2.408 . . . . 0.0 114.804 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.27 -53.97 0.58 Allowed Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.555 1.55 . . . . 0.0 109.396 -156.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.5 p -82.93 166.93 18.47 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.246 0.618 . . . . 0.0 110.78 143.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -117.95 -92.21 0.53 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.161 2.652 . . . . 0.0 118.161 -152.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.3 m 131.14 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 1 C-N-CA 131.797 4.039 . . . . 0.0 113.429 -166.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -134.22 157.72 45.54 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.7 t -54.45 112.52 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -164.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.6 mt -85.85 -55.68 3.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.456 1.102 . . . . 0.0 112.629 153.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -167.55 176.49 1.64 Allowed Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 125.588 1.555 . . . . 0.0 112.185 -159.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.9 -41.81 38.75 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.202 3.268 . . . . 0.0 115.983 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -67.21 -45.06 77.98 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.319 -0.863 . . . . 0.0 113.07 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.58 95.73 4.2 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -151.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -77.28 102.06 6.54 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 144.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -105.21 142.06 35.64 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.114 1.765 . . . . 0.0 113.949 -159.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.4 t -56.31 71.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 127.926 2.49 . . . . 0.0 112.321 167.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 mt . . . . . 0 C--O 1.248 1.0 0 C-N-CA 129.789 3.236 . . . . 0.0 112.838 174.644 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -84.83 163.47 19.03 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 119.276 0.944 . . . . 0.0 112.171 171.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.7 t -112.27 -102.42 0.41 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.546 1.138 . . . . 0.0 112.823 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -68.63 122.17 17.96 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.937 1.295 . . . . 0.0 112.874 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 86.4 61.82 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 128.021 2.529 . . . . 0.0 115.588 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.14 139.49 13.83 Favored Glycine 0 CA--C 1.549 2.184 0 C-N-CA 125.863 1.697 . . . . 0.0 114.48 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -82.39 116.29 21.8 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 118.998 1.399 . . . . 0.0 114.081 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.66 55.59 0.91 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.054 1.742 . . . . 0.0 111.001 171.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.21 163.74 35.1 Favored Glycine 0 CA--C 1.54 1.652 0 O-C-N 120.671 -1.268 . . . . 0.0 114.435 -173.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.99 -64.15 4.31 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 118.697 2.239 . . . . 0.0 118.697 -160.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.3 mt -60.07 116.1 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 O-C-N 120.738 -1.448 . . . . 0.0 112.775 -164.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.01 -12.43 69.54 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 126.153 1.835 . . . . 0.0 116.557 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -111.91 75.21 0.91 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -153.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.2 p -74.42 26.62 0.08 Allowed 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.427 -1.421 . . . . 0.0 113.605 154.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.93 160.35 17.87 Favored Glycine 0 CA--C 1.545 1.939 0 C-N-CA 124.89 1.233 . . . . 0.0 116.008 -165.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.63 124.55 4.08 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 123.292 2.662 . . . . 0.0 111.472 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.7 p -73.84 62.99 0.87 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.964 1.306 . . . . 0.0 113.717 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 t -74.42 53.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 O-C-N 120.184 -1.573 . . . . 0.0 113.477 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.9 t -100.26 159.52 15.05 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 128.161 2.585 . . . . 0.0 114.455 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.35 104.65 16.56 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.616 1.966 . . . . 0.0 113.655 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.0 t -47.15 117.34 1.69 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.181 1.393 . . . . 0.0 112.728 169.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.83 -52.17 0.72 Allowed Glycine 0 CA--C 1.538 1.497 0 C-N-CA 126.144 1.83 . . . . 0.0 109.211 -160.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.9 p -74.42 162.03 29.24 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.198 -0.501 . . . . 0.0 111.11 140.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.0 p -98.57 -90.17 0.29 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -166.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.1 m 125.84 57.26 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 131.628 3.971 . . . . 0.0 110.805 -162.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -118.93 142.23 47.95 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.701 1.601 . . . . 0.0 115.013 -164.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.1 t -51.16 102.04 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 126.449 1.9 . . . . 0.0 114.319 -170.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.3 mt -107.41 -50.12 3.13 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.759 1.224 . . . . 0.0 114.04 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -153.37 166.84 14.71 Favored Pre-proline 0 CA--C 1.557 1.225 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -163.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.51 -35.27 65.84 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.285 2.657 . . . . 0.0 114.982 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -72.17 -54.32 10.04 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.093 1.357 . . . . 0.0 112.513 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.19 120.13 34.32 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.557 1.543 . . . . 0.0 114.354 -166.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -71.97 119.53 16.28 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 126.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -126.43 143.41 51.19 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.115 -0.99 . . . . 0.0 113.393 -151.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.8 m -67.68 81.56 0.18 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.266 -0.896 . . . . 0.0 112.523 171.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 C--O 1.255 1.364 0 CA-C-O 117.286 -1.34 . . . . 0.0 109.645 146.489 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 119.032 -0.508 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -81.07 118.67 22.71 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 119.402 1.001 . . . . 0.0 109.884 168.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.9 t -64.37 168.44 5.7 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -48.52 131.4 17.31 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.904 0.882 . . . . 0.0 112.165 167.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 69.72 74.07 0.23 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.405 1.482 . . . . 0.0 113.338 -173.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.89 145.02 12.7 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 125.128 1.347 . . . . 0.0 114.187 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -70.83 131.63 44.08 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.708 -1.466 . . . . 0.0 114.891 -173.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.17 57.32 1.79 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.263 1.825 . . . . 0.0 110.687 170.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.24 168.59 41.16 Favored Glycine 0 CA--C 1.545 1.963 0 O-C-N 120.47 -1.394 . . . . 0.0 115.502 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.62 -76.1 0.14 Allowed Glycine 0 CA--C 1.545 1.934 0 C-N-CA 127.468 2.461 . . . . 0.0 119.201 -162.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.5 mt -61.24 96.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.055 -1.262 . . . . 0.0 112.564 -164.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.6 13.93 31.2 Favored Glycine 0 CA--C 1.544 1.895 0 C-N-CA 126.279 1.895 . . . . 0.0 116.409 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.05 164.87 28.87 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 120.022 1.911 . . . . 0.0 116.147 -173.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 t -127.08 -65.13 0.96 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.084 2.154 . . . . 0.0 110.406 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.92 75.9 0.07 OUTLIER Glycine 0 CA--C 1.545 1.968 0 N-CA-C 119.407 2.523 . . . . 0.0 119.407 151.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.81 52.55 0.54 Allowed 'Trans proline' 0 CA--C 1.554 1.481 0 C-N-CA 123.514 2.809 . . . . 0.0 112.114 157.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.4 p -73.24 29.75 0.07 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 -162.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.5 t -75.5 66.78 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 O-C-N 119.967 -1.708 . . . . 0.0 111.72 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 52.5 t -59.57 158.88 9.16 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.844 2.057 . . . . 0.0 113.95 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.74 61.77 0.17 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.521 1.529 . . . . 0.0 114.596 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -6.06 75.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 130.12 3.368 . . . . 0.0 116.52 176.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.46 -51.71 0.48 Allowed Glycine 0 CA--C 1.535 1.327 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -158.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.6 p -80.5 160.09 25.34 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.473 0.309 . . . . 0.0 110.393 140.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.1 p -116.21 -84.83 0.63 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -156.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.8 m 127.33 61.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 131.571 3.948 . . . . 0.0 112.102 -167.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -123.54 146.52 48.05 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 125.848 1.659 . . . . 0.0 115.253 -166.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.93 113.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.546 1.939 . . . . 0.0 114.932 -169.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.7 mt -116.45 -46.59 2.77 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -152.63 165.02 18.46 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 120.856 -1.153 . . . . 0.0 113.28 -161.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.79 43.02 0.75 Allowed 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 123.251 2.634 . . . . 0.0 114.204 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -143.41 -54.66 0.38 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.773 2.429 . . . . 0.0 108.552 172.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.26 124.05 48.1 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 128.02 2.528 . . . . 0.0 113.838 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -68.09 134.79 51.18 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.69 120.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -136.82 132.55 34.8 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.977 -1.077 . . . . 0.0 111.618 -144.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.3 t -66.6 67.17 0.06 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.055 1.742 . . . . 0.0 112.293 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--O 1.247 0.974 0 C-N-CA 126.733 2.013 . . . . 0.0 112.242 167.441 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.73 165.27 37.03 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 120.108 1.322 . . . . 0.0 112.771 168.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.5 t -106.31 -162.71 0.87 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.211 1.804 . . . . 0.0 112.037 166.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -52.05 143.49 13.86 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 57.68 8.87 0.73 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 126.712 2.005 . . . . 0.0 116.051 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.8 150.35 35.65 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.248 -1.533 . . . . 0.0 115.933 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -89.28 114.07 25.4 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.273 1.429 . . . . 0.0 113.285 -171.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.35 62.61 0.77 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.965 1.306 . . . . 0.0 112.927 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.88 -128.69 5.93 Favored Glycine 0 CA--C 1.547 2.048 0 N-CA-C 116.444 1.338 . . . . 0.0 116.444 168.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.5 -150.37 26.27 Favored Glycine 0 CA--C 1.549 2.17 0 O-C-N 120.926 -1.338 . . . . 0.0 115.654 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.0 mt -53.79 110.77 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 O-C-N 120.756 -1.438 . . . . 0.0 113.115 175.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.74 -37.54 3.17 Favored Glycine 0 CA--C 1.546 2.018 0 N-CA-C 117.005 1.562 . . . . 0.0 117.005 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.68 81.83 1.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -158.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.7 p -72.75 5.22 3.31 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 166.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 142.85 35.25 Favored Glycine 0 CA--C 1.552 2.356 0 O-C-N 120.375 -1.453 . . . . 0.0 115.286 -173.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -80.31 66.22 8.83 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.664 2.91 . . . . 0.0 112.574 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.9 p -84.36 48.12 1.45 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 119.797 -1.814 . . . . 0.0 115.311 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -51.94 108.45 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 O-C-N 121.063 -1.023 . . . . 0.0 110.515 162.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.72 -178.69 4.77 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -160.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.69 71.27 0.08 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.68 1.592 . . . . 0.0 112.846 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -37.39 107.21 0.06 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.62 1.968 . . . . 0.0 114.483 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.31 -54.94 0.74 Allowed Glycine 0 CA--C 1.536 1.347 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -158.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.6 p -72.37 170.24 14.62 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.485 0.314 . . . . 0.0 111.484 142.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.3 p -119.74 -113.34 0.33 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -168.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 m 154.13 60.4 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 129.887 3.275 . . . . 0.0 110.474 -166.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -129.69 147.01 51.43 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 126.756 2.023 . . . . 0.0 115.742 -166.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.7 m -51.48 131.8 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -168.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.22 -76.1 0.17 Allowed 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 155.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -81.48 153.24 70.96 Favored Pre-proline 0 CA--C 1.561 1.396 0 O-C-N 120.191 -1.568 . . . . 0.0 112.886 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -58.81 -11.59 12.41 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.458 2.772 . . . . 0.0 116.033 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -91.55 -10.86 39.08 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.993 1.317 . . . . 0.0 113.881 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.96 113.62 5.02 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -166.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -74.21 95.75 2.66 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 137.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -101.21 145.95 28.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.774 1.63 . . . . 0.0 113.816 -154.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.7 m -65.57 75.25 0.07 Allowed 'General case' 0 CA--C 1.551 0.992 0 O-C-N 120.767 -1.208 . . . . 0.0 114.084 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.571 -1.204 . . . . 0.0 112.464 165.45 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.501 2.087 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -72.45 68.5 0.79 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.648 1.179 . . . . 0.0 111.663 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -79.71 -117.1 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.337 1.455 . . . . 0.0 113.009 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -63.66 123.18 18.18 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 121.175 -0.953 . . . . 0.0 112.463 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 79.19 39.75 0.11 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 127.806 2.443 . . . . 0.0 115.11 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.28 122.41 7.56 Favored Glycine 0 CA--C 1.551 2.341 0 N-CA-C 116.607 1.403 . . . . 0.0 116.607 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -66.98 112.12 4.17 Favored 'General case' 0 CA--C 1.556 1.21 0 O-C-N 119.872 -1.957 . . . . 0.0 115.773 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -109.77 50.16 0.81 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.849 1.66 . . . . 0.0 111.588 164.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.37 158.55 29.04 Favored Glycine 0 CA--C 1.54 1.617 0 O-C-N 120.202 -1.561 . . . . 0.0 116.353 -171.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.88 -68.14 1.52 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 119.024 2.369 . . . . 0.0 119.024 -161.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.8 mt -60.68 101.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 120.988 -1.301 . . . . 0.0 112.401 -165.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.19 -28.28 10.58 Favored Glycine 0 CA--C 1.546 1.992 0 C-N-CA 126.242 1.877 . . . . 0.0 115.7 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -106.07 62.27 0.66 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -150.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.2 p -68.69 58.77 0.09 Allowed 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.235 -1.541 . . . . 0.0 111.64 159.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.52 161.56 27.98 Favored Glycine 0 CA--C 1.547 2.042 0 N-CA-C 116.214 1.245 . . . . 0.0 116.214 -158.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -83.88 130.15 4.91 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.092 3.195 . . . . 0.0 112.225 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.5 p -79.56 69.34 5.83 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.302 -1.499 . . . . 0.0 112.31 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.3 t -77.19 57.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.983 1.313 . . . . 0.0 112.525 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.1 t -105.53 149.5 26.18 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.829 2.052 . . . . 0.0 115.121 -158.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.07 62.87 6.82 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -171.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -19.76 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.567 2.347 . . . . 0.0 115.397 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.88 -54.38 0.55 Allowed Glycine 0 CA--C 1.54 1.637 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -151.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.7 p -70.79 154.3 41.97 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 122.807 -0.231 . . . . 0.0 111.319 137.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.7 p -101.08 -117.75 0.17 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -162.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.3 m 162.51 51.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 131.058 3.743 . . . . 0.0 111.102 -172.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -121.47 149.88 42.4 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 119.99 -1.694 . . . . 0.0 115.314 -167.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 m -57.4 137.62 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -171.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -152.73 -59.84 0.15 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.859 1.264 . . . . 0.0 113.675 161.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -92.3 150.66 40.53 Favored Pre-proline 0 CA--C 1.561 1.371 0 O-C-N 120.554 -1.341 . . . . 0.0 112.777 168.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.88 -26.32 57.26 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.702 2.935 . . . . 0.0 115.101 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -45.04 70.53 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.217 -0.927 . . . . 0.0 112.989 175.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.21 113.47 19.51 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.413 1.885 . . . . 0.0 114.106 -167.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.7 t -70.36 113.85 7.92 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 136.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -127.2 137.03 52.83 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -147.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -59.82 79.9 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.415 1.086 . . . . 0.0 112.749 167.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.105 146.903 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.7 p . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -72.02 131.61 43.14 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.339 1.456 . . . . 0.0 110.33 165.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -85.74 175.68 8.57 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -49.85 135.76 19.12 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.681 1.193 . . . . 0.0 112.658 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 69.15 -2.28 1.86 Allowed 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -169.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.73 144.88 49.7 Favored Glycine 0 CA--C 1.549 2.178 0 O-C-N 119.906 -1.746 . . . . 0.0 115.185 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.77 136.51 36.76 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -167.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.67 35.54 4.82 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 126.316 1.846 . . . . 0.0 113.241 161.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.26 168.96 21.32 Favored Glycine 0 CA--C 1.54 1.632 0 O-C-N 120.472 -1.392 . . . . 0.0 114.712 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.97 -45.41 83.39 Favored Glycine 0 CA--C 1.544 1.896 0 N-CA-C 117.855 1.902 . . . . 0.0 117.855 -158.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.7 mm -56.92 109.22 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 O-C-N 121.175 -1.191 . . . . 0.0 113.113 -170.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.46 39.11 96.61 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 125.758 1.647 . . . . 0.0 115.418 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.1 178.98 6.78 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 -168.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 91.3 p -136.73 -84.92 0.34 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.805 1.642 . . . . 0.0 111.046 172.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.5 53.04 0.05 OUTLIER Glycine 0 CA--C 1.545 1.95 0 N-CA-C 117.979 1.952 . . . . 0.0 117.979 169.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.1 46.57 1.14 Allowed 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 123.39 2.727 . . . . 0.0 112.674 169.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.3 p -70.94 23.38 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -164.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 t -77.34 63.28 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 O-C-N 119.798 -1.814 . . . . 0.0 112.181 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.1 t -55.43 154.93 5.73 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.564 1.545 . . . . 0.0 114.682 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.17 73.35 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 O-C-N 120.608 -1.308 . . . . 0.0 112.621 165.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.1 t -38.3 109.16 0.09 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.344 1.858 . . . . 0.0 114.687 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.82 -53.24 0.71 Allowed Glycine 0 CA--C 1.537 1.469 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -156.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.3 p -82.05 163.4 22.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.299 0.64 . . . . 0.0 110.736 146.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.8 p -113.44 -120.17 0.3 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -161.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.4 t 171.42 51.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 127.79 2.436 . . . . 0.0 111.315 -169.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -129.54 146.67 51.33 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.676 1.59 . . . . 0.0 115.197 -154.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 m -51.12 127.84 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.3 0.0 OUTLIER -148.76 -99.56 0.08 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 125.112 1.365 . . . . 0.0 113.64 158.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -53.64 146.38 25.85 Favored Pre-proline 0 CA--C 1.565 1.535 0 O-C-N 119.553 -1.967 . . . . 0.0 113.994 169.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -58.23 -28.68 85.14 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.808 3.005 . . . . 0.0 115.045 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -66.22 -33.26 75.34 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 121.035 -1.04 . . . . 0.0 113.77 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.58 115.9 9.97 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.621 1.568 . . . . 0.0 114.917 -166.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -66.43 121.24 14.86 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.842 -1.161 . . . . 0.0 108.525 136.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -129.97 142.8 50.59 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -149.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.7 t -69.19 66.51 0.16 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.832 2.053 . . . . 0.0 112.744 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.9 2.08 . . . . 0.0 112.846 170.872 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.5 2.054 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -106.36 146.97 29.78 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.185 1.394 . . . . 0.0 112.0 169.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -89.53 -166.86 1.7 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 125.072 1.349 . . . . 0.0 114.504 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -59.44 149.96 27.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.282 1.433 . . . . 0.0 114.829 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 61.36 5.12 1.07 Allowed 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.17 130.97 51.79 Favored Glycine 0 CA--C 1.546 1.987 0 O-C-N 119.494 -2.004 . . . . 0.0 115.019 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -66.63 125.7 26.62 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 120.693 -1.475 . . . . 0.0 111.965 175.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -119.32 40.58 3.31 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 125.424 1.489 . . . . 0.0 110.971 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.03 158.77 27.84 Favored Glycine 0 CA--C 1.544 1.904 0 C-N-CA 125.181 1.372 . . . . 0.0 115.195 -170.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.67 -58.77 11.92 Favored Glycine 0 CA--C 1.549 2.187 0 N-CA-C 120.324 2.89 . . . . 0.0 120.324 -158.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.9 mt -57.08 107.34 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 O-C-N 120.643 -1.504 . . . . 0.0 113.22 -165.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.04 19.47 62.87 Favored Glycine 0 CA--C 1.544 1.866 0 C-N-CA 126.254 1.883 . . . . 0.0 115.786 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -140.92 117.02 10.55 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.6 p -120.26 42.85 2.86 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.165 1.386 . . . . 0.0 112.466 163.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.52 122.84 7.17 Favored Glycine 0 CA--C 1.547 2.084 0 C-N-CA 125.083 1.325 . . . . 0.0 114.745 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.46 63.11 7.16 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.588 2.859 . . . . 0.0 111.823 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.8 p -77.56 66.3 3.25 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.273 -1.517 . . . . 0.0 114.28 -176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.26 89.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.905 0.882 . . . . 0.0 109.365 155.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.28 177.44 7.26 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -166.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.43 68.92 0.14 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.878 1.271 . . . . 0.0 113.782 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.2 t -28.75 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 127.156 2.182 . . . . 0.0 114.535 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.63 -54.45 0.62 Allowed Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.283 1.42 . . . . 0.0 109.638 -155.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -77.24 176.3 8.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.287 0.635 . . . . 0.0 111.16 142.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 p -127.92 -124.06 0.23 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.367 1.467 . . . . 0.0 114.582 -167.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 m 167.85 55.08 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 128.867 2.867 . . . . 0.0 111.383 -168.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . 0.266 2.8 pp0? -139.25 169.2 18.2 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -168.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.79 139.88 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -148.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.32 -67.97 0.12 Allowed 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 160.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -88.98 147.64 39.24 Favored Pre-proline 0 CA--C 1.555 1.139 0 O-C-N 120.395 -1.44 . . . . 0.0 112.705 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -54.82 -28.63 58.96 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.531 2.821 . . . . 0.0 115.026 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.85 -44.7 72.85 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 121.077 -1.015 . . . . 0.0 112.698 174.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.21 109.7 15.28 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.042 1.737 . . . . 0.0 115.27 -167.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -64.37 103.59 0.66 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 134.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -111.05 148.8 31.81 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.672 1.589 . . . . 0.0 114.192 -155.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.0 m -68.21 70.58 0.16 Allowed 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.254 1.294 0 CA-C-O 117.65 -1.167 . . . . 0.0 111.304 157.875 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.497 1.895 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -84.98 178.73 7.48 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.558 1.143 . . . . 0.0 111.505 161.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.4 t -86.85 -117.47 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.875 0.87 . . . . 0.0 111.347 167.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -47.83 159.99 0.15 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 172.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 73.38 58.43 0.1 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.303 1.841 . . . . 0.0 115.392 162.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.24 135.86 7.74 Favored Glycine 0 CA--C 1.545 1.958 0 C-N-CA 126.168 1.842 . . . . 0.0 112.653 171.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -76.21 128.85 35.75 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.009 -1.289 . . . . 0.0 113.933 -173.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -111.78 57.66 0.64 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 126.59 1.956 . . . . 0.0 110.892 170.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.12 156.39 27.47 Favored Glycine 0 CA--C 1.544 1.85 0 O-C-N 120.889 -1.132 . . . . 0.0 115.333 -169.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.96 -48.75 5.94 Favored Glycine 0 CA--C 1.546 2.024 0 N-CA-C 118.147 2.019 . . . . 0.0 118.147 -159.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.66 122.97 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.595 -1.533 . . . . 0.0 112.828 -171.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.41 34.96 91.32 Favored Glycine 0 CA--C 1.544 1.855 0 C-N-CA 124.85 1.214 . . . . 0.0 115.089 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.38 -172.6 3.99 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -166.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.1 p -160.52 -87.75 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.659 1.984 . . . . 0.0 110.416 168.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.76 36.66 1.6 Allowed Glycine 0 CA--C 1.552 2.386 0 N-CA-C 119.773 2.669 . . . . 0.0 119.773 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -62.9 37.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.637 0 CA-C-N 122.145 2.972 . . . . 0.0 116.809 165.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.5 p -75.43 57.93 0.96 Allowed 'General case' 0 N--CA 1.481 1.083 0 O-C-N 119.432 -2.043 . . . . 0.0 113.575 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.0 t -73.51 28.8 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.44 0 O-C-N 119.922 -1.736 . . . . 0.0 114.347 -176.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.2 t -95.75 157.68 15.79 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 129.303 3.041 . . . . 0.0 113.549 -173.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.43 108.06 19.38 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.254 1.422 . . . . 0.0 112.766 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -56.11 150.67 13.53 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.31 -47.69 1.02 Allowed Glycine 0 CA--C 1.541 1.703 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -145.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.1 p -77.16 171.21 15.19 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.945 0.898 . . . . 0.0 111.991 147.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 p -107.99 -146.32 0.4 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.886 1.674 . . . . 0.0 114.08 -168.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 m -162.24 68.61 0.26 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 127.459 2.304 . . . . 0.0 109.787 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -124.29 148.58 47.31 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 126.138 1.775 . . . . 0.0 115.668 -158.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.1 m -57.83 118.98 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -168.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.38 -48.88 3.71 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.109 1.363 . . . . 0.0 113.091 162.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -150.82 168.65 10.6 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 127.831 2.452 . . . . 0.0 110.748 -170.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -55.5 -15.77 12.71 Favored 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.095 2.53 . . . . 0.0 117.741 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.76 -45.36 9.35 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.934 1.243 . . . . 0.0 111.942 173.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.77 94.32 5.01 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.474 1.91 . . . . 0.0 112.84 -157.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 t -89.31 99.28 12.31 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 151.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.87 156.36 38.01 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.875 2.07 . . . . 0.0 113.872 -154.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.5 m -64.91 82.66 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 127.192 2.197 . . . . 0.0 112.967 157.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.34 64.67 0.1 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.296 2.238 . . . . 0.0 112.261 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 m -85.18 -89.28 0.11 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.255 1.022 . . . . 0.0 112.241 -161.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -73.57 92.24 1.9 Allowed 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.456 -0.778 . . . . 0.0 109.623 168.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.254 13.6 m-85 98.93 106.46 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 130.22 3.408 . . . . 0.0 112.442 -174.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.83 109.32 0.39 Allowed Glycine 0 CA--C 1.541 1.671 0 C-N-CA 127.184 2.326 . . . . 0.0 111.625 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -72.62 119.39 16.78 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.748 1.219 . . . . 0.0 112.895 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 p -137.29 56.93 1.76 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.948 1.699 . . . . 0.0 111.189 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.5 34.81 1.47 Allowed Glycine 0 CA--C 1.545 1.915 0 N-CA-C 117.607 1.803 . . . . 0.0 117.607 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.23 -70.66 1.55 Allowed Glycine 0 CA--C 1.545 1.911 0 N-CA-C 117.046 1.578 . . . . 0.0 117.046 165.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.9 mt -54.4 112.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 119.015 1.408 . . . . 0.0 113.841 -168.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.18 -11.55 48.86 Favored Glycine 0 CA--C 1.548 2.145 0 C-N-CA 125.651 1.596 . . . . 0.0 115.332 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -110.85 62.62 0.61 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -155.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 t -70.11 64.09 0.23 Allowed 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.701 -1.25 . . . . 0.0 111.039 156.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.74 176.14 20.12 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 -164.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.16 143.48 25.58 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.615 3.543 . . . . 0.0 112.45 -174.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.8 p -123.94 41.33 3.51 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.992 1.317 . . . . 0.0 113.265 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 t -79.35 51.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 O-C-N 120.323 -1.485 . . . . 0.0 112.335 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.6 t -82.4 164.02 21.29 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 128.73 2.812 . . . . 0.0 113.122 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.58 93.71 4.09 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 t -36.84 111.04 0.13 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.838 1.655 . . . . 0.0 114.218 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.74 -50.3 0.89 Allowed Glycine 0 CA--C 1.541 1.704 0 C-N-CA 125.844 1.688 . . . . 0.0 109.536 -158.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.6 p -82.62 152.87 25.72 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.661 1.185 . . . . 0.0 110.695 143.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.1 p -101.44 -107.25 0.24 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -159.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t 146.09 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 131.547 3.939 . . . . 0.0 110.206 -170.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -118.31 127.12 53.4 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 127.536 2.334 . . . . 0.0 114.214 -157.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.9 t -65.17 86.86 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 C-N-CA 125.431 1.492 . . . . 0.0 114.586 -170.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.69 -44.73 8.4 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -152.91 160.21 31.3 Favored Pre-proline 0 CA--C 1.557 1.246 0 O-C-N 121.029 -1.044 . . . . 0.0 113.497 -164.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.67 53.64 3.25 Favored 'Trans proline' 0 CA--C 1.554 1.48 0 C-N-CA 124.268 3.312 . . . . 0.0 113.58 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -159.75 -53.76 0.06 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 129.534 3.133 . . . . 0.0 109.084 176.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.91 119.16 36.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.028 2.131 . . . . 0.0 113.175 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 t -66.55 123.41 19.98 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 120.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -113.67 129.22 56.6 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.94 1.696 . . . . 0.0 111.38 -160.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.0 m -64.43 83.88 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.357 -0.84 . . . . 0.0 111.909 165.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 C--O 1.256 1.432 0 CA-C-O 116.694 -1.622 . . . . 0.0 109.678 153.385 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -67.51 72.52 0.14 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.127 1.771 . . . . 0.0 111.159 171.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 m -82.79 -131.65 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.499 1.52 . . . . 0.0 113.243 -166.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -47.7 121.32 3.96 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.998 1.319 . . . . 0.0 113.682 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 72.48 50.02 0.19 Allowed 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 127.377 2.271 . . . . 0.0 114.336 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.01 133.76 10.11 Favored Glycine 0 CA--C 1.547 2.038 0 C-N-CA 126.111 1.815 . . . . 0.0 115.317 -174.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -73.66 130.39 39.91 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 120.221 2.011 . . . . 0.0 115.023 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.3 m -112.01 -47.28 3.14 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.588 1.555 . . . . 0.0 111.88 166.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 165.49 10.08 Favored Glycine 0 CA--C 1.548 2.107 0 N-CA-C 117.239 1.656 . . . . 0.0 117.239 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.57 -52.64 24.64 Favored Glycine 0 CA--C 1.548 2.113 0 N-CA-C 119.471 2.549 . . . . 0.0 119.471 -157.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.6 114.35 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 120.094 -1.827 . . . . 0.0 112.033 -166.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.67 -16.83 60.44 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 126.031 1.777 . . . . 0.0 116.391 -172.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -111.37 76.22 0.96 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -153.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 p -72.28 24.27 0.05 Allowed 'General case' 0 CA--C 1.554 1.123 0 O-C-N 120.138 -1.601 . . . . 0.0 114.297 158.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.76 157.73 22.38 Favored Glycine 0 CA--C 1.546 1.984 0 O-C-N 120.735 -1.228 . . . . 0.0 116.036 -168.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -83.68 122.47 3.1 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.336 2.69 . . . . 0.0 110.614 172.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -73.76 60.55 0.71 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.638 -1.288 . . . . 0.0 113.853 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 t -72.39 57.21 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 O-C-N 120.168 -1.583 . . . . 0.0 112.045 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.9 t -93.04 154.59 18.03 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.94 2.096 . . . . 0.0 113.726 -171.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.39 83.78 7.38 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.765 -1.209 . . . . 0.0 112.339 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.3 t -44.24 109.71 0.17 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.785 1.234 . . . . 0.0 113.213 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.26 -50.79 0.81 Allowed Glycine 0 CA--C 1.537 1.455 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -156.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.1 p -74.45 155.09 38.4 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.6 0.36 . . . . 0.0 110.892 139.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.3 p -98.59 -106.46 0.2 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -163.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 m 158.42 30.76 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 130.994 3.718 . . . . 0.0 112.584 -172.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -95.02 151.32 19.28 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.361 -2.087 . . . . 0.0 116.369 -164.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.4 t -55.89 115.2 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 126.481 1.912 . . . . 0.0 114.427 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -122.58 -49.51 2.01 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -139.65 162.1 52.93 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.856 1.263 . . . . 0.0 112.558 -167.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.97 49.99 1.7 Allowed 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 123.833 3.022 . . . . 0.0 113.471 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -154.17 -67.75 0.14 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 129.626 3.17 . . . . 0.0 107.746 172.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.87 111.24 23.69 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 127.046 2.138 . . . . 0.0 113.049 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.1 p -58.79 124.14 18.78 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.573 115.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -138.65 140.56 38.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.085 1.354 . . . . 0.0 114.444 -147.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.1 m -67.75 83.07 0.19 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.794 1.238 . . . . 0.0 112.7 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt . . . . . 0 C--O 1.254 1.312 0 CA-C-O 117.405 -1.283 . . . . 0.0 110.467 152.359 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -82.52 156.62 23.93 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.435 1.016 . . . . 0.0 112.913 170.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.0 t -98.38 -145.46 0.32 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.83 1.252 . . . . 0.0 110.46 164.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -47.84 144.7 3.28 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 169.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 81.34 4.19 1.45 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.146 2.178 . . . . 0.0 116.391 172.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.07 153.78 41.49 Favored Glycine 0 CA--C 1.55 2.268 0 O-C-N 120.426 -1.421 . . . . 0.0 115.285 173.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -84.2 135.78 34.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.605 1.562 . . . . 0.0 113.563 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.5 m -131.54 -6.91 3.7 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.24 111.44 0.3 Allowed Glycine 0 CA--C 1.546 1.975 0 CA-C-N 119.975 1.261 . . . . 0.0 115.237 -177.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.55 24.23 0.06 OUTLIER Glycine 0 CA--C 1.541 1.718 0 O-C-N 118.952 -2.499 . . . . 0.0 117.477 -6.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.9 mt -64.12 129.44 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 120.345 2.073 . . . . 0.0 110.683 169.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.5 -39.43 0.74 Allowed Glycine 0 CA--C 1.547 2.084 0 C-N-CA 124.589 1.09 . . . . 0.0 115.648 -174.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -64.93 178.43 0.82 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 126.858 2.063 . . . . 0.0 115.217 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.6 p -134.39 -86.0 0.41 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.916 1.287 . . . . 0.0 110.953 165.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.95 38.56 0.5 Allowed Glycine 0 CA--C 1.546 2.005 0 N-CA-C 118.103 2.001 . . . . 0.0 118.103 169.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -77.82 58.55 6.51 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 CA-C-N 121.086 2.443 . . . . 0.0 111.181 172.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -74.61 57.59 0.74 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.756 1.222 . . . . 0.0 113.923 -171.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 t -78.78 62.52 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 O-C-N 120.429 -1.419 . . . . 0.0 111.28 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.07 -177.96 4.32 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.138 2.175 . . . . 0.0 112.603 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.33 165.88 24.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.749 0.82 . . . . 0.0 112.801 166.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.4 t -106.4 171.93 7.09 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.567 1.147 . . . . 0.0 112.172 171.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.06 -53.68 1.4 Allowed Glycine 0 CA--C 1.546 1.975 0 O-C-N 120.928 -1.108 . . . . 0.0 111.821 -159.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -58.89 147.44 33.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.809 1.243 . . . . 0.0 113.502 157.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.6 p -108.44 -128.4 0.27 Allowed 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -173.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m 179.86 55.88 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 128.2 2.6 . . . . 0.0 111.73 -162.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -124.03 147.47 47.8 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 126.345 1.858 . . . . 0.0 115.215 -159.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.3 m -44.68 110.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 127.459 2.304 . . . . 0.0 116.439 -170.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.83 -49.67 2.21 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.15 1.38 . . . . 0.0 114.378 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -153.45 163.51 23.47 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 125.626 1.57 . . . . 0.0 112.325 -169.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.96 48.77 2.07 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.74 2.96 . . . . 0.0 113.94 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -155.51 -46.16 0.08 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.511 2.724 . . . . 0.0 108.826 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.43 113.46 17.54 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 127.669 2.387 . . . . 0.0 114.015 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -59.08 122.78 14.6 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.36 117.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -139.58 148.3 42.34 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.14 1.376 . . . . 0.0 113.276 -145.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 m -65.35 91.09 0.11 Allowed 'General case' 0 CA--C 1.555 1.168 0 O-C-N 120.687 -1.258 . . . . 0.0 113.574 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.129 1.372 . . . . 0.0 110.208 154.999 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 68.8 p . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -88.41 131.87 34.68 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.936 2.094 . . . . 0.0 110.86 167.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -90.59 176.79 6.55 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -173.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -49.45 140.71 10.1 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.652 1.581 . . . . 0.0 112.932 -174.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 69.48 -20.34 0.17 Allowed 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -44.94 141.31 3.97 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 116.722 1.449 . . . . 0.0 116.722 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -70.22 138.41 51.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.911 2.084 . . . . 0.0 115.182 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 p -150.26 63.71 0.96 Allowed 'General case' 0 CA--C 1.553 1.075 0 O-C-N 121.078 -1.014 . . . . 0.0 111.851 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.2 -155.23 26.26 Favored Glycine 0 CA--C 1.55 2.278 0 C-N-CA 126.163 1.839 . . . . 0.0 115.071 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.95 -144.94 5.82 Favored Glycine 0 CA--C 1.547 2.063 0 C-N-CA 126.368 1.937 . . . . 0.0 117.446 172.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -55.28 107.01 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 O-C-N 120.887 -1.36 . . . . 0.0 112.424 174.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.74 -44.16 2.57 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 116.93 1.532 . . . . 0.0 116.93 159.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -73.93 69.21 1.4 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 119.407 1.603 . . . . 0.0 114.906 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.5 m -80.06 73.89 6.85 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.017 -1.052 . . . . 0.0 109.102 151.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.78 -170.03 12.62 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 -162.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.13 83.56 0.15 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.618 2.879 . . . . 0.0 114.332 -174.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 p -62.45 15.24 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.05 62.46 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 O-C-N 120.088 -1.632 . . . . 0.0 112.385 -162.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.6 t -57.83 162.6 3.1 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 127.282 2.233 . . . . 0.0 113.968 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.22 69.86 0.09 Allowed 'General case' 0 CA--C 1.555 1.158 0 O-C-N 120.155 -1.591 . . . . 0.0 113.781 172.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.4 t -14.28 80.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 129.06 2.944 . . . . 0.0 116.29 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.16 -55.08 0.47 Allowed Glycine 0 CA--C 1.537 1.432 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -158.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.4 p -81.59 158.18 24.47 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 120.704 0.288 . . . . 0.0 110.481 145.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.4 p -122.94 -115.58 0.3 Allowed 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -154.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.9 t 179.9 74.67 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 128.904 2.881 . . . . 0.0 110.631 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.95 131.06 55.4 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 128.233 2.613 . . . . 0.0 113.797 -162.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.6 t -63.85 103.79 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 125.405 1.482 . . . . 0.0 113.836 -173.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 mt -111.77 -51.77 2.83 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -148.05 158.38 41.89 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -161.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -51.57 -18.26 5.68 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 124.009 3.139 . . . . 0.0 117.106 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -90.0 -45.49 9.15 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.916 -1.115 . . . . 0.0 113.209 168.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.3 119.64 34.61 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.047 1.339 . . . . 0.0 114.101 -170.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -68.41 132.7 47.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 117.144 -1.822 . . . . 0.0 108.933 114.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -131.67 136.45 47.7 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -149.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.3 t -68.18 64.51 0.1 Allowed 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.723 1.209 . . . . 0.0 112.279 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.251 1.153 0 C-N-CA 126.311 1.844 . . . . 0.0 111.856 167.103 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -133.75 173.07 11.93 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 126.842 2.057 . . . . 0.0 111.446 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.6 t -121.88 -145.35 0.35 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.345 1.458 . . . . 0.0 111.725 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -50.38 134.37 23.37 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.878 1.271 . . . . 0.0 113.896 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 57.99 25.1 11.84 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 126.612 1.965 . . . . 0.0 115.987 -171.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.36 134.29 20.94 Favored Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.306 1.282 . . . . 0.0 116.306 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -72.95 130.97 41.56 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.271 1.428 . . . . 0.0 113.48 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.78 66.84 1.41 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 127.96 2.504 . . . . 0.0 109.234 160.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.96 170.93 33.22 Favored Glycine 0 CA--C 1.543 1.801 0 C-N-CA 126.479 1.99 . . . . 0.0 113.427 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.75 -54.58 27.4 Favored Glycine 0 CA--C 1.545 1.965 0 N-CA-C 119.325 2.49 . . . . 0.0 119.325 -159.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 mt -53.97 114.58 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 O-C-N 121.229 -1.159 . . . . 0.0 113.784 -165.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.76 36.02 70.33 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 125.84 1.686 . . . . 0.0 115.698 -176.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.07 175.12 9.89 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -160.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 m -158.04 -44.73 0.06 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.337 2.255 . . . . 0.0 111.866 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.18 68.31 1.21 Allowed Glycine 0 CA--C 1.547 2.056 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 164.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -61.37 66.64 0.1 OUTLIER 'Trans proline' 0 CA--C 1.551 1.325 0 C-N-CA 123.432 2.755 . . . . 0.0 111.977 152.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 p -141.57 49.99 1.59 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -157.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.97 91.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 O-C-N 121.174 -0.954 . . . . 0.0 109.307 155.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 171.18 5.46 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -166.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.69 78.95 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.9 t -36.21 123.37 0.75 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.407 1.883 . . . . 0.0 114.588 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.2 -45.73 1.25 Allowed Glycine 0 CA--C 1.543 1.801 0 C-N-CA 124.727 1.156 . . . . 0.0 110.585 -149.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.5 p -103.83 148.87 25.62 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.163 2.185 . . . . 0.0 111.771 161.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.4 p -134.75 113.27 11.48 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.413 1.485 . . . . 0.0 114.653 -158.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.0 t -63.58 88.44 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 126.041 1.736 . . . . 0.0 114.622 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -122.59 146.14 47.7 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.76 114.85 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.8 mt -125.04 -58.81 1.45 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.484 1.514 . . . . 0.0 114.97 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -135.94 162.03 59.15 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 124.222 1.009 . . . . 0.0 112.928 -155.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.66 32.95 0.29 Allowed 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.198 2.598 . . . . 0.0 114.963 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -133.74 -48.59 0.81 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.039 2.136 . . . . 0.0 110.649 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.05 135.31 51.61 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 127.746 2.418 . . . . 0.0 114.742 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.4 t -72.43 124.34 24.96 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.483 127.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -122.1 130.19 53.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.787 1.635 . . . . 0.0 112.641 -151.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.8 m -66.24 92.04 0.18 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 C--O 1.246 0.909 0 C-N-CA 124.11 0.964 . . . . 0.0 111.471 165.298 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.499 1.98 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -88.77 170.7 10.54 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.171 0.988 . . . . 0.0 112.282 171.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.1 t -116.5 -91.44 0.54 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 119.318 0.963 . . . . 0.0 113.173 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -72.14 120.28 17.52 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.545 1.538 . . . . 0.0 112.837 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 90.56 50.44 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 127.548 2.339 . . . . 0.0 116.406 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.06 132.49 10.71 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 125.732 1.634 . . . . 0.0 114.715 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -68.73 132.51 46.95 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 119.101 1.45 . . . . 0.0 113.658 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.9 m -123.43 0.76 8.91 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.68 1.992 . . . . 0.0 115.097 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.62 -146.19 6.71 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.611 1.577 . . . . 0.0 111.719 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.56 -164.52 20.45 Favored Glycine 0 CA--C 1.545 1.945 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -54.18 134.4 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 O-C-N 121.155 -1.203 . . . . 0.0 114.141 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.64 -42.73 3.13 Favored Glycine 0 CA--C 1.543 1.823 0 C-N-CA 124.927 1.251 . . . . 0.0 115.033 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -67.18 171.48 5.68 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 126.167 1.787 . . . . 0.0 114.681 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.0 p -59.47 156.45 13.09 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 130.856 3.662 . . . . 0.0 116.664 6.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.5 -163.67 26.71 Favored Glycine 0 CA--C 1.549 2.159 0 O-C-N 121.351 -0.843 . . . . 0.0 114.968 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.46 82.32 2.11 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 123.69 2.927 . . . . 0.0 113.977 -168.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.8 p -67.73 56.98 0.06 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 126.242 1.817 . . . . 0.0 114.259 172.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.92 52.38 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 O-C-N 119.88 -1.763 . . . . 0.0 112.132 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.75 157.31 17.04 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 128.105 2.562 . . . . 0.0 113.936 -170.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -101.19 127.22 47.86 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.207 1.803 . . . . 0.0 112.299 172.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.0 t -65.44 122.11 16.41 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 171.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.21 -66.99 0.29 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.488 1.994 . . . . 0.0 109.139 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.4 p -60.53 151.58 28.19 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.559 0.743 . . . . 0.0 111.583 137.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.9 p -93.96 -105.86 0.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -169.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 167.98 3.42 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 128.41 2.684 . . . . 0.0 116.184 -170.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -90.73 172.81 8.39 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 -157.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.0 m -54.05 123.25 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 127.469 2.307 . . . . 0.0 116.602 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -163.54 -55.97 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 157.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -84.52 140.48 38.57 Favored Pre-proline 0 CA--C 1.561 1.4 0 O-C-N 119.604 -1.935 . . . . 0.0 112.333 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -39.32 -52.37 2.42 Favored 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 125.264 3.976 . . . . 0.0 115.93 171.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -69.89 -42.9 72.81 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.83 -1.169 . . . . 0.0 113.079 169.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.04 104.98 9.56 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -168.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t -55.23 116.39 2.79 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.648 124.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -129.87 146.79 51.59 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -155.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.0 m -64.17 80.39 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 O-C-N 120.95 -1.094 . . . . 0.0 112.515 166.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 124.256 1.022 . . . . 0.0 110.138 151.598 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.497 1.908 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -64.17 73.85 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.01 1.324 . . . . 0.0 111.897 169.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 t -75.0 -143.54 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.661 -0.649 . . . . 0.0 111.088 160.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -44.7 103.59 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.356 1.463 . . . . 0.0 113.583 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 87.08 84.62 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 129.563 3.145 . . . . 0.0 114.255 -171.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.53 117.26 1.25 Allowed Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.315 1.436 . . . . 0.0 114.732 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -65.42 122.13 16.46 Favored 'General case' 0 CA--C 1.556 1.195 0 O-C-N 119.751 -2.029 . . . . 0.0 112.49 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.4 m -104.9 -52.53 2.84 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.919 1.288 . . . . 0.0 114.387 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.16 132.55 3.58 Favored Glycine 0 CA--C 1.543 1.837 0 C-N-CA 124.185 0.898 . . . . 0.0 114.26 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.27 -157.97 27.46 Favored Glycine 0 CA--C 1.546 2.017 0 C-N-CA 126.424 1.964 . . . . 0.0 113.029 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.0 mt -40.83 110.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 119.333 1.566 . . . . 0.0 112.764 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.37 -33.39 3.2 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 116.296 1.279 . . . . 0.0 116.296 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -82.01 55.56 2.83 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -156.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.2 t -74.53 71.56 1.85 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.357 -1.464 . . . . 0.0 108.612 147.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.0 -172.68 14.88 Favored Glycine 0 CA--C 1.546 2.008 0 N-CA-C 117.82 1.888 . . . . 0.0 117.82 -154.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.41 80.21 2.79 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.152 3.235 . . . . 0.0 112.45 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.5 p -68.9 51.12 0.08 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.856 1.662 . . . . 0.0 114.868 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -78.45 52.54 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 O-C-N 119.728 -1.857 . . . . 0.0 111.704 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 44.5 t -85.59 166.07 16.53 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.915 2.486 . . . . 0.0 115.269 -165.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.28 83.61 1.8 Allowed 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 t -43.29 109.91 0.17 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.834 1.253 . . . . 0.0 113.686 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.98 -52.37 0.79 Allowed Glycine 0 CA--C 1.539 1.584 0 C-N-CA 125.614 1.578 . . . . 0.0 110.158 -160.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.4 p -76.91 163.98 26.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.079 0.552 . . . . 0.0 109.958 140.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.7 p -114.26 -124.19 0.29 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -163.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 m -173.69 32.76 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 128.957 2.903 . . . . 0.0 111.808 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -65.08 141.98 58.54 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 119.867 -1.771 . . . . 0.0 114.676 -162.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 m -64.58 93.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.18 1.392 . . . . 0.0 113.905 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.2 mt -96.59 -48.01 5.7 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -162.86 176.14 2.52 Favored Pre-proline 0 CA--C 1.559 1.326 0 O-C-N 120.832 -1.168 . . . . 0.0 113.94 -165.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.95 -39.15 92.06 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.482 2.788 . . . . 0.0 115.106 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -67.3 -39.55 85.94 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.61 116.73 8.93 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 117.768 2.507 . . . . 0.0 117.768 -164.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.11 125.58 19.54 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.59 111.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -144.04 127.32 16.73 Favored 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -154.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.0 m -63.46 78.58 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.66 1.584 . . . . 0.0 113.043 174.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.6 mt . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.187 151.273 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 . . . . . 0 CA--C 1.553 1.065 0 CA-C-O 121.838 0.828 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.8 m -59.71 -55.65 31.73 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -171.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -115.17 140.77 48.8 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.939 1.296 . . . . 0.0 114.028 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 62.9 41.92 8.16 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 125.564 1.546 . . . . 0.0 113.17 -171.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.09 109.91 3.68 Favored Glycine 0 CA--C 1.54 1.64 0 C-N-CA 126.113 1.815 . . . . 0.0 114.588 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -52.41 124.36 13.23 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.362 1.465 . . . . 0.0 114.09 176.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 m -118.51 -0.37 11.41 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.58 114.64 0.33 Allowed Glycine 0 CA--C 1.546 2.005 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -175.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.63 -160.28 30.15 Favored Glycine 0 CA--C 1.552 2.384 0 C-N-CA 126.391 1.948 . . . . 0.0 115.023 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -45.64 124.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.7 -13.13 49.43 Favored Glycine 0 CA--C 1.544 1.894 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -89.69 167.43 12.91 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 119.08 1.44 . . . . 0.0 114.856 -172.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 94.2 p -131.49 -92.42 0.4 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.635 1.574 . . . . 0.0 110.881 166.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.2 38.61 0.52 Allowed Glycine 0 CA--C 1.548 2.147 0 N-CA-C 118.294 2.078 . . . . 0.0 118.294 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -76.1 50.58 2.88 Favored 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 123.384 2.723 . . . . 0.0 112.198 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.2 p -77.67 66.6 3.4 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.212 -1.555 . . . . 0.0 113.119 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 t -76.46 51.87 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 O-C-N 120.874 -1.141 . . . . 0.0 112.088 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.1 t -98.59 169.4 9.54 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 129.722 3.209 . . . . 0.0 111.915 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.4 159.37 16.44 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.691 -1.256 . . . . 0.0 112.238 169.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.8 t -72.89 -177.13 2.26 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 161.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.68 -57.02 5.03 Favored Glycine 0 CA--C 1.542 1.742 0 O-C-N 120.857 -1.152 . . . . 0.0 111.688 -165.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.1 p -76.8 177.79 7.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.233 1.013 . . . . 0.0 111.224 153.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -129.11 -128.71 0.21 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -159.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.4 m 179.85 62.51 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 128.645 2.778 . . . . 0.0 111.835 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -128.82 157.83 40.4 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -165.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.39 132.77 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -167.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.1 -113.09 0.16 Allowed 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.745 1.218 . . . . 0.0 112.762 151.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.35 157.45 71.42 Favored Pre-proline 0 CA--C 1.562 1.409 0 O-C-N 119.566 -1.959 . . . . 0.0 114.51 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.79 -17.35 0.71 Allowed 'Trans proline' 0 CA--C 1.554 1.506 0 C-N-CA 124.622 3.548 . . . . 0.0 117.969 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -74.15 -25.52 59.79 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.96 105.31 2.73 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -154.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -71.78 117.3 13.19 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 121.465 -0.772 . . . . 0.0 109.422 130.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -138.97 151.32 46.77 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -160.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.7 m -57.97 76.33 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.527 1.931 . . . . 0.0 113.028 169.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 C--O 1.257 1.483 0 C-N-CA 125.161 1.384 . . . . 0.0 111.237 153.593 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? . . . . . 0 CA--C 1.56 1.354 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.8 m -77.01 154.37 33.55 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -168.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -41.13 146.77 0.16 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.134 1.774 . . . . 0.0 114.112 162.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 60.66 12.67 3.8 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.39 140.4 33.67 Favored Glycine 0 CA--C 1.545 1.937 0 O-C-N 119.807 -1.808 . . . . 0.0 115.254 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -64.95 119.31 10.48 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.572 -1.546 . . . . 0.0 112.78 173.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.5 38.28 3.79 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.453 1.479 . . . . 0.0 113.093 166.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.03 159.85 22.76 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 125.088 1.328 . . . . 0.0 114.685 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.87 -49.85 51.7 Favored Glycine 0 CA--C 1.545 1.955 0 N-CA-C 119.066 2.386 . . . . 0.0 119.066 -158.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.3 mt -58.32 119.72 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 O-C-N 120.724 -1.456 . . . . 0.0 112.983 -168.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.23 25.4 75.61 Favored Glycine 0 CA--C 1.543 1.838 0 C-N-CA 124.755 1.169 . . . . 0.0 115.548 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.22 -170.59 3.53 Favored 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 115.734 1.754 . . . . 0.0 115.734 -166.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.8 p -146.34 -69.29 0.26 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.993 2.117 . . . . 0.0 110.702 175.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.1 64.99 0.52 Allowed Glycine 0 CA--C 1.541 1.699 0 N-CA-C 117.584 1.794 . . . . 0.0 117.584 156.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.54 34.73 0.38 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 C-N-CA 122.663 2.242 . . . . 0.0 112.757 166.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.0 p -84.09 66.36 9.21 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 119.814 -1.804 . . . . 0.0 113.393 -170.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 t -65.35 78.45 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.996 0.919 . . . . 0.0 109.762 163.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 174.27 7.68 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 -168.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.54 73.08 0.06 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.329 1.451 . . . . 0.0 113.721 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.8 t -37.8 109.21 0.09 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.549 1.94 . . . . 0.0 114.74 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.78 -55.56 0.72 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.11 1.814 . . . . 0.0 108.69 -158.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.7 p -70.66 168.49 16.39 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.299 -0.451 . . . . 0.0 111.714 141.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -126.03 -114.04 0.28 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.852 1.661 . . . . 0.0 114.616 -166.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.0 m 162.3 65.35 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.806 0 C-N-CA 131.448 3.899 . . . . 0.0 111.504 -169.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -135.79 165.28 25.97 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 -171.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -68.1 136.52 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 118.178 2.659 . . . . 0.0 118.178 -159.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.39 -46.37 0.51 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.321 1.449 . . . . 0.0 114.532 155.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -130.22 161.18 61.77 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.996 1.319 . . . . 0.0 112.914 -176.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.81 50.05 2.01 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 123.43 2.753 . . . . 0.0 113.865 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -152.82 -49.49 0.1 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.467 2.307 . . . . 0.0 110.437 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.35 100.86 9.39 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.387 2.275 . . . . 0.0 113.374 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.0 t -70.26 88.56 0.63 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 140.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -88.32 148.92 24.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.281 1.832 . . . . 0.0 114.093 -158.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 m -63.81 75.53 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.712 -1.243 . . . . 0.0 112.501 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.208 -1.377 . . . . 0.0 110.806 163.712 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.5 t -66.72 -111.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 157.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -62.99 110.88 1.94 Allowed 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.901 -1.124 . . . . 0.0 112.622 170.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.255 27.4 m-85 89.67 94.26 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 129.424 3.09 . . . . 0.0 115.835 177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.88 129.45 3.08 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 126.532 2.015 . . . . 0.0 113.533 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -71.39 133.97 46.32 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 125.126 1.37 . . . . 0.0 113.561 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 m -140.4 20.11 2.39 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.83 129.69 2.54 Favored Glycine 0 CA--C 1.544 1.854 0 O-C-N 120.406 -1.433 . . . . 0.0 115.178 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.36 -158.12 28.68 Favored Glycine 0 CA--C 1.545 1.965 0 C-N-CA 126.124 1.821 . . . . 0.0 112.437 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.1 mt -43.39 105.63 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-N 119.274 1.537 . . . . 0.0 112.352 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.45 -32.84 2.31 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -73.19 56.49 0.46 Allowed 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -167.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.9 m -73.52 60.78 0.67 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.95 1.3 . . . . 0.0 109.389 155.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.7 -173.45 13.31 Favored Glycine 0 CA--C 1.544 1.903 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 -150.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.35 89.63 1.31 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.955 3.103 . . . . 0.0 112.015 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.5 p -72.61 62.75 0.57 Allowed 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.354 -1.467 . . . . 0.0 113.714 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.69 56.37 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 125.332 1.453 . . . . 0.0 112.254 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.3 t -101.55 151.61 21.77 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.725 2.01 . . . . 0.0 113.933 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.5 90.06 6.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.636 1.574 . . . . 0.0 112.641 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -42.72 115.63 0.75 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.424 1.09 . . . . 0.0 112.946 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.74 -51.84 0.75 Allowed Glycine 0 CA--C 1.539 1.533 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -152.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.5 p -82.98 166.8 18.53 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.634 0.373 . . . . 0.0 111.854 140.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.5 p -99.64 -88.41 0.34 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -158.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.3 m 124.78 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 131.507 3.923 . . . . 0.0 111.508 -163.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -119.12 152.94 35.63 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 126.416 1.887 . . . . 0.0 114.067 -172.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.4 m -57.2 123.91 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -171.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.98 -38.71 3.19 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 156.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -160.86 167.81 12.88 Favored Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -165.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.97 -29.01 25.83 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 124.013 3.142 . . . . 0.0 117.347 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -81.54 -19.8 41.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.231 1.013 . . . . 0.0 113.729 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.28 113.48 3.45 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -165.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 t -67.44 140.86 57.14 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.441 118.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -160.39 135.44 7.83 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -145.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.4 m -67.17 76.64 0.14 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.0 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.463 -1.256 . . . . 0.0 111.264 141.657 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 . . . . . 0 CA--C 1.554 1.1 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.0 t -77.93 -102.21 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.257 -0.902 . . . . 0.0 113.034 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.44 127.91 34.69 Favored 'General case' 0 CA--C 1.553 1.091 0 O-C-N 121.034 -1.041 . . . . 0.0 113.459 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.261 37.2 m-85 77.7 47.7 0.05 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 126.931 2.092 . . . . 0.0 115.429 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.62 120.35 6.85 Favored Glycine 0 CA--C 1.545 1.917 0 C-N-CA 125.884 1.707 . . . . 0.0 115.832 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -68.21 103.46 1.58 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.844 1.322 . . . . 0.0 114.312 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -104.04 57.72 0.72 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.944 1.298 . . . . 0.0 110.826 167.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.14 162.81 36.6 Favored Glycine 0 CA--C 1.544 1.881 0 O-C-N 120.467 -1.396 . . . . 0.0 116.472 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.15 -76.21 0.19 Allowed Glycine 0 CA--C 1.544 1.906 0 N-CA-C 119.043 2.377 . . . . 0.0 119.043 -157.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.5 108.25 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 O-C-N 120.981 -1.305 . . . . 0.0 112.075 -164.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.08 -26.97 11.4 Favored Glycine 0 CA--C 1.546 2.025 0 C-N-CA 125.805 1.669 . . . . 0.0 116.446 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -109.73 65.19 0.61 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 -148.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.3 p -70.06 49.39 0.1 Allowed 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.369 -1.457 . . . . 0.0 112.339 162.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.01 156.42 22.15 Favored Glycine 0 CA--C 1.547 2.05 0 N-CA-C 116.33 1.292 . . . . 0.0 116.33 -158.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -82.52 116.93 2.66 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.361 2.708 . . . . 0.0 110.811 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.3 p -71.19 65.66 0.4 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 120.451 -1.406 . . . . 0.0 113.227 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -73.63 61.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 125.248 1.419 . . . . 0.0 112.015 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.2 t -95.06 153.76 17.49 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 127.012 2.125 . . . . 0.0 114.297 -173.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.03 100.37 13.2 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.305 1.042 . . . . 0.0 113.01 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.9 p -49.99 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.954 1.702 . . . . 0.0 114.112 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.83 -48.87 0.32 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.957 1.265 . . . . 0.0 110.235 -159.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.8 p -84.98 158.12 20.59 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 120.873 0.368 . . . . 0.0 111.349 138.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.2 p -101.4 -84.83 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -150.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.5 m 126.03 62.08 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 131.574 3.949 . . . . 0.0 111.049 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -126.91 137.59 53.17 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.3 t -50.52 115.59 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 127.076 2.151 . . . . 0.0 115.101 -170.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.0 mt -101.6 -42.16 6.33 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.907 0.883 . . . . 0.0 113.006 163.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -158.1 166.14 17.16 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 126.905 2.082 . . . . 0.0 110.315 -163.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.93 25.65 0.18 Allowed 'Trans proline' 0 CA--C 1.557 1.65 0 C-N-CA 122.768 2.312 . . . . 0.0 115.005 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -122.29 -66.87 1.0 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.795 2.038 . . . . 0.0 109.902 171.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.43 109.59 22.31 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.549 2.34 . . . . 0.0 113.42 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -76.56 102.35 6.05 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 136.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -97.85 137.91 36.0 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.969 1.708 . . . . 0.0 113.327 -156.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.7 m -64.95 75.84 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.742 -1.224 . . . . 0.0 112.842 166.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.246 0.897 0 C-N-CA 125.41 1.484 . . . . 0.0 111.304 157.878 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 . . . . . 0 CA--C 1.551 0.989 0 N-CA-C 110.819 -0.067 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 t -74.11 178.51 4.99 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -57.68 139.54 53.5 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.035 1.334 . . . . 0.0 114.219 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 73.64 26.65 1.88 Allowed 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 127.6 2.36 . . . . 0.0 115.451 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.43 136.03 12.59 Favored Glycine 0 CA--C 1.549 2.216 0 O-C-N 119.45 -2.031 . . . . 0.0 116.228 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -58.58 126.74 28.88 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 119.747 -2.031 . . . . 0.0 113.732 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.54 45.32 2.06 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 127.317 2.247 . . . . 0.0 110.991 165.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.99 164.32 27.91 Favored Glycine 0 CA--C 1.541 1.694 0 O-C-N 120.615 -1.303 . . . . 0.0 115.06 -169.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.37 -45.4 9.92 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 119.101 2.4 . . . . 0.0 119.101 -149.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.9 mt -53.36 118.48 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 O-C-N 120.693 -1.475 . . . . 0.0 112.919 -170.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.08 33.89 76.68 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 124.645 1.117 . . . . 0.0 115.509 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.1 -179.74 5.96 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -166.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -165.55 -57.21 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.192 2.197 . . . . 0.0 110.59 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 55.15 87.84 0.01 OUTLIER Glycine 0 CA--C 1.548 2.154 0 N-CA-C 118.701 2.241 . . . . 0.0 118.701 155.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -66.92 71.16 0.5 Allowed 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.449 2.766 . . . . 0.0 111.391 166.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -90.08 61.49 5.22 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.672 1.989 . . . . 0.0 113.771 -160.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.26 79.57 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 O-C-N 121.145 -0.972 . . . . 0.0 110.96 171.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.1 t -50.19 153.48 1.44 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.283 2.233 . . . . 0.0 113.907 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.13 74.21 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 O-C-N 120.709 -1.244 . . . . 0.0 113.275 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.9 t -33.45 98.79 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 127.721 2.408 . . . . 0.0 114.804 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.27 -53.97 0.58 Allowed Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.555 1.55 . . . . 0.0 109.396 -156.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.5 p -82.93 166.93 18.47 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.246 0.618 . . . . 0.0 110.78 143.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -117.95 -92.21 0.53 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.161 2.652 . . . . 0.0 118.161 -152.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.3 m 131.14 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 1 C-N-CA 131.797 4.039 . . . . 0.0 113.429 -166.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -134.22 157.72 45.54 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.7 t -54.45 112.52 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -164.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.6 mt -85.85 -55.68 3.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.456 1.102 . . . . 0.0 112.629 153.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -167.55 176.49 1.64 Allowed Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 125.588 1.555 . . . . 0.0 112.185 -159.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.9 -41.81 38.75 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.202 3.268 . . . . 0.0 115.983 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -67.21 -45.06 77.98 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.319 -0.863 . . . . 0.0 113.07 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.58 95.73 4.2 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -151.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -77.28 102.06 6.54 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 144.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -105.21 142.06 35.64 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.114 1.765 . . . . 0.0 113.949 -159.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.4 t -56.31 71.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 127.926 2.49 . . . . 0.0 112.321 167.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 mt . . . . . 0 C--O 1.248 1.0 0 C-N-CA 129.789 3.236 . . . . 0.0 112.838 174.644 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? . . . . . 0 CA--C 1.554 1.121 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.7 t -112.27 -102.42 0.41 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.546 1.138 . . . . 0.0 112.823 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -68.63 122.17 17.96 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.937 1.295 . . . . 0.0 112.874 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 86.4 61.82 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 128.021 2.529 . . . . 0.0 115.588 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.14 139.49 13.83 Favored Glycine 0 CA--C 1.549 2.184 0 C-N-CA 125.863 1.697 . . . . 0.0 114.48 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -82.39 116.29 21.8 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 118.998 1.399 . . . . 0.0 114.081 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.66 55.59 0.91 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.054 1.742 . . . . 0.0 111.001 171.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.21 163.74 35.1 Favored Glycine 0 CA--C 1.54 1.652 0 O-C-N 120.671 -1.268 . . . . 0.0 114.435 -173.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.99 -64.15 4.31 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 118.697 2.239 . . . . 0.0 118.697 -160.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.3 mt -60.07 116.1 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 O-C-N 120.738 -1.448 . . . . 0.0 112.775 -164.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.01 -12.43 69.54 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 126.153 1.835 . . . . 0.0 116.557 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -111.91 75.21 0.91 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -153.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.2 p -74.42 26.62 0.08 Allowed 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.427 -1.421 . . . . 0.0 113.605 154.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.93 160.35 17.87 Favored Glycine 0 CA--C 1.545 1.939 0 C-N-CA 124.89 1.233 . . . . 0.0 116.008 -165.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.63 124.55 4.08 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 123.292 2.662 . . . . 0.0 111.472 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.7 p -73.84 62.99 0.87 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.964 1.306 . . . . 0.0 113.717 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 t -74.42 53.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 O-C-N 120.184 -1.573 . . . . 0.0 113.477 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.9 t -100.26 159.52 15.05 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 128.161 2.585 . . . . 0.0 114.455 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.35 104.65 16.56 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.616 1.966 . . . . 0.0 113.655 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.0 t -47.15 117.34 1.69 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.181 1.393 . . . . 0.0 112.728 169.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.83 -52.17 0.72 Allowed Glycine 0 CA--C 1.538 1.497 0 C-N-CA 126.144 1.83 . . . . 0.0 109.211 -160.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.9 p -74.42 162.03 29.24 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.198 -0.501 . . . . 0.0 111.11 140.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.0 p -98.57 -90.17 0.29 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -166.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.1 m 125.84 57.26 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 131.628 3.971 . . . . 0.0 110.805 -162.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -118.93 142.23 47.95 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.701 1.601 . . . . 0.0 115.013 -164.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.1 t -51.16 102.04 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 126.449 1.9 . . . . 0.0 114.319 -170.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.3 mt -107.41 -50.12 3.13 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.759 1.224 . . . . 0.0 114.04 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -153.37 166.84 14.71 Favored Pre-proline 0 CA--C 1.557 1.225 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -163.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.51 -35.27 65.84 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.285 2.657 . . . . 0.0 114.982 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -72.17 -54.32 10.04 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.093 1.357 . . . . 0.0 112.513 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.19 120.13 34.32 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.557 1.543 . . . . 0.0 114.354 -166.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -71.97 119.53 16.28 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 126.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -126.43 143.41 51.19 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.115 -0.99 . . . . 0.0 113.393 -151.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.8 m -67.68 81.56 0.18 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.266 -0.896 . . . . 0.0 112.523 171.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 C--O 1.255 1.364 0 CA-C-O 117.286 -1.34 . . . . 0.0 109.645 146.489 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.9 t -64.37 168.44 5.7 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -48.52 131.4 17.31 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.904 0.882 . . . . 0.0 112.165 167.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 69.72 74.07 0.23 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.405 1.482 . . . . 0.0 113.338 -173.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.89 145.02 12.7 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 125.128 1.347 . . . . 0.0 114.187 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -70.83 131.63 44.08 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.708 -1.466 . . . . 0.0 114.891 -173.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.17 57.32 1.79 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.263 1.825 . . . . 0.0 110.687 170.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.24 168.59 41.16 Favored Glycine 0 CA--C 1.545 1.963 0 O-C-N 120.47 -1.394 . . . . 0.0 115.502 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.62 -76.1 0.14 Allowed Glycine 0 CA--C 1.545 1.934 0 C-N-CA 127.468 2.461 . . . . 0.0 119.201 -162.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.5 mt -61.24 96.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.055 -1.262 . . . . 0.0 112.564 -164.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.6 13.93 31.2 Favored Glycine 0 CA--C 1.544 1.895 0 C-N-CA 126.279 1.895 . . . . 0.0 116.409 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.05 164.87 28.87 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 120.022 1.911 . . . . 0.0 116.147 -173.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 t -127.08 -65.13 0.96 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.084 2.154 . . . . 0.0 110.406 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.92 75.9 0.07 OUTLIER Glycine 0 CA--C 1.545 1.968 0 N-CA-C 119.407 2.523 . . . . 0.0 119.407 151.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.81 52.55 0.54 Allowed 'Trans proline' 0 CA--C 1.554 1.481 0 C-N-CA 123.514 2.809 . . . . 0.0 112.114 157.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.4 p -73.24 29.75 0.07 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 -162.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.5 t -75.5 66.78 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 O-C-N 119.967 -1.708 . . . . 0.0 111.72 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 52.5 t -59.57 158.88 9.16 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.844 2.057 . . . . 0.0 113.95 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.74 61.77 0.17 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.521 1.529 . . . . 0.0 114.596 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -6.06 75.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 130.12 3.368 . . . . 0.0 116.52 176.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.46 -51.71 0.48 Allowed Glycine 0 CA--C 1.535 1.327 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -158.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.6 p -80.5 160.09 25.34 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.473 0.309 . . . . 0.0 110.393 140.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.1 p -116.21 -84.83 0.63 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -156.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.8 m 127.33 61.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 131.571 3.948 . . . . 0.0 112.102 -167.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -123.54 146.52 48.05 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 125.848 1.659 . . . . 0.0 115.253 -166.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.93 113.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.546 1.939 . . . . 0.0 114.932 -169.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.7 mt -116.45 -46.59 2.77 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -152.63 165.02 18.46 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 120.856 -1.153 . . . . 0.0 113.28 -161.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.79 43.02 0.75 Allowed 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 123.251 2.634 . . . . 0.0 114.204 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -143.41 -54.66 0.38 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.773 2.429 . . . . 0.0 108.552 172.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.26 124.05 48.1 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 128.02 2.528 . . . . 0.0 113.838 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -68.09 134.79 51.18 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.69 120.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -136.82 132.55 34.8 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.977 -1.077 . . . . 0.0 111.618 -144.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.3 t -66.6 67.17 0.06 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.055 1.742 . . . . 0.0 112.293 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--O 1.247 0.974 0 C-N-CA 126.733 2.013 . . . . 0.0 112.242 167.441 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.5 t -106.31 -162.71 0.87 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.211 1.804 . . . . 0.0 112.037 166.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -52.05 143.49 13.86 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -174.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 57.68 8.87 0.73 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 126.712 2.005 . . . . 0.0 116.051 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.8 150.35 35.65 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.248 -1.533 . . . . 0.0 115.933 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -89.28 114.07 25.4 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.273 1.429 . . . . 0.0 113.285 -171.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.35 62.61 0.77 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.965 1.306 . . . . 0.0 112.927 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.88 -128.69 5.93 Favored Glycine 0 CA--C 1.547 2.048 0 N-CA-C 116.444 1.338 . . . . 0.0 116.444 168.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.5 -150.37 26.27 Favored Glycine 0 CA--C 1.549 2.17 0 O-C-N 120.926 -1.338 . . . . 0.0 115.654 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.0 mt -53.79 110.77 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 O-C-N 120.756 -1.438 . . . . 0.0 113.115 175.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.74 -37.54 3.17 Favored Glycine 0 CA--C 1.546 2.018 0 N-CA-C 117.005 1.562 . . . . 0.0 117.005 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.68 81.83 1.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -158.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.7 p -72.75 5.22 3.31 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 166.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 142.85 35.25 Favored Glycine 0 CA--C 1.552 2.356 0 O-C-N 120.375 -1.453 . . . . 0.0 115.286 -173.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -80.31 66.22 8.83 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.664 2.91 . . . . 0.0 112.574 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.9 p -84.36 48.12 1.45 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 119.797 -1.814 . . . . 0.0 115.311 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -51.94 108.45 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 O-C-N 121.063 -1.023 . . . . 0.0 110.515 162.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.72 -178.69 4.77 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -160.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.69 71.27 0.08 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.68 1.592 . . . . 0.0 112.846 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -37.39 107.21 0.06 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.62 1.968 . . . . 0.0 114.483 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.31 -54.94 0.74 Allowed Glycine 0 CA--C 1.536 1.347 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -158.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.6 p -72.37 170.24 14.62 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.485 0.314 . . . . 0.0 111.484 142.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.3 p -119.74 -113.34 0.33 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -168.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 m 154.13 60.4 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 129.887 3.275 . . . . 0.0 110.474 -166.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -129.69 147.01 51.43 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 126.756 2.023 . . . . 0.0 115.742 -166.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.7 m -51.48 131.8 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -168.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.22 -76.1 0.17 Allowed 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 155.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -81.48 153.24 70.96 Favored Pre-proline 0 CA--C 1.561 1.396 0 O-C-N 120.191 -1.568 . . . . 0.0 112.886 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -58.81 -11.59 12.41 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.458 2.772 . . . . 0.0 116.033 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -91.55 -10.86 39.08 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.993 1.317 . . . . 0.0 113.881 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.96 113.62 5.02 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -166.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -74.21 95.75 2.66 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 137.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -101.21 145.95 28.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.774 1.63 . . . . 0.0 113.816 -154.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.7 m -65.57 75.25 0.07 Allowed 'General case' 0 CA--C 1.551 0.992 0 O-C-N 120.767 -1.208 . . . . 0.0 114.084 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.571 -1.204 . . . . 0.0 112.464 165.45 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 . . . . . 0 CA--C 1.556 1.182 0 CA-C-O 121.519 0.676 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -79.71 -117.1 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.337 1.455 . . . . 0.0 113.009 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -63.66 123.18 18.18 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 121.175 -0.953 . . . . 0.0 112.463 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 79.19 39.75 0.11 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 127.806 2.443 . . . . 0.0 115.11 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.28 122.41 7.56 Favored Glycine 0 CA--C 1.551 2.341 0 N-CA-C 116.607 1.403 . . . . 0.0 116.607 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -66.98 112.12 4.17 Favored 'General case' 0 CA--C 1.556 1.21 0 O-C-N 119.872 -1.957 . . . . 0.0 115.773 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -109.77 50.16 0.81 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.849 1.66 . . . . 0.0 111.588 164.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.37 158.55 29.04 Favored Glycine 0 CA--C 1.54 1.617 0 O-C-N 120.202 -1.561 . . . . 0.0 116.353 -171.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.88 -68.14 1.52 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 119.024 2.369 . . . . 0.0 119.024 -161.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.8 mt -60.68 101.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 120.988 -1.301 . . . . 0.0 112.401 -165.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.19 -28.28 10.58 Favored Glycine 0 CA--C 1.546 1.992 0 C-N-CA 126.242 1.877 . . . . 0.0 115.7 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -106.07 62.27 0.66 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -150.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.2 p -68.69 58.77 0.09 Allowed 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.235 -1.541 . . . . 0.0 111.64 159.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.52 161.56 27.98 Favored Glycine 0 CA--C 1.547 2.042 0 N-CA-C 116.214 1.245 . . . . 0.0 116.214 -158.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -83.88 130.15 4.91 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.092 3.195 . . . . 0.0 112.225 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.5 p -79.56 69.34 5.83 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.302 -1.499 . . . . 0.0 112.31 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.3 t -77.19 57.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.983 1.313 . . . . 0.0 112.525 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.1 t -105.53 149.5 26.18 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.829 2.052 . . . . 0.0 115.121 -158.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.07 62.87 6.82 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -171.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -19.76 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.567 2.347 . . . . 0.0 115.397 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.88 -54.38 0.55 Allowed Glycine 0 CA--C 1.54 1.637 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -151.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.7 p -70.79 154.3 41.97 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 122.807 -0.231 . . . . 0.0 111.319 137.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.7 p -101.08 -117.75 0.17 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -162.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.3 m 162.51 51.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 131.058 3.743 . . . . 0.0 111.102 -172.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -121.47 149.88 42.4 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 119.99 -1.694 . . . . 0.0 115.314 -167.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 m -57.4 137.62 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -171.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -152.73 -59.84 0.15 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.859 1.264 . . . . 0.0 113.675 161.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -92.3 150.66 40.53 Favored Pre-proline 0 CA--C 1.561 1.371 0 O-C-N 120.554 -1.341 . . . . 0.0 112.777 168.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.88 -26.32 57.26 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.702 2.935 . . . . 0.0 115.101 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -45.04 70.53 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.217 -0.927 . . . . 0.0 112.989 175.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.21 113.47 19.51 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.413 1.885 . . . . 0.0 114.106 -167.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.7 t -70.36 113.85 7.92 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 136.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -127.2 137.03 52.83 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -147.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -59.82 79.9 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.415 1.086 . . . . 0.0 112.749 167.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.105 146.903 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -85.74 175.68 8.57 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -49.85 135.76 19.12 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.681 1.193 . . . . 0.0 112.658 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 69.15 -2.28 1.86 Allowed 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -169.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.73 144.88 49.7 Favored Glycine 0 CA--C 1.549 2.178 0 O-C-N 119.906 -1.746 . . . . 0.0 115.185 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.77 136.51 36.76 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -167.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.67 35.54 4.82 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 126.316 1.846 . . . . 0.0 113.241 161.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.26 168.96 21.32 Favored Glycine 0 CA--C 1.54 1.632 0 O-C-N 120.472 -1.392 . . . . 0.0 114.712 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.97 -45.41 83.39 Favored Glycine 0 CA--C 1.544 1.896 0 N-CA-C 117.855 1.902 . . . . 0.0 117.855 -158.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.7 mm -56.92 109.22 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 O-C-N 121.175 -1.191 . . . . 0.0 113.113 -170.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.46 39.11 96.61 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 125.758 1.647 . . . . 0.0 115.418 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.1 178.98 6.78 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 -168.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 91.3 p -136.73 -84.92 0.34 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.805 1.642 . . . . 0.0 111.046 172.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.5 53.04 0.05 OUTLIER Glycine 0 CA--C 1.545 1.95 0 N-CA-C 117.979 1.952 . . . . 0.0 117.979 169.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.1 46.57 1.14 Allowed 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 123.39 2.727 . . . . 0.0 112.674 169.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.3 p -70.94 23.38 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -164.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 t -77.34 63.28 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 O-C-N 119.798 -1.814 . . . . 0.0 112.181 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.1 t -55.43 154.93 5.73 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.564 1.545 . . . . 0.0 114.682 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.17 73.35 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 O-C-N 120.608 -1.308 . . . . 0.0 112.621 165.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.1 t -38.3 109.16 0.09 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.344 1.858 . . . . 0.0 114.687 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.82 -53.24 0.71 Allowed Glycine 0 CA--C 1.537 1.469 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -156.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.3 p -82.05 163.4 22.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.299 0.64 . . . . 0.0 110.736 146.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 33.8 p -113.44 -120.17 0.3 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -161.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' THR . 47.4 t 171.42 51.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 127.79 2.436 . . . . 0.0 111.315 -169.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -129.54 146.67 51.33 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.676 1.59 . . . . 0.0 115.197 -154.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 m -51.12 127.84 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.3 0.0 OUTLIER -148.76 -99.56 0.08 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 125.112 1.365 . . . . 0.0 113.64 158.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -53.64 146.38 25.85 Favored Pre-proline 0 CA--C 1.565 1.535 0 O-C-N 119.553 -1.967 . . . . 0.0 113.994 169.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -58.23 -28.68 85.14 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.808 3.005 . . . . 0.0 115.045 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -66.22 -33.26 75.34 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 121.035 -1.04 . . . . 0.0 113.77 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.58 115.9 9.97 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.621 1.568 . . . . 0.0 114.917 -166.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -66.43 121.24 14.86 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.842 -1.161 . . . . 0.0 108.525 136.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -129.97 142.8 50.59 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -149.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.7 t -69.19 66.51 0.16 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.832 2.053 . . . . 0.0 112.744 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.9 2.08 . . . . 0.0 112.846 170.872 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -89.53 -166.86 1.7 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 125.072 1.349 . . . . 0.0 114.504 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -59.44 149.96 27.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.282 1.433 . . . . 0.0 114.829 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 61.36 5.12 1.07 Allowed 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.17 130.97 51.79 Favored Glycine 0 CA--C 1.546 1.987 0 O-C-N 119.494 -2.004 . . . . 0.0 115.019 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -66.63 125.7 26.62 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 120.693 -1.475 . . . . 0.0 111.965 175.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -119.32 40.58 3.31 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 125.424 1.489 . . . . 0.0 110.971 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.03 158.77 27.84 Favored Glycine 0 CA--C 1.544 1.904 0 C-N-CA 125.181 1.372 . . . . 0.0 115.195 -170.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.67 -58.77 11.92 Favored Glycine 0 CA--C 1.549 2.187 0 N-CA-C 120.324 2.89 . . . . 0.0 120.324 -158.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.9 mt -57.08 107.34 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 O-C-N 120.643 -1.504 . . . . 0.0 113.22 -165.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.04 19.47 62.87 Favored Glycine 0 CA--C 1.544 1.866 0 C-N-CA 126.254 1.883 . . . . 0.0 115.786 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -140.92 117.02 10.55 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.6 p -120.26 42.85 2.86 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.165 1.386 . . . . 0.0 112.466 163.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.52 122.84 7.17 Favored Glycine 0 CA--C 1.547 2.084 0 C-N-CA 125.083 1.325 . . . . 0.0 114.745 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.46 63.11 7.16 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.588 2.859 . . . . 0.0 111.823 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.8 p -77.56 66.3 3.25 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.273 -1.517 . . . . 0.0 114.28 -176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.26 89.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.905 0.882 . . . . 0.0 109.365 155.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.28 177.44 7.26 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -166.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.43 68.92 0.14 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.878 1.271 . . . . 0.0 113.782 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.2 t -28.75 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 127.156 2.182 . . . . 0.0 114.535 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.63 -54.45 0.62 Allowed Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.283 1.42 . . . . 0.0 109.638 -155.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -77.24 176.3 8.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.287 0.635 . . . . 0.0 111.16 142.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 p -127.92 -124.06 0.23 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.367 1.467 . . . . 0.0 114.582 -167.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 m 167.85 55.08 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 128.867 2.867 . . . . 0.0 111.383 -168.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . 0.266 2.8 pp0? -139.25 169.2 18.2 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -168.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.79 139.88 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -148.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.32 -67.97 0.12 Allowed 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 160.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -88.98 147.64 39.24 Favored Pre-proline 0 CA--C 1.555 1.139 0 O-C-N 120.395 -1.44 . . . . 0.0 112.705 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -54.82 -28.63 58.96 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.531 2.821 . . . . 0.0 115.026 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.85 -44.7 72.85 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 121.077 -1.015 . . . . 0.0 112.698 174.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.21 109.7 15.28 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.042 1.737 . . . . 0.0 115.27 -167.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -64.37 103.59 0.66 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 134.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -111.05 148.8 31.81 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.672 1.589 . . . . 0.0 114.192 -155.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.0 m -68.21 70.58 0.16 Allowed 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.254 1.294 0 CA-C-O 117.65 -1.167 . . . . 0.0 111.304 157.875 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.4 t -86.85 -117.47 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.875 0.87 . . . . 0.0 111.347 167.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -47.83 159.99 0.15 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 172.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 73.38 58.43 0.1 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.303 1.841 . . . . 0.0 115.392 162.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.24 135.86 7.74 Favored Glycine 0 CA--C 1.545 1.958 0 C-N-CA 126.168 1.842 . . . . 0.0 112.653 171.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -76.21 128.85 35.75 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.009 -1.289 . . . . 0.0 113.933 -173.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -111.78 57.66 0.64 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 126.59 1.956 . . . . 0.0 110.892 170.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.12 156.39 27.47 Favored Glycine 0 CA--C 1.544 1.85 0 O-C-N 120.889 -1.132 . . . . 0.0 115.333 -169.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.96 -48.75 5.94 Favored Glycine 0 CA--C 1.546 2.024 0 N-CA-C 118.147 2.019 . . . . 0.0 118.147 -159.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.66 122.97 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.595 -1.533 . . . . 0.0 112.828 -171.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.41 34.96 91.32 Favored Glycine 0 CA--C 1.544 1.855 0 C-N-CA 124.85 1.214 . . . . 0.0 115.089 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.38 -172.6 3.99 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -166.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.1 p -160.52 -87.75 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.659 1.984 . . . . 0.0 110.416 168.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.76 36.66 1.6 Allowed Glycine 0 CA--C 1.552 2.386 0 N-CA-C 119.773 2.669 . . . . 0.0 119.773 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -62.9 37.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.637 0 CA-C-N 122.145 2.972 . . . . 0.0 116.809 165.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.5 p -75.43 57.93 0.96 Allowed 'General case' 0 N--CA 1.481 1.083 0 O-C-N 119.432 -2.043 . . . . 0.0 113.575 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 18' ' ' VAL . 39.0 t -73.51 28.8 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.44 0 O-C-N 119.922 -1.736 . . . . 0.0 114.347 -176.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.2 t -95.75 157.68 15.79 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 129.303 3.041 . . . . 0.0 113.549 -173.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.43 108.06 19.38 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.254 1.422 . . . . 0.0 112.766 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -56.11 150.67 13.53 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.31 -47.69 1.02 Allowed Glycine 0 CA--C 1.541 1.703 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -145.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.1 p -77.16 171.21 15.19 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.945 0.898 . . . . 0.0 111.991 147.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 p -107.99 -146.32 0.4 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.886 1.674 . . . . 0.0 114.08 -168.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 m -162.24 68.61 0.26 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 127.459 2.304 . . . . 0.0 109.787 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -124.29 148.58 47.31 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 126.138 1.775 . . . . 0.0 115.668 -158.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.1 m -57.83 118.98 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -168.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.38 -48.88 3.71 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.109 1.363 . . . . 0.0 113.091 162.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -150.82 168.65 10.6 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 127.831 2.452 . . . . 0.0 110.748 -170.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -55.5 -15.77 12.71 Favored 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.095 2.53 . . . . 0.0 117.741 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.76 -45.36 9.35 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.934 1.243 . . . . 0.0 111.942 173.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.77 94.32 5.01 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.474 1.91 . . . . 0.0 112.84 -157.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 t -89.31 99.28 12.31 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 151.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.87 156.36 38.01 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.875 2.07 . . . . 0.0 113.872 -154.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.5 m -64.91 82.66 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 127.192 2.197 . . . . 0.0 112.967 157.965 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 . . . . . 0 CA--C 1.554 1.1 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 m -85.18 -89.28 0.11 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.255 1.022 . . . . 0.0 112.241 -161.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -73.57 92.24 1.9 Allowed 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.456 -0.778 . . . . 0.0 109.623 168.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.254 13.6 m-85 98.93 106.46 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 130.22 3.408 . . . . 0.0 112.442 -174.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.83 109.32 0.39 Allowed Glycine 0 CA--C 1.541 1.671 0 C-N-CA 127.184 2.326 . . . . 0.0 111.625 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -72.62 119.39 16.78 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.748 1.219 . . . . 0.0 112.895 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 p -137.29 56.93 1.76 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.948 1.699 . . . . 0.0 111.189 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.5 34.81 1.47 Allowed Glycine 0 CA--C 1.545 1.915 0 N-CA-C 117.607 1.803 . . . . 0.0 117.607 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.23 -70.66 1.55 Allowed Glycine 0 CA--C 1.545 1.911 0 N-CA-C 117.046 1.578 . . . . 0.0 117.046 165.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.9 mt -54.4 112.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 119.015 1.408 . . . . 0.0 113.841 -168.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.18 -11.55 48.86 Favored Glycine 0 CA--C 1.548 2.145 0 C-N-CA 125.651 1.596 . . . . 0.0 115.332 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -110.85 62.62 0.61 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -155.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 t -70.11 64.09 0.23 Allowed 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.701 -1.25 . . . . 0.0 111.039 156.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.74 176.14 20.12 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 -164.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.16 143.48 25.58 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.615 3.543 . . . . 0.0 112.45 -174.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.8 p -123.94 41.33 3.51 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.992 1.317 . . . . 0.0 113.265 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 t -79.35 51.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 O-C-N 120.323 -1.485 . . . . 0.0 112.335 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.6 t -82.4 164.02 21.29 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 128.73 2.812 . . . . 0.0 113.122 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.58 93.71 4.09 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 t -36.84 111.04 0.13 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.838 1.655 . . . . 0.0 114.218 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.74 -50.3 0.89 Allowed Glycine 0 CA--C 1.541 1.704 0 C-N-CA 125.844 1.688 . . . . 0.0 109.536 -158.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.6 p -82.62 152.87 25.72 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.661 1.185 . . . . 0.0 110.695 143.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.1 p -101.44 -107.25 0.24 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -159.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t 146.09 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 131.547 3.939 . . . . 0.0 110.206 -170.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -118.31 127.12 53.4 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 127.536 2.334 . . . . 0.0 114.214 -157.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.9 t -65.17 86.86 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 C-N-CA 125.431 1.492 . . . . 0.0 114.586 -170.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.69 -44.73 8.4 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -152.91 160.21 31.3 Favored Pre-proline 0 CA--C 1.557 1.246 0 O-C-N 121.029 -1.044 . . . . 0.0 113.497 -164.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.67 53.64 3.25 Favored 'Trans proline' 0 CA--C 1.554 1.48 0 C-N-CA 124.268 3.312 . . . . 0.0 113.58 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -159.75 -53.76 0.06 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 129.534 3.133 . . . . 0.0 109.084 176.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.91 119.16 36.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.028 2.131 . . . . 0.0 113.175 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 t -66.55 123.41 19.98 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 120.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -113.67 129.22 56.6 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.94 1.696 . . . . 0.0 111.38 -160.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.0 m -64.43 83.88 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.357 -0.84 . . . . 0.0 111.909 165.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 C--O 1.256 1.432 0 CA-C-O 116.694 -1.622 . . . . 0.0 109.678 153.385 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 . . . . . 0 CA--C 1.553 1.075 0 CA-C-O 120.944 0.402 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 m -82.79 -131.65 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.499 1.52 . . . . 0.0 113.243 -166.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -47.7 121.32 3.96 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.998 1.319 . . . . 0.0 113.682 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 72.48 50.02 0.19 Allowed 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 127.377 2.271 . . . . 0.0 114.336 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.01 133.76 10.11 Favored Glycine 0 CA--C 1.547 2.038 0 C-N-CA 126.111 1.815 . . . . 0.0 115.317 -174.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -73.66 130.39 39.91 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 120.221 2.011 . . . . 0.0 115.023 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.3 m -112.01 -47.28 3.14 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.588 1.555 . . . . 0.0 111.88 166.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 165.49 10.08 Favored Glycine 0 CA--C 1.548 2.107 0 N-CA-C 117.239 1.656 . . . . 0.0 117.239 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.57 -52.64 24.64 Favored Glycine 0 CA--C 1.548 2.113 0 N-CA-C 119.471 2.549 . . . . 0.0 119.471 -157.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.6 114.35 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 120.094 -1.827 . . . . 0.0 112.033 -166.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.67 -16.83 60.44 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 126.031 1.777 . . . . 0.0 116.391 -172.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -111.37 76.22 0.96 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -153.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 p -72.28 24.27 0.05 Allowed 'General case' 0 CA--C 1.554 1.123 0 O-C-N 120.138 -1.601 . . . . 0.0 114.297 158.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.76 157.73 22.38 Favored Glycine 0 CA--C 1.546 1.984 0 O-C-N 120.735 -1.228 . . . . 0.0 116.036 -168.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -83.68 122.47 3.1 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.336 2.69 . . . . 0.0 110.614 172.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -73.76 60.55 0.71 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.638 -1.288 . . . . 0.0 113.853 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 t -72.39 57.21 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 O-C-N 120.168 -1.583 . . . . 0.0 112.045 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.9 t -93.04 154.59 18.03 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.94 2.096 . . . . 0.0 113.726 -171.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.39 83.78 7.38 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.765 -1.209 . . . . 0.0 112.339 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.3 t -44.24 109.71 0.17 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.785 1.234 . . . . 0.0 113.213 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.26 -50.79 0.81 Allowed Glycine 0 CA--C 1.537 1.455 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -156.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.1 p -74.45 155.09 38.4 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.6 0.36 . . . . 0.0 110.892 139.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.3 p -98.59 -106.46 0.2 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -163.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 m 158.42 30.76 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 130.994 3.718 . . . . 0.0 112.584 -172.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -95.02 151.32 19.28 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.361 -2.087 . . . . 0.0 116.369 -164.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.4 t -55.89 115.2 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 126.481 1.912 . . . . 0.0 114.427 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -122.58 -49.51 2.01 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -139.65 162.1 52.93 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.856 1.263 . . . . 0.0 112.558 -167.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.97 49.99 1.7 Allowed 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 123.833 3.022 . . . . 0.0 113.471 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -154.17 -67.75 0.14 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 129.626 3.17 . . . . 0.0 107.746 172.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.87 111.24 23.69 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 127.046 2.138 . . . . 0.0 113.049 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.1 p -58.79 124.14 18.78 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.573 115.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -138.65 140.56 38.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.085 1.354 . . . . 0.0 114.444 -147.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.1 m -67.75 83.07 0.19 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.794 1.238 . . . . 0.0 112.7 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt . . . . . 0 C--O 1.254 1.312 0 CA-C-O 117.405 -1.283 . . . . 0.0 110.467 152.359 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 . . . . . 0 CA--C 1.546 0.802 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.0 t -98.38 -145.46 0.32 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.83 1.252 . . . . 0.0 110.46 164.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -47.84 144.7 3.28 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 169.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 81.34 4.19 1.45 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.146 2.178 . . . . 0.0 116.391 172.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.07 153.78 41.49 Favored Glycine 0 CA--C 1.55 2.268 0 O-C-N 120.426 -1.421 . . . . 0.0 115.285 173.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -84.2 135.78 34.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.605 1.562 . . . . 0.0 113.563 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.5 m -131.54 -6.91 3.7 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.24 111.44 0.3 Allowed Glycine 0 CA--C 1.546 1.975 0 CA-C-N 119.975 1.261 . . . . 0.0 115.237 -177.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.55 24.23 0.06 OUTLIER Glycine 0 CA--C 1.541 1.718 0 O-C-N 118.952 -2.499 . . . . 0.0 117.477 -6.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.9 mt -64.12 129.44 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 120.345 2.073 . . . . 0.0 110.683 169.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.5 -39.43 0.74 Allowed Glycine 0 CA--C 1.547 2.084 0 C-N-CA 124.589 1.09 . . . . 0.0 115.648 -174.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -64.93 178.43 0.82 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 126.858 2.063 . . . . 0.0 115.217 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.6 p -134.39 -86.0 0.41 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.916 1.287 . . . . 0.0 110.953 165.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.95 38.56 0.5 Allowed Glycine 0 CA--C 1.546 2.005 0 N-CA-C 118.103 2.001 . . . . 0.0 118.103 169.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -77.82 58.55 6.51 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 CA-C-N 121.086 2.443 . . . . 0.0 111.181 172.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -74.61 57.59 0.74 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.756 1.222 . . . . 0.0 113.923 -171.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 t -78.78 62.52 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 O-C-N 120.429 -1.419 . . . . 0.0 111.28 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.07 -177.96 4.32 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.138 2.175 . . . . 0.0 112.603 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.33 165.88 24.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.749 0.82 . . . . 0.0 112.801 166.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.4 t -106.4 171.93 7.09 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.567 1.147 . . . . 0.0 112.172 171.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.06 -53.68 1.4 Allowed Glycine 0 CA--C 1.546 1.975 0 O-C-N 120.928 -1.108 . . . . 0.0 111.821 -159.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -58.89 147.44 33.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.809 1.243 . . . . 0.0 113.502 157.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.6 p -108.44 -128.4 0.27 Allowed 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -173.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m 179.86 55.88 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 128.2 2.6 . . . . 0.0 111.73 -162.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -124.03 147.47 47.8 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 126.345 1.858 . . . . 0.0 115.215 -159.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.3 m -44.68 110.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 127.459 2.304 . . . . 0.0 116.439 -170.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.83 -49.67 2.21 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.15 1.38 . . . . 0.0 114.378 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -153.45 163.51 23.47 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 125.626 1.57 . . . . 0.0 112.325 -169.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.96 48.77 2.07 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.74 2.96 . . . . 0.0 113.94 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -155.51 -46.16 0.08 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.511 2.724 . . . . 0.0 108.826 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.43 113.46 17.54 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 127.669 2.387 . . . . 0.0 114.015 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -59.08 122.78 14.6 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.36 117.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -139.58 148.3 42.34 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.14 1.376 . . . . 0.0 113.276 -145.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 m -65.35 91.09 0.11 Allowed 'General case' 0 CA--C 1.555 1.168 0 O-C-N 120.687 -1.258 . . . . 0.0 113.574 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.129 1.372 . . . . 0.0 110.208 154.999 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 CA--C 1.55 0.952 0 N-CA-C 110.86 -0.052 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -90.59 176.79 6.55 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -173.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -49.45 140.71 10.1 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.652 1.581 . . . . 0.0 112.932 -174.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 69.48 -20.34 0.17 Allowed 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -44.94 141.31 3.97 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 116.722 1.449 . . . . 0.0 116.722 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -70.22 138.41 51.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.911 2.084 . . . . 0.0 115.182 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 p -150.26 63.71 0.96 Allowed 'General case' 0 CA--C 1.553 1.075 0 O-C-N 121.078 -1.014 . . . . 0.0 111.851 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.2 -155.23 26.26 Favored Glycine 0 CA--C 1.55 2.278 0 C-N-CA 126.163 1.839 . . . . 0.0 115.071 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.95 -144.94 5.82 Favored Glycine 0 CA--C 1.547 2.063 0 C-N-CA 126.368 1.937 . . . . 0.0 117.446 172.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -55.28 107.01 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 O-C-N 120.887 -1.36 . . . . 0.0 112.424 174.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.74 -44.16 2.57 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 116.93 1.532 . . . . 0.0 116.93 159.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -73.93 69.21 1.4 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 119.407 1.603 . . . . 0.0 114.906 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.5 m -80.06 73.89 6.85 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.017 -1.052 . . . . 0.0 109.102 151.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.78 -170.03 12.62 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 -162.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.13 83.56 0.15 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.618 2.879 . . . . 0.0 114.332 -174.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 p -62.45 15.24 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.05 62.46 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 O-C-N 120.088 -1.632 . . . . 0.0 112.385 -162.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.6 t -57.83 162.6 3.1 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 127.282 2.233 . . . . 0.0 113.968 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.22 69.86 0.09 Allowed 'General case' 0 CA--C 1.555 1.158 0 O-C-N 120.155 -1.591 . . . . 0.0 113.781 172.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.4 t -14.28 80.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 129.06 2.944 . . . . 0.0 116.29 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.16 -55.08 0.47 Allowed Glycine 0 CA--C 1.537 1.432 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -158.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.4 p -81.59 158.18 24.47 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 120.704 0.288 . . . . 0.0 110.481 145.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.4 p -122.94 -115.58 0.3 Allowed 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -154.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.9 t 179.9 74.67 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 128.904 2.881 . . . . 0.0 110.631 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.95 131.06 55.4 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 128.233 2.613 . . . . 0.0 113.797 -162.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.6 t -63.85 103.79 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 125.405 1.482 . . . . 0.0 113.836 -173.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 mt -111.77 -51.77 2.83 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -148.05 158.38 41.89 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -161.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -51.57 -18.26 5.68 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 124.009 3.139 . . . . 0.0 117.106 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -90.0 -45.49 9.15 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.916 -1.115 . . . . 0.0 113.209 168.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.3 119.64 34.61 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.047 1.339 . . . . 0.0 114.101 -170.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -68.41 132.7 47.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 117.144 -1.822 . . . . 0.0 108.933 114.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -131.67 136.45 47.7 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -149.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.3 t -68.18 64.51 0.1 Allowed 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.723 1.209 . . . . 0.0 112.279 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.251 1.153 0 C-N-CA 126.311 1.844 . . . . 0.0 111.856 167.103 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 CA--C 1.558 1.273 0 CA-C-O 120.451 0.167 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.6 t -121.88 -145.35 0.35 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.345 1.458 . . . . 0.0 111.725 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -50.38 134.37 23.37 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.878 1.271 . . . . 0.0 113.896 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 57.99 25.1 11.84 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 126.612 1.965 . . . . 0.0 115.987 -171.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.36 134.29 20.94 Favored Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.306 1.282 . . . . 0.0 116.306 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -72.95 130.97 41.56 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.271 1.428 . . . . 0.0 113.48 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.78 66.84 1.41 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 127.96 2.504 . . . . 0.0 109.234 160.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.96 170.93 33.22 Favored Glycine 0 CA--C 1.543 1.801 0 C-N-CA 126.479 1.99 . . . . 0.0 113.427 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.75 -54.58 27.4 Favored Glycine 0 CA--C 1.545 1.965 0 N-CA-C 119.325 2.49 . . . . 0.0 119.325 -159.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 mt -53.97 114.58 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 O-C-N 121.229 -1.159 . . . . 0.0 113.784 -165.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.76 36.02 70.33 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 125.84 1.686 . . . . 0.0 115.698 -176.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.07 175.12 9.89 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -160.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 m -158.04 -44.73 0.06 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.337 2.255 . . . . 0.0 111.866 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.18 68.31 1.21 Allowed Glycine 0 CA--C 1.547 2.056 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 164.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -61.37 66.64 0.1 OUTLIER 'Trans proline' 0 CA--C 1.551 1.325 0 C-N-CA 123.432 2.755 . . . . 0.0 111.977 152.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 p -141.57 49.99 1.59 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -157.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.97 91.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 O-C-N 121.174 -0.954 . . . . 0.0 109.307 155.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 171.18 5.46 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -166.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.69 78.95 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.9 t -36.21 123.37 0.75 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.407 1.883 . . . . 0.0 114.588 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.2 -45.73 1.25 Allowed Glycine 0 CA--C 1.543 1.801 0 C-N-CA 124.727 1.156 . . . . 0.0 110.585 -149.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.5 p -103.83 148.87 25.62 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.163 2.185 . . . . 0.0 111.771 161.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.4 p -134.75 113.27 11.48 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.413 1.485 . . . . 0.0 114.653 -158.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.0 t -63.58 88.44 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 126.041 1.736 . . . . 0.0 114.622 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -122.59 146.14 47.7 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.76 114.85 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.8 mt -125.04 -58.81 1.45 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.484 1.514 . . . . 0.0 114.97 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -135.94 162.03 59.15 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 124.222 1.009 . . . . 0.0 112.928 -155.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.66 32.95 0.29 Allowed 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.198 2.598 . . . . 0.0 114.963 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -133.74 -48.59 0.81 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.039 2.136 . . . . 0.0 110.649 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.05 135.31 51.61 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 127.746 2.418 . . . . 0.0 114.742 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.4 t -72.43 124.34 24.96 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.483 127.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -122.1 130.19 53.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.787 1.635 . . . . 0.0 112.641 -151.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.8 m -66.24 92.04 0.18 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 C--O 1.246 0.909 0 C-N-CA 124.11 0.964 . . . . 0.0 111.471 165.298 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? . . . . . 0 CA--C 1.556 1.209 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.1 t -116.5 -91.44 0.54 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 119.318 0.963 . . . . 0.0 113.173 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -72.14 120.28 17.52 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.545 1.538 . . . . 0.0 112.837 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 90.56 50.44 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 127.548 2.339 . . . . 0.0 116.406 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.06 132.49 10.71 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 125.732 1.634 . . . . 0.0 114.715 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -68.73 132.51 46.95 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 119.101 1.45 . . . . 0.0 113.658 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.9 m -123.43 0.76 8.91 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.68 1.992 . . . . 0.0 115.097 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.62 -146.19 6.71 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.611 1.577 . . . . 0.0 111.719 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.56 -164.52 20.45 Favored Glycine 0 CA--C 1.545 1.945 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -54.18 134.4 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 O-C-N 121.155 -1.203 . . . . 0.0 114.141 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.64 -42.73 3.13 Favored Glycine 0 CA--C 1.543 1.823 0 C-N-CA 124.927 1.251 . . . . 0.0 115.033 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -67.18 171.48 5.68 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 126.167 1.787 . . . . 0.0 114.681 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.0 p -59.47 156.45 13.09 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 130.856 3.662 . . . . 0.0 116.664 6.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.5 -163.67 26.71 Favored Glycine 0 CA--C 1.549 2.159 0 O-C-N 121.351 -0.843 . . . . 0.0 114.968 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.46 82.32 2.11 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 123.69 2.927 . . . . 0.0 113.977 -168.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.8 p -67.73 56.98 0.06 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 126.242 1.817 . . . . 0.0 114.259 172.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.92 52.38 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 O-C-N 119.88 -1.763 . . . . 0.0 112.132 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.75 157.31 17.04 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 128.105 2.562 . . . . 0.0 113.936 -170.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -101.19 127.22 47.86 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.207 1.803 . . . . 0.0 112.299 172.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.0 t -65.44 122.11 16.41 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 171.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.21 -66.99 0.29 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.488 1.994 . . . . 0.0 109.139 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.4 p -60.53 151.58 28.19 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.559 0.743 . . . . 0.0 111.583 137.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.9 p -93.96 -105.86 0.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -169.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 167.98 3.42 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 128.41 2.684 . . . . 0.0 116.184 -170.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -90.73 172.81 8.39 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 -157.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.0 m -54.05 123.25 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 127.469 2.307 . . . . 0.0 116.602 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -163.54 -55.97 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 157.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -84.52 140.48 38.57 Favored Pre-proline 0 CA--C 1.561 1.4 0 O-C-N 119.604 -1.935 . . . . 0.0 112.333 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -39.32 -52.37 2.42 Favored 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 125.264 3.976 . . . . 0.0 115.93 171.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -69.89 -42.9 72.81 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.83 -1.169 . . . . 0.0 113.079 169.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.04 104.98 9.56 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -168.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t -55.23 116.39 2.79 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.648 124.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -129.87 146.79 51.59 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -155.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.0 m -64.17 80.39 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 O-C-N 120.95 -1.094 . . . . 0.0 112.515 166.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 124.256 1.022 . . . . 0.0 110.138 151.598 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 . . . . . 0 CA--C 1.552 1.031 0 CA-C-O 122.032 0.92 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 t -75.0 -143.54 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.661 -0.649 . . . . 0.0 111.088 160.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -44.7 103.59 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.356 1.463 . . . . 0.0 113.583 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 87.08 84.62 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 129.563 3.145 . . . . 0.0 114.255 -171.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.53 117.26 1.25 Allowed Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.315 1.436 . . . . 0.0 114.732 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -65.42 122.13 16.46 Favored 'General case' 0 CA--C 1.556 1.195 0 O-C-N 119.751 -2.029 . . . . 0.0 112.49 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.4 m -104.9 -52.53 2.84 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.919 1.288 . . . . 0.0 114.387 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.16 132.55 3.58 Favored Glycine 0 CA--C 1.543 1.837 0 C-N-CA 124.185 0.898 . . . . 0.0 114.26 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.27 -157.97 27.46 Favored Glycine 0 CA--C 1.546 2.017 0 C-N-CA 126.424 1.964 . . . . 0.0 113.029 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.0 mt -40.83 110.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 119.333 1.566 . . . . 0.0 112.764 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.37 -33.39 3.2 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 116.296 1.279 . . . . 0.0 116.296 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -82.01 55.56 2.83 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -156.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.2 t -74.53 71.56 1.85 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.357 -1.464 . . . . 0.0 108.612 147.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.0 -172.68 14.88 Favored Glycine 0 CA--C 1.546 2.008 0 N-CA-C 117.82 1.888 . . . . 0.0 117.82 -154.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.41 80.21 2.79 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.152 3.235 . . . . 0.0 112.45 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.5 p -68.9 51.12 0.08 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.856 1.662 . . . . 0.0 114.868 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -78.45 52.54 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 O-C-N 119.728 -1.857 . . . . 0.0 111.704 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 44.5 t -85.59 166.07 16.53 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.915 2.486 . . . . 0.0 115.269 -165.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.28 83.61 1.8 Allowed 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 t -43.29 109.91 0.17 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.834 1.253 . . . . 0.0 113.686 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.98 -52.37 0.79 Allowed Glycine 0 CA--C 1.539 1.584 0 C-N-CA 125.614 1.578 . . . . 0.0 110.158 -160.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.4 p -76.91 163.98 26.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.079 0.552 . . . . 0.0 109.958 140.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.7 p -114.26 -124.19 0.29 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -163.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 m -173.69 32.76 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 128.957 2.903 . . . . 0.0 111.808 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -65.08 141.98 58.54 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 119.867 -1.771 . . . . 0.0 114.676 -162.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 m -64.58 93.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.18 1.392 . . . . 0.0 113.905 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.2 mt -96.59 -48.01 5.7 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -162.86 176.14 2.52 Favored Pre-proline 0 CA--C 1.559 1.326 0 O-C-N 120.832 -1.168 . . . . 0.0 113.94 -165.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.95 -39.15 92.06 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.482 2.788 . . . . 0.0 115.106 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -67.3 -39.55 85.94 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.61 116.73 8.93 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 117.768 2.507 . . . . 0.0 117.768 -164.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.11 125.58 19.54 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.59 111.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -144.04 127.32 16.73 Favored 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -154.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.0 m -63.46 78.58 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.66 1.584 . . . . 0.0 113.043 174.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.6 mt . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.187 151.273 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -74.92 61.11 1.01 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.841 1.657 . . . . 0.0 111.704 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.8 m -59.71 -55.65 31.73 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -171.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -115.17 140.77 48.8 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.939 1.296 . . . . 0.0 114.028 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 62.9 41.92 8.16 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 125.564 1.546 . . . . 0.0 113.17 -171.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.09 109.91 3.68 Favored Glycine 0 CA--C 1.54 1.64 0 C-N-CA 126.113 1.815 . . . . 0.0 114.588 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -52.41 124.36 13.23 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.362 1.465 . . . . 0.0 114.09 176.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 m -118.51 -0.37 11.41 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.58 114.64 0.33 Allowed Glycine 0 CA--C 1.546 2.005 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -175.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.63 -160.28 30.15 Favored Glycine 0 CA--C 1.552 2.384 0 C-N-CA 126.391 1.948 . . . . 0.0 115.023 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -45.64 124.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.7 -13.13 49.43 Favored Glycine 0 CA--C 1.544 1.894 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -89.69 167.43 12.91 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 119.08 1.44 . . . . 0.0 114.856 -172.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 94.2 p -131.49 -92.42 0.4 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.635 1.574 . . . . 0.0 110.881 166.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.2 38.61 0.52 Allowed Glycine 0 CA--C 1.548 2.147 0 N-CA-C 118.294 2.078 . . . . 0.0 118.294 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -76.1 50.58 2.88 Favored 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 123.384 2.723 . . . . 0.0 112.198 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.2 p -77.67 66.6 3.4 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.212 -1.555 . . . . 0.0 113.119 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 t -76.46 51.87 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 O-C-N 120.874 -1.141 . . . . 0.0 112.088 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.1 t -98.59 169.4 9.54 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 129.722 3.209 . . . . 0.0 111.915 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.4 159.37 16.44 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.691 -1.256 . . . . 0.0 112.238 169.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.8 t -72.89 -177.13 2.26 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 161.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.68 -57.02 5.03 Favored Glycine 0 CA--C 1.542 1.742 0 O-C-N 120.857 -1.152 . . . . 0.0 111.688 -165.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.1 p -76.8 177.79 7.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.233 1.013 . . . . 0.0 111.224 153.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -129.11 -128.71 0.21 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -159.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.4 m 179.85 62.51 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 128.645 2.778 . . . . 0.0 111.835 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -128.82 157.83 40.4 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -165.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.39 132.77 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -167.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.1 -113.09 0.16 Allowed 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.745 1.218 . . . . 0.0 112.762 151.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.35 157.45 71.42 Favored Pre-proline 0 CA--C 1.562 1.409 0 O-C-N 119.566 -1.959 . . . . 0.0 114.51 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.79 -17.35 0.71 Allowed 'Trans proline' 0 CA--C 1.554 1.506 0 C-N-CA 124.622 3.548 . . . . 0.0 117.969 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -74.15 -25.52 59.79 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.96 105.31 2.73 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -154.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -71.78 117.3 13.19 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 121.465 -0.772 . . . . 0.0 109.422 130.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -138.97 151.32 46.77 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -160.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.7 m -57.97 76.33 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.527 1.931 . . . . 0.0 113.028 169.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 C--O 1.257 1.483 0 C-N-CA 125.161 1.384 . . . . 0.0 111.237 153.593 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 26.9 p . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 118.449 -0.786 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -106.55 156.02 19.01 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 125.974 1.71 . . . . 0.0 112.882 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.8 m -77.01 154.37 33.55 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -168.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -41.13 146.77 0.16 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.134 1.774 . . . . 0.0 114.112 162.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 60.66 12.67 3.8 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.39 140.4 33.67 Favored Glycine 0 CA--C 1.545 1.937 0 O-C-N 119.807 -1.808 . . . . 0.0 115.254 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -64.95 119.31 10.48 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.572 -1.546 . . . . 0.0 112.78 173.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.5 38.28 3.79 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.453 1.479 . . . . 0.0 113.093 166.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.03 159.85 22.76 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 125.088 1.328 . . . . 0.0 114.685 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.87 -49.85 51.7 Favored Glycine 0 CA--C 1.545 1.955 0 N-CA-C 119.066 2.386 . . . . 0.0 119.066 -158.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.3 mt -58.32 119.72 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 O-C-N 120.724 -1.456 . . . . 0.0 112.983 -168.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.23 25.4 75.61 Favored Glycine 0 CA--C 1.543 1.838 0 C-N-CA 124.755 1.169 . . . . 0.0 115.548 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.22 -170.59 3.53 Favored 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 115.734 1.754 . . . . 0.0 115.734 -166.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.8 p -146.34 -69.29 0.26 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.993 2.117 . . . . 0.0 110.702 175.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.1 64.99 0.52 Allowed Glycine 0 CA--C 1.541 1.699 0 N-CA-C 117.584 1.794 . . . . 0.0 117.584 156.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.54 34.73 0.38 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 C-N-CA 122.663 2.242 . . . . 0.0 112.757 166.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.0 p -84.09 66.36 9.21 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 119.814 -1.804 . . . . 0.0 113.393 -170.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 t -65.35 78.45 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.996 0.919 . . . . 0.0 109.762 163.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 174.27 7.68 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 -168.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.54 73.08 0.06 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.329 1.451 . . . . 0.0 113.721 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.8 t -37.8 109.21 0.09 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.549 1.94 . . . . 0.0 114.74 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.78 -55.56 0.72 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.11 1.814 . . . . 0.0 108.69 -158.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.7 p -70.66 168.49 16.39 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.299 -0.451 . . . . 0.0 111.714 141.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -126.03 -114.04 0.28 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.852 1.661 . . . . 0.0 114.616 -166.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.0 m 162.3 65.35 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.806 0 C-N-CA 131.448 3.899 . . . . 0.0 111.504 -169.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -135.79 165.28 25.97 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 -171.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -68.1 136.52 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 118.178 2.659 . . . . 0.0 118.178 -159.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.39 -46.37 0.51 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.321 1.449 . . . . 0.0 114.532 155.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -130.22 161.18 61.77 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.996 1.319 . . . . 0.0 112.914 -176.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.81 50.05 2.01 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 123.43 2.753 . . . . 0.0 113.865 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -152.82 -49.49 0.1 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.467 2.307 . . . . 0.0 110.437 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.35 100.86 9.39 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.387 2.275 . . . . 0.0 113.374 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.0 t -70.26 88.56 0.63 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 140.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -88.32 148.92 24.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.281 1.832 . . . . 0.0 114.093 -158.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 m -63.81 75.53 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.712 -1.243 . . . . 0.0 112.501 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.208 -1.377 . . . . 0.0 110.806 163.712 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.857 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -80.85 94.19 6.41 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.297 0.953 . . . . 0.0 112.073 -177.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.5 t -66.72 -111.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 157.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -62.99 110.88 1.94 Allowed 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.901 -1.124 . . . . 0.0 112.622 170.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.255 27.4 m-85 89.67 94.26 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 129.424 3.09 . . . . 0.0 115.835 177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.88 129.45 3.08 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 126.532 2.015 . . . . 0.0 113.533 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -71.39 133.97 46.32 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 125.126 1.37 . . . . 0.0 113.561 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 m -140.4 20.11 2.39 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.83 129.69 2.54 Favored Glycine 0 CA--C 1.544 1.854 0 O-C-N 120.406 -1.433 . . . . 0.0 115.178 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.36 -158.12 28.68 Favored Glycine 0 CA--C 1.545 1.965 0 C-N-CA 126.124 1.821 . . . . 0.0 112.437 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.1 mt -43.39 105.63 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-N 119.274 1.537 . . . . 0.0 112.352 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.45 -32.84 2.31 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -73.19 56.49 0.46 Allowed 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -167.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.9 m -73.52 60.78 0.67 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.95 1.3 . . . . 0.0 109.389 155.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.7 -173.45 13.31 Favored Glycine 0 CA--C 1.544 1.903 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 -150.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.35 89.63 1.31 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.955 3.103 . . . . 0.0 112.015 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.5 p -72.61 62.75 0.57 Allowed 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.354 -1.467 . . . . 0.0 113.714 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.69 56.37 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 125.332 1.453 . . . . 0.0 112.254 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.3 t -101.55 151.61 21.77 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.725 2.01 . . . . 0.0 113.933 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.5 90.06 6.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.636 1.574 . . . . 0.0 112.641 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -42.72 115.63 0.75 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.424 1.09 . . . . 0.0 112.946 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.74 -51.84 0.75 Allowed Glycine 0 CA--C 1.539 1.533 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -152.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.5 p -82.98 166.8 18.53 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.634 0.373 . . . . 0.0 111.854 140.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.5 p -99.64 -88.41 0.34 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -158.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.3 m 124.78 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 131.507 3.923 . . . . 0.0 111.508 -163.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -119.12 152.94 35.63 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 126.416 1.887 . . . . 0.0 114.067 -172.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.4 m -57.2 123.91 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -171.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.98 -38.71 3.19 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 156.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -160.86 167.81 12.88 Favored Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -165.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.97 -29.01 25.83 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 124.013 3.142 . . . . 0.0 117.347 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -81.54 -19.8 41.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.231 1.013 . . . . 0.0 113.729 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.28 113.48 3.45 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -165.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 t -67.44 140.86 57.14 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.441 118.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -160.39 135.44 7.83 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -145.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.4 m -67.17 76.64 0.14 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.0 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.463 -1.256 . . . . 0.0 111.264 141.657 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -76.52 100.28 5.23 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 119.696 1.135 . . . . 0.0 112.021 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.0 t -77.93 -102.21 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.257 -0.902 . . . . 0.0 113.034 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.44 127.91 34.69 Favored 'General case' 0 CA--C 1.553 1.091 0 O-C-N 121.034 -1.041 . . . . 0.0 113.459 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.261 37.2 m-85 77.7 47.7 0.05 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 126.931 2.092 . . . . 0.0 115.429 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.62 120.35 6.85 Favored Glycine 0 CA--C 1.545 1.917 0 C-N-CA 125.884 1.707 . . . . 0.0 115.832 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -68.21 103.46 1.58 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.844 1.322 . . . . 0.0 114.312 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -104.04 57.72 0.72 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.944 1.298 . . . . 0.0 110.826 167.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.14 162.81 36.6 Favored Glycine 0 CA--C 1.544 1.881 0 O-C-N 120.467 -1.396 . . . . 0.0 116.472 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.15 -76.21 0.19 Allowed Glycine 0 CA--C 1.544 1.906 0 N-CA-C 119.043 2.377 . . . . 0.0 119.043 -157.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.5 108.25 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 O-C-N 120.981 -1.305 . . . . 0.0 112.075 -164.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.08 -26.97 11.4 Favored Glycine 0 CA--C 1.546 2.025 0 C-N-CA 125.805 1.669 . . . . 0.0 116.446 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -109.73 65.19 0.61 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 -148.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.3 p -70.06 49.39 0.1 Allowed 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.369 -1.457 . . . . 0.0 112.339 162.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.01 156.42 22.15 Favored Glycine 0 CA--C 1.547 2.05 0 N-CA-C 116.33 1.292 . . . . 0.0 116.33 -158.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -82.52 116.93 2.66 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.361 2.708 . . . . 0.0 110.811 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.3 p -71.19 65.66 0.4 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 120.451 -1.406 . . . . 0.0 113.227 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -73.63 61.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 125.248 1.419 . . . . 0.0 112.015 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.2 t -95.06 153.76 17.49 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 127.012 2.125 . . . . 0.0 114.297 -173.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.03 100.37 13.2 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.305 1.042 . . . . 0.0 113.01 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.9 p -49.99 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.954 1.702 . . . . 0.0 114.112 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.83 -48.87 0.32 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.957 1.265 . . . . 0.0 110.235 -159.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.8 p -84.98 158.12 20.59 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 120.873 0.368 . . . . 0.0 111.349 138.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.2 p -101.4 -84.83 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -150.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.5 m 126.03 62.08 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 131.574 3.949 . . . . 0.0 111.049 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -126.91 137.59 53.17 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.3 t -50.52 115.59 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 127.076 2.151 . . . . 0.0 115.101 -170.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.0 mt -101.6 -42.16 6.33 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.907 0.883 . . . . 0.0 113.006 163.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -158.1 166.14 17.16 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 126.905 2.082 . . . . 0.0 110.315 -163.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.93 25.65 0.18 Allowed 'Trans proline' 0 CA--C 1.557 1.65 0 C-N-CA 122.768 2.312 . . . . 0.0 115.005 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -122.29 -66.87 1.0 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.795 2.038 . . . . 0.0 109.902 171.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.43 109.59 22.31 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.549 2.34 . . . . 0.0 113.42 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -76.56 102.35 6.05 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 136.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -97.85 137.91 36.0 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.969 1.708 . . . . 0.0 113.327 -156.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.7 m -64.95 75.84 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.742 -1.224 . . . . 0.0 112.842 166.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.246 0.897 0 C-N-CA 125.41 1.484 . . . . 0.0 111.304 157.878 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -86.45 125.73 33.91 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.686 1.194 . . . . 0.0 110.819 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 t -74.11 178.51 4.99 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -57.68 139.54 53.5 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.035 1.334 . . . . 0.0 114.219 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 73.64 26.65 1.88 Allowed 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 127.6 2.36 . . . . 0.0 115.451 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.43 136.03 12.59 Favored Glycine 0 CA--C 1.549 2.216 0 O-C-N 119.45 -2.031 . . . . 0.0 116.228 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -58.58 126.74 28.88 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 119.747 -2.031 . . . . 0.0 113.732 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.54 45.32 2.06 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 127.317 2.247 . . . . 0.0 110.991 165.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.99 164.32 27.91 Favored Glycine 0 CA--C 1.541 1.694 0 O-C-N 120.615 -1.303 . . . . 0.0 115.06 -169.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.37 -45.4 9.92 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 119.101 2.4 . . . . 0.0 119.101 -149.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.9 mt -53.36 118.48 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 O-C-N 120.693 -1.475 . . . . 0.0 112.919 -170.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.08 33.89 76.68 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 124.645 1.117 . . . . 0.0 115.509 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.1 -179.74 5.96 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -166.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -165.55 -57.21 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.192 2.197 . . . . 0.0 110.59 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 55.15 87.84 0.01 OUTLIER Glycine 0 CA--C 1.548 2.154 0 N-CA-C 118.701 2.241 . . . . 0.0 118.701 155.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -66.92 71.16 0.5 Allowed 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.449 2.766 . . . . 0.0 111.391 166.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -90.08 61.49 5.22 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.672 1.989 . . . . 0.0 113.771 -160.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.26 79.57 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 O-C-N 121.145 -0.972 . . . . 0.0 110.96 171.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.1 t -50.19 153.48 1.44 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.283 2.233 . . . . 0.0 113.907 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.13 74.21 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 O-C-N 120.709 -1.244 . . . . 0.0 113.275 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.9 t -33.45 98.79 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 127.721 2.408 . . . . 0.0 114.804 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.27 -53.97 0.58 Allowed Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.555 1.55 . . . . 0.0 109.396 -156.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.5 p -82.93 166.93 18.47 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.246 0.618 . . . . 0.0 110.78 143.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -117.95 -92.21 0.53 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.161 2.652 . . . . 0.0 118.161 -152.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.3 m 131.14 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 1 C-N-CA 131.797 4.039 . . . . 0.0 113.429 -166.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -134.22 157.72 45.54 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.7 t -54.45 112.52 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -164.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.6 mt -85.85 -55.68 3.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.456 1.102 . . . . 0.0 112.629 153.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -167.55 176.49 1.64 Allowed Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 125.588 1.555 . . . . 0.0 112.185 -159.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.9 -41.81 38.75 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.202 3.268 . . . . 0.0 115.983 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -67.21 -45.06 77.98 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.319 -0.863 . . . . 0.0 113.07 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.58 95.73 4.2 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -151.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -77.28 102.06 6.54 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 144.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -105.21 142.06 35.64 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.114 1.765 . . . . 0.0 113.949 -159.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.4 t -56.31 71.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 127.926 2.49 . . . . 0.0 112.321 167.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 mt . . . . . 0 C--O 1.248 1.0 0 C-N-CA 129.789 3.236 . . . . 0.0 112.838 174.644 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -84.83 163.47 19.03 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 119.276 0.944 . . . . 0.0 112.171 171.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.7 t -112.27 -102.42 0.41 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.546 1.138 . . . . 0.0 112.823 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -68.63 122.17 17.96 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.937 1.295 . . . . 0.0 112.874 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 86.4 61.82 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 128.021 2.529 . . . . 0.0 115.588 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.14 139.49 13.83 Favored Glycine 0 CA--C 1.549 2.184 0 C-N-CA 125.863 1.697 . . . . 0.0 114.48 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -82.39 116.29 21.8 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 118.998 1.399 . . . . 0.0 114.081 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.66 55.59 0.91 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.054 1.742 . . . . 0.0 111.001 171.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.21 163.74 35.1 Favored Glycine 0 CA--C 1.54 1.652 0 O-C-N 120.671 -1.268 . . . . 0.0 114.435 -173.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.99 -64.15 4.31 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 118.697 2.239 . . . . 0.0 118.697 -160.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.3 mt -60.07 116.1 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 O-C-N 120.738 -1.448 . . . . 0.0 112.775 -164.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.01 -12.43 69.54 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 126.153 1.835 . . . . 0.0 116.557 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -111.91 75.21 0.91 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -153.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.2 p -74.42 26.62 0.08 Allowed 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.427 -1.421 . . . . 0.0 113.605 154.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.93 160.35 17.87 Favored Glycine 0 CA--C 1.545 1.939 0 C-N-CA 124.89 1.233 . . . . 0.0 116.008 -165.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.63 124.55 4.08 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 123.292 2.662 . . . . 0.0 111.472 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.7 p -73.84 62.99 0.87 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.964 1.306 . . . . 0.0 113.717 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 t -74.42 53.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 O-C-N 120.184 -1.573 . . . . 0.0 113.477 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.9 t -100.26 159.52 15.05 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 128.161 2.585 . . . . 0.0 114.455 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.35 104.65 16.56 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.616 1.966 . . . . 0.0 113.655 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.0 t -47.15 117.34 1.69 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.181 1.393 . . . . 0.0 112.728 169.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.83 -52.17 0.72 Allowed Glycine 0 CA--C 1.538 1.497 0 C-N-CA 126.144 1.83 . . . . 0.0 109.211 -160.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.9 p -74.42 162.03 29.24 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.198 -0.501 . . . . 0.0 111.11 140.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.0 p -98.57 -90.17 0.29 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -166.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.1 m 125.84 57.26 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 131.628 3.971 . . . . 0.0 110.805 -162.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -118.93 142.23 47.95 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.701 1.601 . . . . 0.0 115.013 -164.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.1 t -51.16 102.04 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 126.449 1.9 . . . . 0.0 114.319 -170.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.3 mt -107.41 -50.12 3.13 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.759 1.224 . . . . 0.0 114.04 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -153.37 166.84 14.71 Favored Pre-proline 0 CA--C 1.557 1.225 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -163.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.51 -35.27 65.84 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.285 2.657 . . . . 0.0 114.982 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -72.17 -54.32 10.04 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.093 1.357 . . . . 0.0 112.513 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.19 120.13 34.32 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.557 1.543 . . . . 0.0 114.354 -166.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -71.97 119.53 16.28 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 126.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -126.43 143.41 51.19 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.115 -0.99 . . . . 0.0 113.393 -151.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.8 m -67.68 81.56 0.18 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.266 -0.896 . . . . 0.0 112.523 171.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 C--O 1.255 1.364 0 CA-C-O 117.286 -1.34 . . . . 0.0 109.645 146.489 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 119.032 -0.508 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -81.07 118.67 22.71 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 119.402 1.001 . . . . 0.0 109.884 168.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.9 t -64.37 168.44 5.7 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -48.52 131.4 17.31 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.904 0.882 . . . . 0.0 112.165 167.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 69.72 74.07 0.23 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.405 1.482 . . . . 0.0 113.338 -173.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.89 145.02 12.7 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 125.128 1.347 . . . . 0.0 114.187 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -70.83 131.63 44.08 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.708 -1.466 . . . . 0.0 114.891 -173.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.17 57.32 1.79 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.263 1.825 . . . . 0.0 110.687 170.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.24 168.59 41.16 Favored Glycine 0 CA--C 1.545 1.963 0 O-C-N 120.47 -1.394 . . . . 0.0 115.502 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.62 -76.1 0.14 Allowed Glycine 0 CA--C 1.545 1.934 0 C-N-CA 127.468 2.461 . . . . 0.0 119.201 -162.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.5 mt -61.24 96.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.055 -1.262 . . . . 0.0 112.564 -164.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.6 13.93 31.2 Favored Glycine 0 CA--C 1.544 1.895 0 C-N-CA 126.279 1.895 . . . . 0.0 116.409 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.05 164.87 28.87 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 120.022 1.911 . . . . 0.0 116.147 -173.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 t -127.08 -65.13 0.96 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.084 2.154 . . . . 0.0 110.406 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.92 75.9 0.07 OUTLIER Glycine 0 CA--C 1.545 1.968 0 N-CA-C 119.407 2.523 . . . . 0.0 119.407 151.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.81 52.55 0.54 Allowed 'Trans proline' 0 CA--C 1.554 1.481 0 C-N-CA 123.514 2.809 . . . . 0.0 112.114 157.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.4 p -73.24 29.75 0.07 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 -162.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.5 t -75.5 66.78 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 O-C-N 119.967 -1.708 . . . . 0.0 111.72 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 52.5 t -59.57 158.88 9.16 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.844 2.057 . . . . 0.0 113.95 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.74 61.77 0.17 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.521 1.529 . . . . 0.0 114.596 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -6.06 75.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 130.12 3.368 . . . . 0.0 116.52 176.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.46 -51.71 0.48 Allowed Glycine 0 CA--C 1.535 1.327 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -158.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.6 p -80.5 160.09 25.34 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.473 0.309 . . . . 0.0 110.393 140.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.1 p -116.21 -84.83 0.63 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -156.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.8 m 127.33 61.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 131.571 3.948 . . . . 0.0 112.102 -167.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -123.54 146.52 48.05 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 125.848 1.659 . . . . 0.0 115.253 -166.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.93 113.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.546 1.939 . . . . 0.0 114.932 -169.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.7 mt -116.45 -46.59 2.77 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -152.63 165.02 18.46 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 120.856 -1.153 . . . . 0.0 113.28 -161.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.79 43.02 0.75 Allowed 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 123.251 2.634 . . . . 0.0 114.204 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -143.41 -54.66 0.38 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.773 2.429 . . . . 0.0 108.552 172.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.26 124.05 48.1 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 128.02 2.528 . . . . 0.0 113.838 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -68.09 134.79 51.18 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.69 120.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -136.82 132.55 34.8 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.977 -1.077 . . . . 0.0 111.618 -144.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.3 t -66.6 67.17 0.06 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.055 1.742 . . . . 0.0 112.293 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--O 1.247 0.974 0 C-N-CA 126.733 2.013 . . . . 0.0 112.242 167.441 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -155.73 165.27 37.03 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 120.108 1.322 . . . . 0.0 112.771 168.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.5 t -106.31 -162.71 0.87 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.211 1.804 . . . . 0.0 112.037 166.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -52.05 143.49 13.86 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -174.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 57.68 8.87 0.73 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 126.712 2.005 . . . . 0.0 116.051 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.8 150.35 35.65 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.248 -1.533 . . . . 0.0 115.933 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -89.28 114.07 25.4 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.273 1.429 . . . . 0.0 113.285 -171.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.35 62.61 0.77 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.965 1.306 . . . . 0.0 112.927 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.88 -128.69 5.93 Favored Glycine 0 CA--C 1.547 2.048 0 N-CA-C 116.444 1.338 . . . . 0.0 116.444 168.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.5 -150.37 26.27 Favored Glycine 0 CA--C 1.549 2.17 0 O-C-N 120.926 -1.338 . . . . 0.0 115.654 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.0 mt -53.79 110.77 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 O-C-N 120.756 -1.438 . . . . 0.0 113.115 175.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.74 -37.54 3.17 Favored Glycine 0 CA--C 1.546 2.018 0 N-CA-C 117.005 1.562 . . . . 0.0 117.005 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.68 81.83 1.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -158.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.7 p -72.75 5.22 3.31 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 166.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 142.85 35.25 Favored Glycine 0 CA--C 1.552 2.356 0 O-C-N 120.375 -1.453 . . . . 0.0 115.286 -173.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -80.31 66.22 8.83 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.664 2.91 . . . . 0.0 112.574 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.9 p -84.36 48.12 1.45 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 119.797 -1.814 . . . . 0.0 115.311 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -51.94 108.45 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 O-C-N 121.063 -1.023 . . . . 0.0 110.515 162.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.72 -178.69 4.77 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -160.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.69 71.27 0.08 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.68 1.592 . . . . 0.0 112.846 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -37.39 107.21 0.06 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.62 1.968 . . . . 0.0 114.483 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.31 -54.94 0.74 Allowed Glycine 0 CA--C 1.536 1.347 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -158.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.6 p -72.37 170.24 14.62 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.485 0.314 . . . . 0.0 111.484 142.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.3 p -119.74 -113.34 0.33 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -168.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 m 154.13 60.4 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 129.887 3.275 . . . . 0.0 110.474 -166.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -129.69 147.01 51.43 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 126.756 2.023 . . . . 0.0 115.742 -166.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.7 m -51.48 131.8 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -168.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.22 -76.1 0.17 Allowed 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 155.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -81.48 153.24 70.96 Favored Pre-proline 0 CA--C 1.561 1.396 0 O-C-N 120.191 -1.568 . . . . 0.0 112.886 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -58.81 -11.59 12.41 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.458 2.772 . . . . 0.0 116.033 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -91.55 -10.86 39.08 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.993 1.317 . . . . 0.0 113.881 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.96 113.62 5.02 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -166.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -74.21 95.75 2.66 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 137.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -101.21 145.95 28.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.774 1.63 . . . . 0.0 113.816 -154.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.7 m -65.57 75.25 0.07 Allowed 'General case' 0 CA--C 1.551 0.992 0 O-C-N 120.767 -1.208 . . . . 0.0 114.084 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.571 -1.204 . . . . 0.0 112.464 165.45 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.501 2.087 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -72.45 68.5 0.79 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.648 1.179 . . . . 0.0 111.663 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -79.71 -117.1 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.337 1.455 . . . . 0.0 113.009 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -63.66 123.18 18.18 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 121.175 -0.953 . . . . 0.0 112.463 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 79.19 39.75 0.11 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 127.806 2.443 . . . . 0.0 115.11 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.28 122.41 7.56 Favored Glycine 0 CA--C 1.551 2.341 0 N-CA-C 116.607 1.403 . . . . 0.0 116.607 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -66.98 112.12 4.17 Favored 'General case' 0 CA--C 1.556 1.21 0 O-C-N 119.872 -1.957 . . . . 0.0 115.773 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -109.77 50.16 0.81 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.849 1.66 . . . . 0.0 111.588 164.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.37 158.55 29.04 Favored Glycine 0 CA--C 1.54 1.617 0 O-C-N 120.202 -1.561 . . . . 0.0 116.353 -171.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.88 -68.14 1.52 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 119.024 2.369 . . . . 0.0 119.024 -161.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.8 mt -60.68 101.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 120.988 -1.301 . . . . 0.0 112.401 -165.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.19 -28.28 10.58 Favored Glycine 0 CA--C 1.546 1.992 0 C-N-CA 126.242 1.877 . . . . 0.0 115.7 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -106.07 62.27 0.66 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -150.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.2 p -68.69 58.77 0.09 Allowed 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.235 -1.541 . . . . 0.0 111.64 159.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.52 161.56 27.98 Favored Glycine 0 CA--C 1.547 2.042 0 N-CA-C 116.214 1.245 . . . . 0.0 116.214 -158.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -83.88 130.15 4.91 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.092 3.195 . . . . 0.0 112.225 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.5 p -79.56 69.34 5.83 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.302 -1.499 . . . . 0.0 112.31 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.3 t -77.19 57.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.983 1.313 . . . . 0.0 112.525 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.1 t -105.53 149.5 26.18 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.829 2.052 . . . . 0.0 115.121 -158.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.07 62.87 6.82 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -171.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -19.76 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.567 2.347 . . . . 0.0 115.397 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.88 -54.38 0.55 Allowed Glycine 0 CA--C 1.54 1.637 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -151.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.7 p -70.79 154.3 41.97 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 122.807 -0.231 . . . . 0.0 111.319 137.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.7 p -101.08 -117.75 0.17 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -162.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.3 m 162.51 51.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 131.058 3.743 . . . . 0.0 111.102 -172.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -121.47 149.88 42.4 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 119.99 -1.694 . . . . 0.0 115.314 -167.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 m -57.4 137.62 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -171.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -152.73 -59.84 0.15 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.859 1.264 . . . . 0.0 113.675 161.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -92.3 150.66 40.53 Favored Pre-proline 0 CA--C 1.561 1.371 0 O-C-N 120.554 -1.341 . . . . 0.0 112.777 168.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.88 -26.32 57.26 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.702 2.935 . . . . 0.0 115.101 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -45.04 70.53 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.217 -0.927 . . . . 0.0 112.989 175.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.21 113.47 19.51 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.413 1.885 . . . . 0.0 114.106 -167.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.7 t -70.36 113.85 7.92 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 136.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -127.2 137.03 52.83 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -147.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -59.82 79.9 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.415 1.086 . . . . 0.0 112.749 167.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.105 146.903 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.7 p . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -72.02 131.61 43.14 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.339 1.456 . . . . 0.0 110.33 165.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -85.74 175.68 8.57 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -49.85 135.76 19.12 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.681 1.193 . . . . 0.0 112.658 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 69.15 -2.28 1.86 Allowed 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -169.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.73 144.88 49.7 Favored Glycine 0 CA--C 1.549 2.178 0 O-C-N 119.906 -1.746 . . . . 0.0 115.185 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.77 136.51 36.76 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -167.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.67 35.54 4.82 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 126.316 1.846 . . . . 0.0 113.241 161.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.26 168.96 21.32 Favored Glycine 0 CA--C 1.54 1.632 0 O-C-N 120.472 -1.392 . . . . 0.0 114.712 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.97 -45.41 83.39 Favored Glycine 0 CA--C 1.544 1.896 0 N-CA-C 117.855 1.902 . . . . 0.0 117.855 -158.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.7 mm -56.92 109.22 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 O-C-N 121.175 -1.191 . . . . 0.0 113.113 -170.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.46 39.11 96.61 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 125.758 1.647 . . . . 0.0 115.418 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.1 178.98 6.78 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 -168.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 91.3 p -136.73 -84.92 0.34 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.805 1.642 . . . . 0.0 111.046 172.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.5 53.04 0.05 OUTLIER Glycine 0 CA--C 1.545 1.95 0 N-CA-C 117.979 1.952 . . . . 0.0 117.979 169.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.1 46.57 1.14 Allowed 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 123.39 2.727 . . . . 0.0 112.674 169.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.3 p -70.94 23.38 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -164.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 t -77.34 63.28 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 O-C-N 119.798 -1.814 . . . . 0.0 112.181 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.1 t -55.43 154.93 5.73 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.564 1.545 . . . . 0.0 114.682 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.17 73.35 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 O-C-N 120.608 -1.308 . . . . 0.0 112.621 165.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.1 t -38.3 109.16 0.09 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.344 1.858 . . . . 0.0 114.687 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.82 -53.24 0.71 Allowed Glycine 0 CA--C 1.537 1.469 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -156.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.3 p -82.05 163.4 22.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.299 0.64 . . . . 0.0 110.736 146.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 33.8 p -113.44 -120.17 0.3 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -161.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' THR . 47.4 t 171.42 51.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 127.79 2.436 . . . . 0.0 111.315 -169.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -129.54 146.67 51.33 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.676 1.59 . . . . 0.0 115.197 -154.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 m -51.12 127.84 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.3 0.0 OUTLIER -148.76 -99.56 0.08 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 125.112 1.365 . . . . 0.0 113.64 158.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -53.64 146.38 25.85 Favored Pre-proline 0 CA--C 1.565 1.535 0 O-C-N 119.553 -1.967 . . . . 0.0 113.994 169.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -58.23 -28.68 85.14 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.808 3.005 . . . . 0.0 115.045 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -66.22 -33.26 75.34 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 121.035 -1.04 . . . . 0.0 113.77 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.58 115.9 9.97 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.621 1.568 . . . . 0.0 114.917 -166.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -66.43 121.24 14.86 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.842 -1.161 . . . . 0.0 108.525 136.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -129.97 142.8 50.59 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -149.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.7 t -69.19 66.51 0.16 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.832 2.053 . . . . 0.0 112.744 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.9 2.08 . . . . 0.0 112.846 170.872 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.5 2.054 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -106.36 146.97 29.78 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.185 1.394 . . . . 0.0 112.0 169.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -89.53 -166.86 1.7 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 125.072 1.349 . . . . 0.0 114.504 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -59.44 149.96 27.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.282 1.433 . . . . 0.0 114.829 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 61.36 5.12 1.07 Allowed 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.17 130.97 51.79 Favored Glycine 0 CA--C 1.546 1.987 0 O-C-N 119.494 -2.004 . . . . 0.0 115.019 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -66.63 125.7 26.62 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 120.693 -1.475 . . . . 0.0 111.965 175.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -119.32 40.58 3.31 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 125.424 1.489 . . . . 0.0 110.971 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.03 158.77 27.84 Favored Glycine 0 CA--C 1.544 1.904 0 C-N-CA 125.181 1.372 . . . . 0.0 115.195 -170.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.67 -58.77 11.92 Favored Glycine 0 CA--C 1.549 2.187 0 N-CA-C 120.324 2.89 . . . . 0.0 120.324 -158.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.9 mt -57.08 107.34 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 O-C-N 120.643 -1.504 . . . . 0.0 113.22 -165.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.04 19.47 62.87 Favored Glycine 0 CA--C 1.544 1.866 0 C-N-CA 126.254 1.883 . . . . 0.0 115.786 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -140.92 117.02 10.55 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.6 p -120.26 42.85 2.86 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.165 1.386 . . . . 0.0 112.466 163.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.52 122.84 7.17 Favored Glycine 0 CA--C 1.547 2.084 0 C-N-CA 125.083 1.325 . . . . 0.0 114.745 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.46 63.11 7.16 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.588 2.859 . . . . 0.0 111.823 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.8 p -77.56 66.3 3.25 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.273 -1.517 . . . . 0.0 114.28 -176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.26 89.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.905 0.882 . . . . 0.0 109.365 155.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.28 177.44 7.26 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -166.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.43 68.92 0.14 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.878 1.271 . . . . 0.0 113.782 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.2 t -28.75 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 127.156 2.182 . . . . 0.0 114.535 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.63 -54.45 0.62 Allowed Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.283 1.42 . . . . 0.0 109.638 -155.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -77.24 176.3 8.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.287 0.635 . . . . 0.0 111.16 142.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 p -127.92 -124.06 0.23 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.367 1.467 . . . . 0.0 114.582 -167.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 m 167.85 55.08 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 128.867 2.867 . . . . 0.0 111.383 -168.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . 0.266 2.8 pp0? -139.25 169.2 18.2 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -168.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.79 139.88 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -148.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.32 -67.97 0.12 Allowed 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 160.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -88.98 147.64 39.24 Favored Pre-proline 0 CA--C 1.555 1.139 0 O-C-N 120.395 -1.44 . . . . 0.0 112.705 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -54.82 -28.63 58.96 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.531 2.821 . . . . 0.0 115.026 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.85 -44.7 72.85 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 121.077 -1.015 . . . . 0.0 112.698 174.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.21 109.7 15.28 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.042 1.737 . . . . 0.0 115.27 -167.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -64.37 103.59 0.66 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 134.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -111.05 148.8 31.81 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.672 1.589 . . . . 0.0 114.192 -155.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.0 m -68.21 70.58 0.16 Allowed 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.254 1.294 0 CA-C-O 117.65 -1.167 . . . . 0.0 111.304 157.875 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.497 1.895 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -84.98 178.73 7.48 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.558 1.143 . . . . 0.0 111.505 161.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.4 t -86.85 -117.47 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.875 0.87 . . . . 0.0 111.347 167.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -47.83 159.99 0.15 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 172.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 73.38 58.43 0.1 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.303 1.841 . . . . 0.0 115.392 162.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.24 135.86 7.74 Favored Glycine 0 CA--C 1.545 1.958 0 C-N-CA 126.168 1.842 . . . . 0.0 112.653 171.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -76.21 128.85 35.75 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.009 -1.289 . . . . 0.0 113.933 -173.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -111.78 57.66 0.64 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 126.59 1.956 . . . . 0.0 110.892 170.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.12 156.39 27.47 Favored Glycine 0 CA--C 1.544 1.85 0 O-C-N 120.889 -1.132 . . . . 0.0 115.333 -169.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.96 -48.75 5.94 Favored Glycine 0 CA--C 1.546 2.024 0 N-CA-C 118.147 2.019 . . . . 0.0 118.147 -159.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.66 122.97 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.595 -1.533 . . . . 0.0 112.828 -171.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.41 34.96 91.32 Favored Glycine 0 CA--C 1.544 1.855 0 C-N-CA 124.85 1.214 . . . . 0.0 115.089 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.38 -172.6 3.99 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -166.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.1 p -160.52 -87.75 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.659 1.984 . . . . 0.0 110.416 168.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.76 36.66 1.6 Allowed Glycine 0 CA--C 1.552 2.386 0 N-CA-C 119.773 2.669 . . . . 0.0 119.773 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -62.9 37.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.637 0 CA-C-N 122.145 2.972 . . . . 0.0 116.809 165.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.5 p -75.43 57.93 0.96 Allowed 'General case' 0 N--CA 1.481 1.083 0 O-C-N 119.432 -2.043 . . . . 0.0 113.575 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 18' ' ' VAL . 39.0 t -73.51 28.8 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.44 0 O-C-N 119.922 -1.736 . . . . 0.0 114.347 -176.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.2 t -95.75 157.68 15.79 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 129.303 3.041 . . . . 0.0 113.549 -173.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.43 108.06 19.38 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.254 1.422 . . . . 0.0 112.766 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -56.11 150.67 13.53 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.31 -47.69 1.02 Allowed Glycine 0 CA--C 1.541 1.703 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -145.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.1 p -77.16 171.21 15.19 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.945 0.898 . . . . 0.0 111.991 147.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 p -107.99 -146.32 0.4 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.886 1.674 . . . . 0.0 114.08 -168.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 m -162.24 68.61 0.26 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 127.459 2.304 . . . . 0.0 109.787 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -124.29 148.58 47.31 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 126.138 1.775 . . . . 0.0 115.668 -158.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.1 m -57.83 118.98 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -168.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.38 -48.88 3.71 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.109 1.363 . . . . 0.0 113.091 162.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -150.82 168.65 10.6 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 127.831 2.452 . . . . 0.0 110.748 -170.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -55.5 -15.77 12.71 Favored 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.095 2.53 . . . . 0.0 117.741 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.76 -45.36 9.35 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.934 1.243 . . . . 0.0 111.942 173.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.77 94.32 5.01 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.474 1.91 . . . . 0.0 112.84 -157.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 t -89.31 99.28 12.31 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 151.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.87 156.36 38.01 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.875 2.07 . . . . 0.0 113.872 -154.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.5 m -64.91 82.66 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 127.192 2.197 . . . . 0.0 112.967 157.965 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.34 64.67 0.1 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.296 2.238 . . . . 0.0 112.261 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 m -85.18 -89.28 0.11 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.255 1.022 . . . . 0.0 112.241 -161.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -73.57 92.24 1.9 Allowed 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.456 -0.778 . . . . 0.0 109.623 168.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.254 13.6 m-85 98.93 106.46 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 130.22 3.408 . . . . 0.0 112.442 -174.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.83 109.32 0.39 Allowed Glycine 0 CA--C 1.541 1.671 0 C-N-CA 127.184 2.326 . . . . 0.0 111.625 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -72.62 119.39 16.78 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.748 1.219 . . . . 0.0 112.895 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 p -137.29 56.93 1.76 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.948 1.699 . . . . 0.0 111.189 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.5 34.81 1.47 Allowed Glycine 0 CA--C 1.545 1.915 0 N-CA-C 117.607 1.803 . . . . 0.0 117.607 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.23 -70.66 1.55 Allowed Glycine 0 CA--C 1.545 1.911 0 N-CA-C 117.046 1.578 . . . . 0.0 117.046 165.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.9 mt -54.4 112.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 119.015 1.408 . . . . 0.0 113.841 -168.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.18 -11.55 48.86 Favored Glycine 0 CA--C 1.548 2.145 0 C-N-CA 125.651 1.596 . . . . 0.0 115.332 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -110.85 62.62 0.61 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -155.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 t -70.11 64.09 0.23 Allowed 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.701 -1.25 . . . . 0.0 111.039 156.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.74 176.14 20.12 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 -164.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.16 143.48 25.58 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.615 3.543 . . . . 0.0 112.45 -174.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.8 p -123.94 41.33 3.51 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.992 1.317 . . . . 0.0 113.265 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 t -79.35 51.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 O-C-N 120.323 -1.485 . . . . 0.0 112.335 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.6 t -82.4 164.02 21.29 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 128.73 2.812 . . . . 0.0 113.122 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.58 93.71 4.09 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 t -36.84 111.04 0.13 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.838 1.655 . . . . 0.0 114.218 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.74 -50.3 0.89 Allowed Glycine 0 CA--C 1.541 1.704 0 C-N-CA 125.844 1.688 . . . . 0.0 109.536 -158.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.6 p -82.62 152.87 25.72 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.661 1.185 . . . . 0.0 110.695 143.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.1 p -101.44 -107.25 0.24 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -159.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t 146.09 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 131.547 3.939 . . . . 0.0 110.206 -170.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -118.31 127.12 53.4 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 127.536 2.334 . . . . 0.0 114.214 -157.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.9 t -65.17 86.86 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 C-N-CA 125.431 1.492 . . . . 0.0 114.586 -170.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.69 -44.73 8.4 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -152.91 160.21 31.3 Favored Pre-proline 0 CA--C 1.557 1.246 0 O-C-N 121.029 -1.044 . . . . 0.0 113.497 -164.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.67 53.64 3.25 Favored 'Trans proline' 0 CA--C 1.554 1.48 0 C-N-CA 124.268 3.312 . . . . 0.0 113.58 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -159.75 -53.76 0.06 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 129.534 3.133 . . . . 0.0 109.084 176.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.91 119.16 36.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.028 2.131 . . . . 0.0 113.175 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 t -66.55 123.41 19.98 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 120.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -113.67 129.22 56.6 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.94 1.696 . . . . 0.0 111.38 -160.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.0 m -64.43 83.88 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.357 -0.84 . . . . 0.0 111.909 165.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 C--O 1.256 1.432 0 CA-C-O 116.694 -1.622 . . . . 0.0 109.678 153.385 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -67.51 72.52 0.14 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.127 1.771 . . . . 0.0 111.159 171.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 m -82.79 -131.65 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.499 1.52 . . . . 0.0 113.243 -166.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -47.7 121.32 3.96 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.998 1.319 . . . . 0.0 113.682 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 72.48 50.02 0.19 Allowed 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 127.377 2.271 . . . . 0.0 114.336 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.01 133.76 10.11 Favored Glycine 0 CA--C 1.547 2.038 0 C-N-CA 126.111 1.815 . . . . 0.0 115.317 -174.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -73.66 130.39 39.91 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 120.221 2.011 . . . . 0.0 115.023 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.3 m -112.01 -47.28 3.14 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.588 1.555 . . . . 0.0 111.88 166.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 165.49 10.08 Favored Glycine 0 CA--C 1.548 2.107 0 N-CA-C 117.239 1.656 . . . . 0.0 117.239 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.57 -52.64 24.64 Favored Glycine 0 CA--C 1.548 2.113 0 N-CA-C 119.471 2.549 . . . . 0.0 119.471 -157.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.6 114.35 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 120.094 -1.827 . . . . 0.0 112.033 -166.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.67 -16.83 60.44 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 126.031 1.777 . . . . 0.0 116.391 -172.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -111.37 76.22 0.96 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -153.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 p -72.28 24.27 0.05 Allowed 'General case' 0 CA--C 1.554 1.123 0 O-C-N 120.138 -1.601 . . . . 0.0 114.297 158.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.76 157.73 22.38 Favored Glycine 0 CA--C 1.546 1.984 0 O-C-N 120.735 -1.228 . . . . 0.0 116.036 -168.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -83.68 122.47 3.1 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.336 2.69 . . . . 0.0 110.614 172.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -73.76 60.55 0.71 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.638 -1.288 . . . . 0.0 113.853 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 t -72.39 57.21 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 O-C-N 120.168 -1.583 . . . . 0.0 112.045 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.9 t -93.04 154.59 18.03 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.94 2.096 . . . . 0.0 113.726 -171.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.39 83.78 7.38 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.765 -1.209 . . . . 0.0 112.339 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.3 t -44.24 109.71 0.17 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.785 1.234 . . . . 0.0 113.213 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.26 -50.79 0.81 Allowed Glycine 0 CA--C 1.537 1.455 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -156.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.1 p -74.45 155.09 38.4 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.6 0.36 . . . . 0.0 110.892 139.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.3 p -98.59 -106.46 0.2 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -163.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 m 158.42 30.76 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 130.994 3.718 . . . . 0.0 112.584 -172.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -95.02 151.32 19.28 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.361 -2.087 . . . . 0.0 116.369 -164.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.4 t -55.89 115.2 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 126.481 1.912 . . . . 0.0 114.427 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -122.58 -49.51 2.01 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -139.65 162.1 52.93 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.856 1.263 . . . . 0.0 112.558 -167.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.97 49.99 1.7 Allowed 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 123.833 3.022 . . . . 0.0 113.471 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -154.17 -67.75 0.14 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 129.626 3.17 . . . . 0.0 107.746 172.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.87 111.24 23.69 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 127.046 2.138 . . . . 0.0 113.049 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.1 p -58.79 124.14 18.78 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.573 115.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -138.65 140.56 38.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.085 1.354 . . . . 0.0 114.444 -147.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.1 m -67.75 83.07 0.19 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.794 1.238 . . . . 0.0 112.7 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt . . . . . 0 C--O 1.254 1.312 0 CA-C-O 117.405 -1.283 . . . . 0.0 110.467 152.359 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -82.52 156.62 23.93 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.435 1.016 . . . . 0.0 112.913 170.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.0 t -98.38 -145.46 0.32 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.83 1.252 . . . . 0.0 110.46 164.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -47.84 144.7 3.28 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 169.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 81.34 4.19 1.45 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.146 2.178 . . . . 0.0 116.391 172.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.07 153.78 41.49 Favored Glycine 0 CA--C 1.55 2.268 0 O-C-N 120.426 -1.421 . . . . 0.0 115.285 173.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -84.2 135.78 34.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.605 1.562 . . . . 0.0 113.563 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.5 m -131.54 -6.91 3.7 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.24 111.44 0.3 Allowed Glycine 0 CA--C 1.546 1.975 0 CA-C-N 119.975 1.261 . . . . 0.0 115.237 -177.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.55 24.23 0.06 OUTLIER Glycine 0 CA--C 1.541 1.718 0 O-C-N 118.952 -2.499 . . . . 0.0 117.477 -6.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.9 mt -64.12 129.44 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 120.345 2.073 . . . . 0.0 110.683 169.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.5 -39.43 0.74 Allowed Glycine 0 CA--C 1.547 2.084 0 C-N-CA 124.589 1.09 . . . . 0.0 115.648 -174.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -64.93 178.43 0.82 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 126.858 2.063 . . . . 0.0 115.217 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.6 p -134.39 -86.0 0.41 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.916 1.287 . . . . 0.0 110.953 165.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.95 38.56 0.5 Allowed Glycine 0 CA--C 1.546 2.005 0 N-CA-C 118.103 2.001 . . . . 0.0 118.103 169.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -77.82 58.55 6.51 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 CA-C-N 121.086 2.443 . . . . 0.0 111.181 172.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -74.61 57.59 0.74 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.756 1.222 . . . . 0.0 113.923 -171.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 t -78.78 62.52 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 O-C-N 120.429 -1.419 . . . . 0.0 111.28 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.07 -177.96 4.32 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.138 2.175 . . . . 0.0 112.603 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.33 165.88 24.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.749 0.82 . . . . 0.0 112.801 166.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.4 t -106.4 171.93 7.09 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.567 1.147 . . . . 0.0 112.172 171.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.06 -53.68 1.4 Allowed Glycine 0 CA--C 1.546 1.975 0 O-C-N 120.928 -1.108 . . . . 0.0 111.821 -159.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -58.89 147.44 33.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.809 1.243 . . . . 0.0 113.502 157.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.6 p -108.44 -128.4 0.27 Allowed 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -173.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m 179.86 55.88 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 128.2 2.6 . . . . 0.0 111.73 -162.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -124.03 147.47 47.8 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 126.345 1.858 . . . . 0.0 115.215 -159.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.3 m -44.68 110.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 127.459 2.304 . . . . 0.0 116.439 -170.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.83 -49.67 2.21 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.15 1.38 . . . . 0.0 114.378 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -153.45 163.51 23.47 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 125.626 1.57 . . . . 0.0 112.325 -169.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.96 48.77 2.07 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.74 2.96 . . . . 0.0 113.94 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -155.51 -46.16 0.08 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.511 2.724 . . . . 0.0 108.826 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.43 113.46 17.54 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 127.669 2.387 . . . . 0.0 114.015 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -59.08 122.78 14.6 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.36 117.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -139.58 148.3 42.34 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.14 1.376 . . . . 0.0 113.276 -145.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 m -65.35 91.09 0.11 Allowed 'General case' 0 CA--C 1.555 1.168 0 O-C-N 120.687 -1.258 . . . . 0.0 113.574 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.129 1.372 . . . . 0.0 110.208 154.999 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 68.8 p . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -88.41 131.87 34.68 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.936 2.094 . . . . 0.0 110.86 167.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -90.59 176.79 6.55 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -173.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -49.45 140.71 10.1 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.652 1.581 . . . . 0.0 112.932 -174.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 69.48 -20.34 0.17 Allowed 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -44.94 141.31 3.97 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 116.722 1.449 . . . . 0.0 116.722 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -70.22 138.41 51.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.911 2.084 . . . . 0.0 115.182 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 p -150.26 63.71 0.96 Allowed 'General case' 0 CA--C 1.553 1.075 0 O-C-N 121.078 -1.014 . . . . 0.0 111.851 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.2 -155.23 26.26 Favored Glycine 0 CA--C 1.55 2.278 0 C-N-CA 126.163 1.839 . . . . 0.0 115.071 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.95 -144.94 5.82 Favored Glycine 0 CA--C 1.547 2.063 0 C-N-CA 126.368 1.937 . . . . 0.0 117.446 172.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -55.28 107.01 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 O-C-N 120.887 -1.36 . . . . 0.0 112.424 174.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.74 -44.16 2.57 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 116.93 1.532 . . . . 0.0 116.93 159.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -73.93 69.21 1.4 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 119.407 1.603 . . . . 0.0 114.906 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.5 m -80.06 73.89 6.85 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.017 -1.052 . . . . 0.0 109.102 151.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.78 -170.03 12.62 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 -162.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.13 83.56 0.15 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.618 2.879 . . . . 0.0 114.332 -174.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 p -62.45 15.24 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.05 62.46 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 O-C-N 120.088 -1.632 . . . . 0.0 112.385 -162.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.6 t -57.83 162.6 3.1 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 127.282 2.233 . . . . 0.0 113.968 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.22 69.86 0.09 Allowed 'General case' 0 CA--C 1.555 1.158 0 O-C-N 120.155 -1.591 . . . . 0.0 113.781 172.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.4 t -14.28 80.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 129.06 2.944 . . . . 0.0 116.29 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.16 -55.08 0.47 Allowed Glycine 0 CA--C 1.537 1.432 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -158.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.4 p -81.59 158.18 24.47 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 120.704 0.288 . . . . 0.0 110.481 145.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.4 p -122.94 -115.58 0.3 Allowed 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -154.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.9 t 179.9 74.67 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 128.904 2.881 . . . . 0.0 110.631 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.95 131.06 55.4 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 128.233 2.613 . . . . 0.0 113.797 -162.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.6 t -63.85 103.79 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 125.405 1.482 . . . . 0.0 113.836 -173.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 mt -111.77 -51.77 2.83 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -148.05 158.38 41.89 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -161.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -51.57 -18.26 5.68 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 124.009 3.139 . . . . 0.0 117.106 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -90.0 -45.49 9.15 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.916 -1.115 . . . . 0.0 113.209 168.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.3 119.64 34.61 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.047 1.339 . . . . 0.0 114.101 -170.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -68.41 132.7 47.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 117.144 -1.822 . . . . 0.0 108.933 114.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -131.67 136.45 47.7 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -149.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.3 t -68.18 64.51 0.1 Allowed 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.723 1.209 . . . . 0.0 112.279 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.251 1.153 0 C-N-CA 126.311 1.844 . . . . 0.0 111.856 167.103 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -133.75 173.07 11.93 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 126.842 2.057 . . . . 0.0 111.446 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.6 t -121.88 -145.35 0.35 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.345 1.458 . . . . 0.0 111.725 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -50.38 134.37 23.37 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.878 1.271 . . . . 0.0 113.896 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 57.99 25.1 11.84 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 126.612 1.965 . . . . 0.0 115.987 -171.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.36 134.29 20.94 Favored Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.306 1.282 . . . . 0.0 116.306 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -72.95 130.97 41.56 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.271 1.428 . . . . 0.0 113.48 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.78 66.84 1.41 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 127.96 2.504 . . . . 0.0 109.234 160.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.96 170.93 33.22 Favored Glycine 0 CA--C 1.543 1.801 0 C-N-CA 126.479 1.99 . . . . 0.0 113.427 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.75 -54.58 27.4 Favored Glycine 0 CA--C 1.545 1.965 0 N-CA-C 119.325 2.49 . . . . 0.0 119.325 -159.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 mt -53.97 114.58 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 O-C-N 121.229 -1.159 . . . . 0.0 113.784 -165.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.76 36.02 70.33 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 125.84 1.686 . . . . 0.0 115.698 -176.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.07 175.12 9.89 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -160.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 m -158.04 -44.73 0.06 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.337 2.255 . . . . 0.0 111.866 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.18 68.31 1.21 Allowed Glycine 0 CA--C 1.547 2.056 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 164.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -61.37 66.64 0.1 OUTLIER 'Trans proline' 0 CA--C 1.551 1.325 0 C-N-CA 123.432 2.755 . . . . 0.0 111.977 152.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 p -141.57 49.99 1.59 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -157.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.97 91.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 O-C-N 121.174 -0.954 . . . . 0.0 109.307 155.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 171.18 5.46 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -166.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.69 78.95 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.9 t -36.21 123.37 0.75 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.407 1.883 . . . . 0.0 114.588 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.2 -45.73 1.25 Allowed Glycine 0 CA--C 1.543 1.801 0 C-N-CA 124.727 1.156 . . . . 0.0 110.585 -149.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.5 p -103.83 148.87 25.62 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.163 2.185 . . . . 0.0 111.771 161.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.4 p -134.75 113.27 11.48 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.413 1.485 . . . . 0.0 114.653 -158.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.0 t -63.58 88.44 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 126.041 1.736 . . . . 0.0 114.622 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -122.59 146.14 47.7 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.76 114.85 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.8 mt -125.04 -58.81 1.45 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.484 1.514 . . . . 0.0 114.97 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -135.94 162.03 59.15 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 124.222 1.009 . . . . 0.0 112.928 -155.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.66 32.95 0.29 Allowed 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.198 2.598 . . . . 0.0 114.963 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -133.74 -48.59 0.81 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.039 2.136 . . . . 0.0 110.649 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.05 135.31 51.61 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 127.746 2.418 . . . . 0.0 114.742 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.4 t -72.43 124.34 24.96 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.483 127.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -122.1 130.19 53.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.787 1.635 . . . . 0.0 112.641 -151.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.8 m -66.24 92.04 0.18 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 C--O 1.246 0.909 0 C-N-CA 124.11 0.964 . . . . 0.0 111.471 165.298 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.499 1.98 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -88.77 170.7 10.54 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.171 0.988 . . . . 0.0 112.282 171.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.1 t -116.5 -91.44 0.54 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 119.318 0.963 . . . . 0.0 113.173 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -72.14 120.28 17.52 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.545 1.538 . . . . 0.0 112.837 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 90.56 50.44 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 127.548 2.339 . . . . 0.0 116.406 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.06 132.49 10.71 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 125.732 1.634 . . . . 0.0 114.715 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -68.73 132.51 46.95 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 119.101 1.45 . . . . 0.0 113.658 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.9 m -123.43 0.76 8.91 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.68 1.992 . . . . 0.0 115.097 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.62 -146.19 6.71 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.611 1.577 . . . . 0.0 111.719 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.56 -164.52 20.45 Favored Glycine 0 CA--C 1.545 1.945 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -54.18 134.4 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 O-C-N 121.155 -1.203 . . . . 0.0 114.141 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.64 -42.73 3.13 Favored Glycine 0 CA--C 1.543 1.823 0 C-N-CA 124.927 1.251 . . . . 0.0 115.033 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -67.18 171.48 5.68 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 126.167 1.787 . . . . 0.0 114.681 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.0 p -59.47 156.45 13.09 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 130.856 3.662 . . . . 0.0 116.664 6.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.5 -163.67 26.71 Favored Glycine 0 CA--C 1.549 2.159 0 O-C-N 121.351 -0.843 . . . . 0.0 114.968 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.46 82.32 2.11 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 123.69 2.927 . . . . 0.0 113.977 -168.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.8 p -67.73 56.98 0.06 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 126.242 1.817 . . . . 0.0 114.259 172.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.92 52.38 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 O-C-N 119.88 -1.763 . . . . 0.0 112.132 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.75 157.31 17.04 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 128.105 2.562 . . . . 0.0 113.936 -170.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -101.19 127.22 47.86 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.207 1.803 . . . . 0.0 112.299 172.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.0 t -65.44 122.11 16.41 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 171.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.21 -66.99 0.29 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.488 1.994 . . . . 0.0 109.139 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.4 p -60.53 151.58 28.19 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.559 0.743 . . . . 0.0 111.583 137.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.9 p -93.96 -105.86 0.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -169.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 167.98 3.42 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 128.41 2.684 . . . . 0.0 116.184 -170.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -90.73 172.81 8.39 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 -157.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.0 m -54.05 123.25 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 127.469 2.307 . . . . 0.0 116.602 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -163.54 -55.97 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 157.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -84.52 140.48 38.57 Favored Pre-proline 0 CA--C 1.561 1.4 0 O-C-N 119.604 -1.935 . . . . 0.0 112.333 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -39.32 -52.37 2.42 Favored 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 125.264 3.976 . . . . 0.0 115.93 171.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -69.89 -42.9 72.81 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.83 -1.169 . . . . 0.0 113.079 169.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.04 104.98 9.56 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -168.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t -55.23 116.39 2.79 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.648 124.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -129.87 146.79 51.59 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -155.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.0 m -64.17 80.39 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 O-C-N 120.95 -1.094 . . . . 0.0 112.515 166.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 124.256 1.022 . . . . 0.0 110.138 151.598 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.497 1.908 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -64.17 73.85 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.01 1.324 . . . . 0.0 111.897 169.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 t -75.0 -143.54 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.661 -0.649 . . . . 0.0 111.088 160.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -44.7 103.59 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.356 1.463 . . . . 0.0 113.583 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 87.08 84.62 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 129.563 3.145 . . . . 0.0 114.255 -171.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.53 117.26 1.25 Allowed Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.315 1.436 . . . . 0.0 114.732 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -65.42 122.13 16.46 Favored 'General case' 0 CA--C 1.556 1.195 0 O-C-N 119.751 -2.029 . . . . 0.0 112.49 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.4 m -104.9 -52.53 2.84 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.919 1.288 . . . . 0.0 114.387 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.16 132.55 3.58 Favored Glycine 0 CA--C 1.543 1.837 0 C-N-CA 124.185 0.898 . . . . 0.0 114.26 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.27 -157.97 27.46 Favored Glycine 0 CA--C 1.546 2.017 0 C-N-CA 126.424 1.964 . . . . 0.0 113.029 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.0 mt -40.83 110.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 119.333 1.566 . . . . 0.0 112.764 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.37 -33.39 3.2 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 116.296 1.279 . . . . 0.0 116.296 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -82.01 55.56 2.83 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -156.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.2 t -74.53 71.56 1.85 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.357 -1.464 . . . . 0.0 108.612 147.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.0 -172.68 14.88 Favored Glycine 0 CA--C 1.546 2.008 0 N-CA-C 117.82 1.888 . . . . 0.0 117.82 -154.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.41 80.21 2.79 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.152 3.235 . . . . 0.0 112.45 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.5 p -68.9 51.12 0.08 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.856 1.662 . . . . 0.0 114.868 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -78.45 52.54 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 O-C-N 119.728 -1.857 . . . . 0.0 111.704 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 44.5 t -85.59 166.07 16.53 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.915 2.486 . . . . 0.0 115.269 -165.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.28 83.61 1.8 Allowed 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 t -43.29 109.91 0.17 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.834 1.253 . . . . 0.0 113.686 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.98 -52.37 0.79 Allowed Glycine 0 CA--C 1.539 1.584 0 C-N-CA 125.614 1.578 . . . . 0.0 110.158 -160.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.4 p -76.91 163.98 26.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.079 0.552 . . . . 0.0 109.958 140.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.7 p -114.26 -124.19 0.29 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -163.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 m -173.69 32.76 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 128.957 2.903 . . . . 0.0 111.808 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -65.08 141.98 58.54 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 119.867 -1.771 . . . . 0.0 114.676 -162.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 m -64.58 93.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.18 1.392 . . . . 0.0 113.905 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.2 mt -96.59 -48.01 5.7 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -162.86 176.14 2.52 Favored Pre-proline 0 CA--C 1.559 1.326 0 O-C-N 120.832 -1.168 . . . . 0.0 113.94 -165.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.95 -39.15 92.06 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.482 2.788 . . . . 0.0 115.106 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -67.3 -39.55 85.94 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.61 116.73 8.93 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 117.768 2.507 . . . . 0.0 117.768 -164.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.11 125.58 19.54 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.59 111.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -144.04 127.32 16.73 Favored 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -154.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.0 m -63.46 78.58 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.66 1.584 . . . . 0.0 113.043 174.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.6 mt . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.187 151.273 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 . . . . . 0 CA--C 1.553 1.065 0 CA-C-O 121.838 0.828 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.8 m -59.71 -55.65 31.73 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -171.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -115.17 140.77 48.8 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.939 1.296 . . . . 0.0 114.028 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 62.9 41.92 8.16 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 125.564 1.546 . . . . 0.0 113.17 -171.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.09 109.91 3.68 Favored Glycine 0 CA--C 1.54 1.64 0 C-N-CA 126.113 1.815 . . . . 0.0 114.588 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -52.41 124.36 13.23 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.362 1.465 . . . . 0.0 114.09 176.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 m -118.51 -0.37 11.41 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.58 114.64 0.33 Allowed Glycine 0 CA--C 1.546 2.005 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -175.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.63 -160.28 30.15 Favored Glycine 0 CA--C 1.552 2.384 0 C-N-CA 126.391 1.948 . . . . 0.0 115.023 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -45.64 124.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.7 -13.13 49.43 Favored Glycine 0 CA--C 1.544 1.894 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -89.69 167.43 12.91 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 119.08 1.44 . . . . 0.0 114.856 -172.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 94.2 p -131.49 -92.42 0.4 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.635 1.574 . . . . 0.0 110.881 166.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.2 38.61 0.52 Allowed Glycine 0 CA--C 1.548 2.147 0 N-CA-C 118.294 2.078 . . . . 0.0 118.294 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -76.1 50.58 2.88 Favored 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 123.384 2.723 . . . . 0.0 112.198 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.2 p -77.67 66.6 3.4 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.212 -1.555 . . . . 0.0 113.119 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 t -76.46 51.87 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 O-C-N 120.874 -1.141 . . . . 0.0 112.088 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.1 t -98.59 169.4 9.54 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 129.722 3.209 . . . . 0.0 111.915 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.4 159.37 16.44 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.691 -1.256 . . . . 0.0 112.238 169.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.8 t -72.89 -177.13 2.26 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 161.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.68 -57.02 5.03 Favored Glycine 0 CA--C 1.542 1.742 0 O-C-N 120.857 -1.152 . . . . 0.0 111.688 -165.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.1 p -76.8 177.79 7.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.233 1.013 . . . . 0.0 111.224 153.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -129.11 -128.71 0.21 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -159.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.4 m 179.85 62.51 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 128.645 2.778 . . . . 0.0 111.835 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -128.82 157.83 40.4 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -165.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.39 132.77 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -167.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.1 -113.09 0.16 Allowed 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.745 1.218 . . . . 0.0 112.762 151.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.35 157.45 71.42 Favored Pre-proline 0 CA--C 1.562 1.409 0 O-C-N 119.566 -1.959 . . . . 0.0 114.51 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.79 -17.35 0.71 Allowed 'Trans proline' 0 CA--C 1.554 1.506 0 C-N-CA 124.622 3.548 . . . . 0.0 117.969 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -74.15 -25.52 59.79 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.96 105.31 2.73 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -154.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -71.78 117.3 13.19 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 121.465 -0.772 . . . . 0.0 109.422 130.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -138.97 151.32 46.77 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -160.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.7 m -57.97 76.33 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.527 1.931 . . . . 0.0 113.028 169.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 C--O 1.257 1.483 0 C-N-CA 125.161 1.384 . . . . 0.0 111.237 153.593 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? . . . . . 0 CA--C 1.56 1.354 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.8 m -77.01 154.37 33.55 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -168.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -41.13 146.77 0.16 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.134 1.774 . . . . 0.0 114.112 162.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 60.66 12.67 3.8 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.39 140.4 33.67 Favored Glycine 0 CA--C 1.545 1.937 0 O-C-N 119.807 -1.808 . . . . 0.0 115.254 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -64.95 119.31 10.48 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.572 -1.546 . . . . 0.0 112.78 173.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.5 38.28 3.79 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.453 1.479 . . . . 0.0 113.093 166.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.03 159.85 22.76 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 125.088 1.328 . . . . 0.0 114.685 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.87 -49.85 51.7 Favored Glycine 0 CA--C 1.545 1.955 0 N-CA-C 119.066 2.386 . . . . 0.0 119.066 -158.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.3 mt -58.32 119.72 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 O-C-N 120.724 -1.456 . . . . 0.0 112.983 -168.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.23 25.4 75.61 Favored Glycine 0 CA--C 1.543 1.838 0 C-N-CA 124.755 1.169 . . . . 0.0 115.548 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.22 -170.59 3.53 Favored 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 115.734 1.754 . . . . 0.0 115.734 -166.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.8 p -146.34 -69.29 0.26 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.993 2.117 . . . . 0.0 110.702 175.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.1 64.99 0.52 Allowed Glycine 0 CA--C 1.541 1.699 0 N-CA-C 117.584 1.794 . . . . 0.0 117.584 156.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.54 34.73 0.38 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 C-N-CA 122.663 2.242 . . . . 0.0 112.757 166.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.0 p -84.09 66.36 9.21 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 119.814 -1.804 . . . . 0.0 113.393 -170.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 t -65.35 78.45 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.996 0.919 . . . . 0.0 109.762 163.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 174.27 7.68 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 -168.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.54 73.08 0.06 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.329 1.451 . . . . 0.0 113.721 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.8 t -37.8 109.21 0.09 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.549 1.94 . . . . 0.0 114.74 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.78 -55.56 0.72 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.11 1.814 . . . . 0.0 108.69 -158.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.7 p -70.66 168.49 16.39 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.299 -0.451 . . . . 0.0 111.714 141.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -126.03 -114.04 0.28 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.852 1.661 . . . . 0.0 114.616 -166.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.0 m 162.3 65.35 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.806 0 C-N-CA 131.448 3.899 . . . . 0.0 111.504 -169.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -135.79 165.28 25.97 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 -171.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -68.1 136.52 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 118.178 2.659 . . . . 0.0 118.178 -159.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.39 -46.37 0.51 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.321 1.449 . . . . 0.0 114.532 155.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -130.22 161.18 61.77 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.996 1.319 . . . . 0.0 112.914 -176.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.81 50.05 2.01 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 123.43 2.753 . . . . 0.0 113.865 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -152.82 -49.49 0.1 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.467 2.307 . . . . 0.0 110.437 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.35 100.86 9.39 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.387 2.275 . . . . 0.0 113.374 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.0 t -70.26 88.56 0.63 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 140.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -88.32 148.92 24.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.281 1.832 . . . . 0.0 114.093 -158.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 m -63.81 75.53 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.712 -1.243 . . . . 0.0 112.501 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.208 -1.377 . . . . 0.0 110.806 163.712 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.5 t -66.72 -111.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 157.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -62.99 110.88 1.94 Allowed 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.901 -1.124 . . . . 0.0 112.622 170.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.255 27.4 m-85 89.67 94.26 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 129.424 3.09 . . . . 0.0 115.835 177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.88 129.45 3.08 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 126.532 2.015 . . . . 0.0 113.533 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -71.39 133.97 46.32 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 125.126 1.37 . . . . 0.0 113.561 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 m -140.4 20.11 2.39 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.83 129.69 2.54 Favored Glycine 0 CA--C 1.544 1.854 0 O-C-N 120.406 -1.433 . . . . 0.0 115.178 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.36 -158.12 28.68 Favored Glycine 0 CA--C 1.545 1.965 0 C-N-CA 126.124 1.821 . . . . 0.0 112.437 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.1 mt -43.39 105.63 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-N 119.274 1.537 . . . . 0.0 112.352 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.45 -32.84 2.31 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -73.19 56.49 0.46 Allowed 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -167.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.9 m -73.52 60.78 0.67 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.95 1.3 . . . . 0.0 109.389 155.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.7 -173.45 13.31 Favored Glycine 0 CA--C 1.544 1.903 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 -150.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.35 89.63 1.31 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.955 3.103 . . . . 0.0 112.015 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.5 p -72.61 62.75 0.57 Allowed 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.354 -1.467 . . . . 0.0 113.714 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.69 56.37 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 125.332 1.453 . . . . 0.0 112.254 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.3 t -101.55 151.61 21.77 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.725 2.01 . . . . 0.0 113.933 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.5 90.06 6.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.636 1.574 . . . . 0.0 112.641 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -42.72 115.63 0.75 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.424 1.09 . . . . 0.0 112.946 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.74 -51.84 0.75 Allowed Glycine 0 CA--C 1.539 1.533 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -152.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.5 p -82.98 166.8 18.53 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.634 0.373 . . . . 0.0 111.854 140.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.5 p -99.64 -88.41 0.34 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -158.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.3 m 124.78 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 131.507 3.923 . . . . 0.0 111.508 -163.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -119.12 152.94 35.63 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 126.416 1.887 . . . . 0.0 114.067 -172.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.4 m -57.2 123.91 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -171.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.98 -38.71 3.19 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 156.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -160.86 167.81 12.88 Favored Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -165.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.97 -29.01 25.83 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 124.013 3.142 . . . . 0.0 117.347 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -81.54 -19.8 41.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.231 1.013 . . . . 0.0 113.729 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.28 113.48 3.45 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -165.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 t -67.44 140.86 57.14 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.441 118.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -160.39 135.44 7.83 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -145.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.4 m -67.17 76.64 0.14 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.0 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.463 -1.256 . . . . 0.0 111.264 141.657 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 . . . . . 0 CA--C 1.554 1.1 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.0 t -77.93 -102.21 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.257 -0.902 . . . . 0.0 113.034 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.44 127.91 34.69 Favored 'General case' 0 CA--C 1.553 1.091 0 O-C-N 121.034 -1.041 . . . . 0.0 113.459 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.261 37.2 m-85 77.7 47.7 0.05 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 126.931 2.092 . . . . 0.0 115.429 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.62 120.35 6.85 Favored Glycine 0 CA--C 1.545 1.917 0 C-N-CA 125.884 1.707 . . . . 0.0 115.832 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -68.21 103.46 1.58 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.844 1.322 . . . . 0.0 114.312 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -104.04 57.72 0.72 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.944 1.298 . . . . 0.0 110.826 167.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.14 162.81 36.6 Favored Glycine 0 CA--C 1.544 1.881 0 O-C-N 120.467 -1.396 . . . . 0.0 116.472 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.15 -76.21 0.19 Allowed Glycine 0 CA--C 1.544 1.906 0 N-CA-C 119.043 2.377 . . . . 0.0 119.043 -157.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.5 108.25 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 O-C-N 120.981 -1.305 . . . . 0.0 112.075 -164.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.08 -26.97 11.4 Favored Glycine 0 CA--C 1.546 2.025 0 C-N-CA 125.805 1.669 . . . . 0.0 116.446 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -109.73 65.19 0.61 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 -148.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.3 p -70.06 49.39 0.1 Allowed 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.369 -1.457 . . . . 0.0 112.339 162.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.01 156.42 22.15 Favored Glycine 0 CA--C 1.547 2.05 0 N-CA-C 116.33 1.292 . . . . 0.0 116.33 -158.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -82.52 116.93 2.66 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.361 2.708 . . . . 0.0 110.811 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.3 p -71.19 65.66 0.4 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 120.451 -1.406 . . . . 0.0 113.227 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -73.63 61.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 125.248 1.419 . . . . 0.0 112.015 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.2 t -95.06 153.76 17.49 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 127.012 2.125 . . . . 0.0 114.297 -173.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.03 100.37 13.2 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.305 1.042 . . . . 0.0 113.01 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.9 p -49.99 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.954 1.702 . . . . 0.0 114.112 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.83 -48.87 0.32 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.957 1.265 . . . . 0.0 110.235 -159.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.8 p -84.98 158.12 20.59 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 120.873 0.368 . . . . 0.0 111.349 138.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.2 p -101.4 -84.83 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -150.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.5 m 126.03 62.08 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 131.574 3.949 . . . . 0.0 111.049 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -126.91 137.59 53.17 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.3 t -50.52 115.59 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 127.076 2.151 . . . . 0.0 115.101 -170.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.0 mt -101.6 -42.16 6.33 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.907 0.883 . . . . 0.0 113.006 163.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -158.1 166.14 17.16 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 126.905 2.082 . . . . 0.0 110.315 -163.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.93 25.65 0.18 Allowed 'Trans proline' 0 CA--C 1.557 1.65 0 C-N-CA 122.768 2.312 . . . . 0.0 115.005 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -122.29 -66.87 1.0 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.795 2.038 . . . . 0.0 109.902 171.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.43 109.59 22.31 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.549 2.34 . . . . 0.0 113.42 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -76.56 102.35 6.05 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 136.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -97.85 137.91 36.0 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.969 1.708 . . . . 0.0 113.327 -156.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.7 m -64.95 75.84 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.742 -1.224 . . . . 0.0 112.842 166.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.246 0.897 0 C-N-CA 125.41 1.484 . . . . 0.0 111.304 157.878 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 . . . . . 0 CA--C 1.551 0.989 0 N-CA-C 110.819 -0.067 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 t -74.11 178.51 4.99 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -57.68 139.54 53.5 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.035 1.334 . . . . 0.0 114.219 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 73.64 26.65 1.88 Allowed 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 127.6 2.36 . . . . 0.0 115.451 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.43 136.03 12.59 Favored Glycine 0 CA--C 1.549 2.216 0 O-C-N 119.45 -2.031 . . . . 0.0 116.228 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -58.58 126.74 28.88 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 119.747 -2.031 . . . . 0.0 113.732 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.54 45.32 2.06 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 127.317 2.247 . . . . 0.0 110.991 165.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.99 164.32 27.91 Favored Glycine 0 CA--C 1.541 1.694 0 O-C-N 120.615 -1.303 . . . . 0.0 115.06 -169.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.37 -45.4 9.92 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 119.101 2.4 . . . . 0.0 119.101 -149.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.9 mt -53.36 118.48 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 O-C-N 120.693 -1.475 . . . . 0.0 112.919 -170.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.08 33.89 76.68 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 124.645 1.117 . . . . 0.0 115.509 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.1 -179.74 5.96 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -166.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -165.55 -57.21 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.192 2.197 . . . . 0.0 110.59 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 55.15 87.84 0.01 OUTLIER Glycine 0 CA--C 1.548 2.154 0 N-CA-C 118.701 2.241 . . . . 0.0 118.701 155.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -66.92 71.16 0.5 Allowed 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.449 2.766 . . . . 0.0 111.391 166.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -90.08 61.49 5.22 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.672 1.989 . . . . 0.0 113.771 -160.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.26 79.57 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 O-C-N 121.145 -0.972 . . . . 0.0 110.96 171.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.1 t -50.19 153.48 1.44 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.283 2.233 . . . . 0.0 113.907 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.13 74.21 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 O-C-N 120.709 -1.244 . . . . 0.0 113.275 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.9 t -33.45 98.79 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 127.721 2.408 . . . . 0.0 114.804 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.27 -53.97 0.58 Allowed Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.555 1.55 . . . . 0.0 109.396 -156.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.5 p -82.93 166.93 18.47 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.246 0.618 . . . . 0.0 110.78 143.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -117.95 -92.21 0.53 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.161 2.652 . . . . 0.0 118.161 -152.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.3 m 131.14 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 1 C-N-CA 131.797 4.039 . . . . 0.0 113.429 -166.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -134.22 157.72 45.54 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.7 t -54.45 112.52 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -164.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.6 mt -85.85 -55.68 3.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.456 1.102 . . . . 0.0 112.629 153.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -167.55 176.49 1.64 Allowed Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 125.588 1.555 . . . . 0.0 112.185 -159.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.9 -41.81 38.75 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.202 3.268 . . . . 0.0 115.983 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -67.21 -45.06 77.98 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.319 -0.863 . . . . 0.0 113.07 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.58 95.73 4.2 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -151.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -77.28 102.06 6.54 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 144.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -105.21 142.06 35.64 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.114 1.765 . . . . 0.0 113.949 -159.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.4 t -56.31 71.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 127.926 2.49 . . . . 0.0 112.321 167.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 mt . . . . . 0 C--O 1.248 1.0 0 C-N-CA 129.789 3.236 . . . . 0.0 112.838 174.644 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? . . . . . 0 CA--C 1.554 1.121 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.7 t -112.27 -102.42 0.41 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.546 1.138 . . . . 0.0 112.823 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -68.63 122.17 17.96 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.937 1.295 . . . . 0.0 112.874 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 86.4 61.82 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 128.021 2.529 . . . . 0.0 115.588 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.14 139.49 13.83 Favored Glycine 0 CA--C 1.549 2.184 0 C-N-CA 125.863 1.697 . . . . 0.0 114.48 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -82.39 116.29 21.8 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 118.998 1.399 . . . . 0.0 114.081 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.66 55.59 0.91 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.054 1.742 . . . . 0.0 111.001 171.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.21 163.74 35.1 Favored Glycine 0 CA--C 1.54 1.652 0 O-C-N 120.671 -1.268 . . . . 0.0 114.435 -173.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.99 -64.15 4.31 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 118.697 2.239 . . . . 0.0 118.697 -160.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.3 mt -60.07 116.1 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 O-C-N 120.738 -1.448 . . . . 0.0 112.775 -164.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.01 -12.43 69.54 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 126.153 1.835 . . . . 0.0 116.557 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -111.91 75.21 0.91 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -153.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.2 p -74.42 26.62 0.08 Allowed 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.427 -1.421 . . . . 0.0 113.605 154.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.93 160.35 17.87 Favored Glycine 0 CA--C 1.545 1.939 0 C-N-CA 124.89 1.233 . . . . 0.0 116.008 -165.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.63 124.55 4.08 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 123.292 2.662 . . . . 0.0 111.472 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.7 p -73.84 62.99 0.87 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.964 1.306 . . . . 0.0 113.717 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 t -74.42 53.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 O-C-N 120.184 -1.573 . . . . 0.0 113.477 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.9 t -100.26 159.52 15.05 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 128.161 2.585 . . . . 0.0 114.455 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.35 104.65 16.56 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.616 1.966 . . . . 0.0 113.655 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.0 t -47.15 117.34 1.69 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.181 1.393 . . . . 0.0 112.728 169.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.83 -52.17 0.72 Allowed Glycine 0 CA--C 1.538 1.497 0 C-N-CA 126.144 1.83 . . . . 0.0 109.211 -160.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.9 p -74.42 162.03 29.24 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.198 -0.501 . . . . 0.0 111.11 140.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.0 p -98.57 -90.17 0.29 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -166.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.1 m 125.84 57.26 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 131.628 3.971 . . . . 0.0 110.805 -162.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -118.93 142.23 47.95 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.701 1.601 . . . . 0.0 115.013 -164.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.1 t -51.16 102.04 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 126.449 1.9 . . . . 0.0 114.319 -170.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.3 mt -107.41 -50.12 3.13 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.759 1.224 . . . . 0.0 114.04 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -153.37 166.84 14.71 Favored Pre-proline 0 CA--C 1.557 1.225 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -163.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.51 -35.27 65.84 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.285 2.657 . . . . 0.0 114.982 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -72.17 -54.32 10.04 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.093 1.357 . . . . 0.0 112.513 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.19 120.13 34.32 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.557 1.543 . . . . 0.0 114.354 -166.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -71.97 119.53 16.28 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 126.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -126.43 143.41 51.19 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.115 -0.99 . . . . 0.0 113.393 -151.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.8 m -67.68 81.56 0.18 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.266 -0.896 . . . . 0.0 112.523 171.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 C--O 1.255 1.364 0 CA-C-O 117.286 -1.34 . . . . 0.0 109.645 146.489 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.9 t -64.37 168.44 5.7 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -48.52 131.4 17.31 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.904 0.882 . . . . 0.0 112.165 167.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 69.72 74.07 0.23 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.405 1.482 . . . . 0.0 113.338 -173.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.89 145.02 12.7 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 125.128 1.347 . . . . 0.0 114.187 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -70.83 131.63 44.08 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.708 -1.466 . . . . 0.0 114.891 -173.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.17 57.32 1.79 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.263 1.825 . . . . 0.0 110.687 170.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.24 168.59 41.16 Favored Glycine 0 CA--C 1.545 1.963 0 O-C-N 120.47 -1.394 . . . . 0.0 115.502 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.62 -76.1 0.14 Allowed Glycine 0 CA--C 1.545 1.934 0 C-N-CA 127.468 2.461 . . . . 0.0 119.201 -162.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.5 mt -61.24 96.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.055 -1.262 . . . . 0.0 112.564 -164.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.6 13.93 31.2 Favored Glycine 0 CA--C 1.544 1.895 0 C-N-CA 126.279 1.895 . . . . 0.0 116.409 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.05 164.87 28.87 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 120.022 1.911 . . . . 0.0 116.147 -173.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 t -127.08 -65.13 0.96 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.084 2.154 . . . . 0.0 110.406 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.92 75.9 0.07 OUTLIER Glycine 0 CA--C 1.545 1.968 0 N-CA-C 119.407 2.523 . . . . 0.0 119.407 151.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.81 52.55 0.54 Allowed 'Trans proline' 0 CA--C 1.554 1.481 0 C-N-CA 123.514 2.809 . . . . 0.0 112.114 157.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.4 p -73.24 29.75 0.07 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 -162.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.5 t -75.5 66.78 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 O-C-N 119.967 -1.708 . . . . 0.0 111.72 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 52.5 t -59.57 158.88 9.16 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.844 2.057 . . . . 0.0 113.95 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.74 61.77 0.17 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.521 1.529 . . . . 0.0 114.596 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -6.06 75.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 130.12 3.368 . . . . 0.0 116.52 176.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.46 -51.71 0.48 Allowed Glycine 0 CA--C 1.535 1.327 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -158.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.6 p -80.5 160.09 25.34 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.473 0.309 . . . . 0.0 110.393 140.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.1 p -116.21 -84.83 0.63 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -156.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.8 m 127.33 61.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 131.571 3.948 . . . . 0.0 112.102 -167.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -123.54 146.52 48.05 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 125.848 1.659 . . . . 0.0 115.253 -166.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.93 113.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.546 1.939 . . . . 0.0 114.932 -169.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.7 mt -116.45 -46.59 2.77 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -152.63 165.02 18.46 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 120.856 -1.153 . . . . 0.0 113.28 -161.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.79 43.02 0.75 Allowed 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 123.251 2.634 . . . . 0.0 114.204 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -143.41 -54.66 0.38 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.773 2.429 . . . . 0.0 108.552 172.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.26 124.05 48.1 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 128.02 2.528 . . . . 0.0 113.838 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -68.09 134.79 51.18 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.69 120.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -136.82 132.55 34.8 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.977 -1.077 . . . . 0.0 111.618 -144.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.3 t -66.6 67.17 0.06 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.055 1.742 . . . . 0.0 112.293 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--O 1.247 0.974 0 C-N-CA 126.733 2.013 . . . . 0.0 112.242 167.441 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.5 t -106.31 -162.71 0.87 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.211 1.804 . . . . 0.0 112.037 166.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -52.05 143.49 13.86 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -174.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 57.68 8.87 0.73 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 126.712 2.005 . . . . 0.0 116.051 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.8 150.35 35.65 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.248 -1.533 . . . . 0.0 115.933 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -89.28 114.07 25.4 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.273 1.429 . . . . 0.0 113.285 -171.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.35 62.61 0.77 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.965 1.306 . . . . 0.0 112.927 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.88 -128.69 5.93 Favored Glycine 0 CA--C 1.547 2.048 0 N-CA-C 116.444 1.338 . . . . 0.0 116.444 168.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.5 -150.37 26.27 Favored Glycine 0 CA--C 1.549 2.17 0 O-C-N 120.926 -1.338 . . . . 0.0 115.654 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.0 mt -53.79 110.77 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 O-C-N 120.756 -1.438 . . . . 0.0 113.115 175.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.74 -37.54 3.17 Favored Glycine 0 CA--C 1.546 2.018 0 N-CA-C 117.005 1.562 . . . . 0.0 117.005 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.68 81.83 1.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -158.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.7 p -72.75 5.22 3.31 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 166.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 142.85 35.25 Favored Glycine 0 CA--C 1.552 2.356 0 O-C-N 120.375 -1.453 . . . . 0.0 115.286 -173.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -80.31 66.22 8.83 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.664 2.91 . . . . 0.0 112.574 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.9 p -84.36 48.12 1.45 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 119.797 -1.814 . . . . 0.0 115.311 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -51.94 108.45 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 O-C-N 121.063 -1.023 . . . . 0.0 110.515 162.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.72 -178.69 4.77 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -160.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.69 71.27 0.08 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.68 1.592 . . . . 0.0 112.846 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -37.39 107.21 0.06 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.62 1.968 . . . . 0.0 114.483 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.31 -54.94 0.74 Allowed Glycine 0 CA--C 1.536 1.347 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -158.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.6 p -72.37 170.24 14.62 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.485 0.314 . . . . 0.0 111.484 142.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.3 p -119.74 -113.34 0.33 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -168.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 m 154.13 60.4 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 129.887 3.275 . . . . 0.0 110.474 -166.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -129.69 147.01 51.43 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 126.756 2.023 . . . . 0.0 115.742 -166.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.7 m -51.48 131.8 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -168.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.22 -76.1 0.17 Allowed 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 155.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -81.48 153.24 70.96 Favored Pre-proline 0 CA--C 1.561 1.396 0 O-C-N 120.191 -1.568 . . . . 0.0 112.886 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -58.81 -11.59 12.41 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.458 2.772 . . . . 0.0 116.033 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -91.55 -10.86 39.08 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.993 1.317 . . . . 0.0 113.881 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.96 113.62 5.02 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -166.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -74.21 95.75 2.66 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 137.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -101.21 145.95 28.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.774 1.63 . . . . 0.0 113.816 -154.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.7 m -65.57 75.25 0.07 Allowed 'General case' 0 CA--C 1.551 0.992 0 O-C-N 120.767 -1.208 . . . . 0.0 114.084 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.571 -1.204 . . . . 0.0 112.464 165.45 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 . . . . . 0 CA--C 1.556 1.182 0 CA-C-O 121.519 0.676 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -79.71 -117.1 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.337 1.455 . . . . 0.0 113.009 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -63.66 123.18 18.18 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 121.175 -0.953 . . . . 0.0 112.463 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 79.19 39.75 0.11 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 127.806 2.443 . . . . 0.0 115.11 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.28 122.41 7.56 Favored Glycine 0 CA--C 1.551 2.341 0 N-CA-C 116.607 1.403 . . . . 0.0 116.607 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -66.98 112.12 4.17 Favored 'General case' 0 CA--C 1.556 1.21 0 O-C-N 119.872 -1.957 . . . . 0.0 115.773 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -109.77 50.16 0.81 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.849 1.66 . . . . 0.0 111.588 164.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.37 158.55 29.04 Favored Glycine 0 CA--C 1.54 1.617 0 O-C-N 120.202 -1.561 . . . . 0.0 116.353 -171.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.88 -68.14 1.52 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 119.024 2.369 . . . . 0.0 119.024 -161.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.8 mt -60.68 101.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 120.988 -1.301 . . . . 0.0 112.401 -165.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.19 -28.28 10.58 Favored Glycine 0 CA--C 1.546 1.992 0 C-N-CA 126.242 1.877 . . . . 0.0 115.7 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -106.07 62.27 0.66 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -150.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.2 p -68.69 58.77 0.09 Allowed 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.235 -1.541 . . . . 0.0 111.64 159.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.52 161.56 27.98 Favored Glycine 0 CA--C 1.547 2.042 0 N-CA-C 116.214 1.245 . . . . 0.0 116.214 -158.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -83.88 130.15 4.91 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.092 3.195 . . . . 0.0 112.225 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.5 p -79.56 69.34 5.83 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.302 -1.499 . . . . 0.0 112.31 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.3 t -77.19 57.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.983 1.313 . . . . 0.0 112.525 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.1 t -105.53 149.5 26.18 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.829 2.052 . . . . 0.0 115.121 -158.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.07 62.87 6.82 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -171.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -19.76 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.567 2.347 . . . . 0.0 115.397 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.88 -54.38 0.55 Allowed Glycine 0 CA--C 1.54 1.637 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -151.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.7 p -70.79 154.3 41.97 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 122.807 -0.231 . . . . 0.0 111.319 137.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.7 p -101.08 -117.75 0.17 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -162.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.3 m 162.51 51.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 131.058 3.743 . . . . 0.0 111.102 -172.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -121.47 149.88 42.4 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 119.99 -1.694 . . . . 0.0 115.314 -167.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 m -57.4 137.62 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -171.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -152.73 -59.84 0.15 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.859 1.264 . . . . 0.0 113.675 161.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -92.3 150.66 40.53 Favored Pre-proline 0 CA--C 1.561 1.371 0 O-C-N 120.554 -1.341 . . . . 0.0 112.777 168.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.88 -26.32 57.26 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.702 2.935 . . . . 0.0 115.101 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -45.04 70.53 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.217 -0.927 . . . . 0.0 112.989 175.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.21 113.47 19.51 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.413 1.885 . . . . 0.0 114.106 -167.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.7 t -70.36 113.85 7.92 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 136.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -127.2 137.03 52.83 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -147.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -59.82 79.9 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.415 1.086 . . . . 0.0 112.749 167.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.105 146.903 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -85.74 175.68 8.57 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -49.85 135.76 19.12 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.681 1.193 . . . . 0.0 112.658 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 69.15 -2.28 1.86 Allowed 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -169.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.73 144.88 49.7 Favored Glycine 0 CA--C 1.549 2.178 0 O-C-N 119.906 -1.746 . . . . 0.0 115.185 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.77 136.51 36.76 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -167.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.67 35.54 4.82 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 126.316 1.846 . . . . 0.0 113.241 161.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.26 168.96 21.32 Favored Glycine 0 CA--C 1.54 1.632 0 O-C-N 120.472 -1.392 . . . . 0.0 114.712 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.97 -45.41 83.39 Favored Glycine 0 CA--C 1.544 1.896 0 N-CA-C 117.855 1.902 . . . . 0.0 117.855 -158.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.7 mm -56.92 109.22 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 O-C-N 121.175 -1.191 . . . . 0.0 113.113 -170.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.46 39.11 96.61 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 125.758 1.647 . . . . 0.0 115.418 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.1 178.98 6.78 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 -168.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 91.3 p -136.73 -84.92 0.34 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.805 1.642 . . . . 0.0 111.046 172.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.5 53.04 0.05 OUTLIER Glycine 0 CA--C 1.545 1.95 0 N-CA-C 117.979 1.952 . . . . 0.0 117.979 169.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.1 46.57 1.14 Allowed 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 123.39 2.727 . . . . 0.0 112.674 169.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.3 p -70.94 23.38 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -164.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 t -77.34 63.28 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 O-C-N 119.798 -1.814 . . . . 0.0 112.181 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.1 t -55.43 154.93 5.73 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.564 1.545 . . . . 0.0 114.682 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.17 73.35 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 O-C-N 120.608 -1.308 . . . . 0.0 112.621 165.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.1 t -38.3 109.16 0.09 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.344 1.858 . . . . 0.0 114.687 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.82 -53.24 0.71 Allowed Glycine 0 CA--C 1.537 1.469 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -156.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.3 p -82.05 163.4 22.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.299 0.64 . . . . 0.0 110.736 146.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 33.8 p -113.44 -120.17 0.3 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -161.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' THR . 47.4 t 171.42 51.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 127.79 2.436 . . . . 0.0 111.315 -169.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -129.54 146.67 51.33 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.676 1.59 . . . . 0.0 115.197 -154.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 m -51.12 127.84 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.3 0.0 OUTLIER -148.76 -99.56 0.08 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 125.112 1.365 . . . . 0.0 113.64 158.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -53.64 146.38 25.85 Favored Pre-proline 0 CA--C 1.565 1.535 0 O-C-N 119.553 -1.967 . . . . 0.0 113.994 169.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -58.23 -28.68 85.14 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.808 3.005 . . . . 0.0 115.045 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -66.22 -33.26 75.34 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 121.035 -1.04 . . . . 0.0 113.77 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.58 115.9 9.97 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.621 1.568 . . . . 0.0 114.917 -166.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -66.43 121.24 14.86 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.842 -1.161 . . . . 0.0 108.525 136.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -129.97 142.8 50.59 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -149.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.7 t -69.19 66.51 0.16 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.832 2.053 . . . . 0.0 112.744 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.9 2.08 . . . . 0.0 112.846 170.872 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -89.53 -166.86 1.7 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 125.072 1.349 . . . . 0.0 114.504 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -59.44 149.96 27.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.282 1.433 . . . . 0.0 114.829 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 61.36 5.12 1.07 Allowed 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.17 130.97 51.79 Favored Glycine 0 CA--C 1.546 1.987 0 O-C-N 119.494 -2.004 . . . . 0.0 115.019 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -66.63 125.7 26.62 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 120.693 -1.475 . . . . 0.0 111.965 175.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -119.32 40.58 3.31 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 125.424 1.489 . . . . 0.0 110.971 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.03 158.77 27.84 Favored Glycine 0 CA--C 1.544 1.904 0 C-N-CA 125.181 1.372 . . . . 0.0 115.195 -170.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.67 -58.77 11.92 Favored Glycine 0 CA--C 1.549 2.187 0 N-CA-C 120.324 2.89 . . . . 0.0 120.324 -158.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.9 mt -57.08 107.34 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 O-C-N 120.643 -1.504 . . . . 0.0 113.22 -165.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.04 19.47 62.87 Favored Glycine 0 CA--C 1.544 1.866 0 C-N-CA 126.254 1.883 . . . . 0.0 115.786 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -140.92 117.02 10.55 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.6 p -120.26 42.85 2.86 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.165 1.386 . . . . 0.0 112.466 163.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.52 122.84 7.17 Favored Glycine 0 CA--C 1.547 2.084 0 C-N-CA 125.083 1.325 . . . . 0.0 114.745 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.46 63.11 7.16 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.588 2.859 . . . . 0.0 111.823 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.8 p -77.56 66.3 3.25 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.273 -1.517 . . . . 0.0 114.28 -176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.26 89.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.905 0.882 . . . . 0.0 109.365 155.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.28 177.44 7.26 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -166.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.43 68.92 0.14 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.878 1.271 . . . . 0.0 113.782 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.2 t -28.75 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 127.156 2.182 . . . . 0.0 114.535 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.63 -54.45 0.62 Allowed Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.283 1.42 . . . . 0.0 109.638 -155.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -77.24 176.3 8.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.287 0.635 . . . . 0.0 111.16 142.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 p -127.92 -124.06 0.23 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.367 1.467 . . . . 0.0 114.582 -167.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 m 167.85 55.08 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 128.867 2.867 . . . . 0.0 111.383 -168.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . 0.266 2.8 pp0? -139.25 169.2 18.2 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -168.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.79 139.88 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -148.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.32 -67.97 0.12 Allowed 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 160.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -88.98 147.64 39.24 Favored Pre-proline 0 CA--C 1.555 1.139 0 O-C-N 120.395 -1.44 . . . . 0.0 112.705 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -54.82 -28.63 58.96 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.531 2.821 . . . . 0.0 115.026 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.85 -44.7 72.85 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 121.077 -1.015 . . . . 0.0 112.698 174.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.21 109.7 15.28 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.042 1.737 . . . . 0.0 115.27 -167.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -64.37 103.59 0.66 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 134.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -111.05 148.8 31.81 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.672 1.589 . . . . 0.0 114.192 -155.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.0 m -68.21 70.58 0.16 Allowed 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.254 1.294 0 CA-C-O 117.65 -1.167 . . . . 0.0 111.304 157.875 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.4 t -86.85 -117.47 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.875 0.87 . . . . 0.0 111.347 167.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -47.83 159.99 0.15 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 172.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 73.38 58.43 0.1 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.303 1.841 . . . . 0.0 115.392 162.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.24 135.86 7.74 Favored Glycine 0 CA--C 1.545 1.958 0 C-N-CA 126.168 1.842 . . . . 0.0 112.653 171.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -76.21 128.85 35.75 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.009 -1.289 . . . . 0.0 113.933 -173.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -111.78 57.66 0.64 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 126.59 1.956 . . . . 0.0 110.892 170.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.12 156.39 27.47 Favored Glycine 0 CA--C 1.544 1.85 0 O-C-N 120.889 -1.132 . . . . 0.0 115.333 -169.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.96 -48.75 5.94 Favored Glycine 0 CA--C 1.546 2.024 0 N-CA-C 118.147 2.019 . . . . 0.0 118.147 -159.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.66 122.97 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.595 -1.533 . . . . 0.0 112.828 -171.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.41 34.96 91.32 Favored Glycine 0 CA--C 1.544 1.855 0 C-N-CA 124.85 1.214 . . . . 0.0 115.089 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.38 -172.6 3.99 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -166.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.1 p -160.52 -87.75 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.659 1.984 . . . . 0.0 110.416 168.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.76 36.66 1.6 Allowed Glycine 0 CA--C 1.552 2.386 0 N-CA-C 119.773 2.669 . . . . 0.0 119.773 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -62.9 37.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.637 0 CA-C-N 122.145 2.972 . . . . 0.0 116.809 165.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.5 p -75.43 57.93 0.96 Allowed 'General case' 0 N--CA 1.481 1.083 0 O-C-N 119.432 -2.043 . . . . 0.0 113.575 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 18' ' ' VAL . 39.0 t -73.51 28.8 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.44 0 O-C-N 119.922 -1.736 . . . . 0.0 114.347 -176.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.2 t -95.75 157.68 15.79 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 129.303 3.041 . . . . 0.0 113.549 -173.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.43 108.06 19.38 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.254 1.422 . . . . 0.0 112.766 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -56.11 150.67 13.53 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.31 -47.69 1.02 Allowed Glycine 0 CA--C 1.541 1.703 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -145.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.1 p -77.16 171.21 15.19 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.945 0.898 . . . . 0.0 111.991 147.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 p -107.99 -146.32 0.4 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.886 1.674 . . . . 0.0 114.08 -168.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 m -162.24 68.61 0.26 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 127.459 2.304 . . . . 0.0 109.787 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -124.29 148.58 47.31 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 126.138 1.775 . . . . 0.0 115.668 -158.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.1 m -57.83 118.98 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -168.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.38 -48.88 3.71 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.109 1.363 . . . . 0.0 113.091 162.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -150.82 168.65 10.6 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 127.831 2.452 . . . . 0.0 110.748 -170.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -55.5 -15.77 12.71 Favored 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.095 2.53 . . . . 0.0 117.741 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.76 -45.36 9.35 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.934 1.243 . . . . 0.0 111.942 173.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.77 94.32 5.01 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.474 1.91 . . . . 0.0 112.84 -157.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 t -89.31 99.28 12.31 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 151.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.87 156.36 38.01 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.875 2.07 . . . . 0.0 113.872 -154.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.5 m -64.91 82.66 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 127.192 2.197 . . . . 0.0 112.967 157.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 . . . . . 0 CA--C 1.554 1.1 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 m -85.18 -89.28 0.11 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.255 1.022 . . . . 0.0 112.241 -161.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -73.57 92.24 1.9 Allowed 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.456 -0.778 . . . . 0.0 109.623 168.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.254 13.6 m-85 98.93 106.46 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 130.22 3.408 . . . . 0.0 112.442 -174.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.83 109.32 0.39 Allowed Glycine 0 CA--C 1.541 1.671 0 C-N-CA 127.184 2.326 . . . . 0.0 111.625 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -72.62 119.39 16.78 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.748 1.219 . . . . 0.0 112.895 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 p -137.29 56.93 1.76 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.948 1.699 . . . . 0.0 111.189 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.5 34.81 1.47 Allowed Glycine 0 CA--C 1.545 1.915 0 N-CA-C 117.607 1.803 . . . . 0.0 117.607 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.23 -70.66 1.55 Allowed Glycine 0 CA--C 1.545 1.911 0 N-CA-C 117.046 1.578 . . . . 0.0 117.046 165.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.9 mt -54.4 112.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 119.015 1.408 . . . . 0.0 113.841 -168.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.18 -11.55 48.86 Favored Glycine 0 CA--C 1.548 2.145 0 C-N-CA 125.651 1.596 . . . . 0.0 115.332 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -110.85 62.62 0.61 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -155.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 t -70.11 64.09 0.23 Allowed 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.701 -1.25 . . . . 0.0 111.039 156.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.74 176.14 20.12 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 -164.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.16 143.48 25.58 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.615 3.543 . . . . 0.0 112.45 -174.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.8 p -123.94 41.33 3.51 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.992 1.317 . . . . 0.0 113.265 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 t -79.35 51.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 O-C-N 120.323 -1.485 . . . . 0.0 112.335 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.6 t -82.4 164.02 21.29 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 128.73 2.812 . . . . 0.0 113.122 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.58 93.71 4.09 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 t -36.84 111.04 0.13 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.838 1.655 . . . . 0.0 114.218 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.74 -50.3 0.89 Allowed Glycine 0 CA--C 1.541 1.704 0 C-N-CA 125.844 1.688 . . . . 0.0 109.536 -158.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.6 p -82.62 152.87 25.72 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.661 1.185 . . . . 0.0 110.695 143.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.1 p -101.44 -107.25 0.24 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -159.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t 146.09 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 131.547 3.939 . . . . 0.0 110.206 -170.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -118.31 127.12 53.4 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 127.536 2.334 . . . . 0.0 114.214 -157.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.9 t -65.17 86.86 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 C-N-CA 125.431 1.492 . . . . 0.0 114.586 -170.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.69 -44.73 8.4 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -152.91 160.21 31.3 Favored Pre-proline 0 CA--C 1.557 1.246 0 O-C-N 121.029 -1.044 . . . . 0.0 113.497 -164.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.67 53.64 3.25 Favored 'Trans proline' 0 CA--C 1.554 1.48 0 C-N-CA 124.268 3.312 . . . . 0.0 113.58 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -159.75 -53.76 0.06 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 129.534 3.133 . . . . 0.0 109.084 176.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.91 119.16 36.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.028 2.131 . . . . 0.0 113.175 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 t -66.55 123.41 19.98 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 120.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -113.67 129.22 56.6 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.94 1.696 . . . . 0.0 111.38 -160.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.0 m -64.43 83.88 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.357 -0.84 . . . . 0.0 111.909 165.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 C--O 1.256 1.432 0 CA-C-O 116.694 -1.622 . . . . 0.0 109.678 153.385 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 . . . . . 0 CA--C 1.553 1.075 0 CA-C-O 120.944 0.402 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 m -82.79 -131.65 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.499 1.52 . . . . 0.0 113.243 -166.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -47.7 121.32 3.96 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.998 1.319 . . . . 0.0 113.682 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 72.48 50.02 0.19 Allowed 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 127.377 2.271 . . . . 0.0 114.336 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.01 133.76 10.11 Favored Glycine 0 CA--C 1.547 2.038 0 C-N-CA 126.111 1.815 . . . . 0.0 115.317 -174.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -73.66 130.39 39.91 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 120.221 2.011 . . . . 0.0 115.023 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.3 m -112.01 -47.28 3.14 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.588 1.555 . . . . 0.0 111.88 166.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 165.49 10.08 Favored Glycine 0 CA--C 1.548 2.107 0 N-CA-C 117.239 1.656 . . . . 0.0 117.239 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.57 -52.64 24.64 Favored Glycine 0 CA--C 1.548 2.113 0 N-CA-C 119.471 2.549 . . . . 0.0 119.471 -157.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.6 114.35 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 120.094 -1.827 . . . . 0.0 112.033 -166.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.67 -16.83 60.44 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 126.031 1.777 . . . . 0.0 116.391 -172.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -111.37 76.22 0.96 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -153.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 p -72.28 24.27 0.05 Allowed 'General case' 0 CA--C 1.554 1.123 0 O-C-N 120.138 -1.601 . . . . 0.0 114.297 158.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.76 157.73 22.38 Favored Glycine 0 CA--C 1.546 1.984 0 O-C-N 120.735 -1.228 . . . . 0.0 116.036 -168.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -83.68 122.47 3.1 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.336 2.69 . . . . 0.0 110.614 172.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -73.76 60.55 0.71 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.638 -1.288 . . . . 0.0 113.853 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 t -72.39 57.21 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 O-C-N 120.168 -1.583 . . . . 0.0 112.045 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.9 t -93.04 154.59 18.03 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.94 2.096 . . . . 0.0 113.726 -171.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.39 83.78 7.38 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.765 -1.209 . . . . 0.0 112.339 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.3 t -44.24 109.71 0.17 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.785 1.234 . . . . 0.0 113.213 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.26 -50.79 0.81 Allowed Glycine 0 CA--C 1.537 1.455 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -156.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.1 p -74.45 155.09 38.4 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.6 0.36 . . . . 0.0 110.892 139.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.3 p -98.59 -106.46 0.2 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -163.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 m 158.42 30.76 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 130.994 3.718 . . . . 0.0 112.584 -172.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -95.02 151.32 19.28 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.361 -2.087 . . . . 0.0 116.369 -164.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.4 t -55.89 115.2 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 126.481 1.912 . . . . 0.0 114.427 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -122.58 -49.51 2.01 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -139.65 162.1 52.93 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.856 1.263 . . . . 0.0 112.558 -167.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.97 49.99 1.7 Allowed 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 123.833 3.022 . . . . 0.0 113.471 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -154.17 -67.75 0.14 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 129.626 3.17 . . . . 0.0 107.746 172.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.87 111.24 23.69 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 127.046 2.138 . . . . 0.0 113.049 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.1 p -58.79 124.14 18.78 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.573 115.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -138.65 140.56 38.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.085 1.354 . . . . 0.0 114.444 -147.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.1 m -67.75 83.07 0.19 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.794 1.238 . . . . 0.0 112.7 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt . . . . . 0 C--O 1.254 1.312 0 CA-C-O 117.405 -1.283 . . . . 0.0 110.467 152.359 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 . . . . . 0 CA--C 1.546 0.802 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.0 t -98.38 -145.46 0.32 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.83 1.252 . . . . 0.0 110.46 164.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -47.84 144.7 3.28 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 169.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 81.34 4.19 1.45 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.146 2.178 . . . . 0.0 116.391 172.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.07 153.78 41.49 Favored Glycine 0 CA--C 1.55 2.268 0 O-C-N 120.426 -1.421 . . . . 0.0 115.285 173.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -84.2 135.78 34.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.605 1.562 . . . . 0.0 113.563 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.5 m -131.54 -6.91 3.7 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.24 111.44 0.3 Allowed Glycine 0 CA--C 1.546 1.975 0 CA-C-N 119.975 1.261 . . . . 0.0 115.237 -177.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.55 24.23 0.06 OUTLIER Glycine 0 CA--C 1.541 1.718 0 O-C-N 118.952 -2.499 . . . . 0.0 117.477 -6.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.9 mt -64.12 129.44 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 120.345 2.073 . . . . 0.0 110.683 169.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.5 -39.43 0.74 Allowed Glycine 0 CA--C 1.547 2.084 0 C-N-CA 124.589 1.09 . . . . 0.0 115.648 -174.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -64.93 178.43 0.82 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 126.858 2.063 . . . . 0.0 115.217 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.6 p -134.39 -86.0 0.41 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.916 1.287 . . . . 0.0 110.953 165.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.95 38.56 0.5 Allowed Glycine 0 CA--C 1.546 2.005 0 N-CA-C 118.103 2.001 . . . . 0.0 118.103 169.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -77.82 58.55 6.51 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 CA-C-N 121.086 2.443 . . . . 0.0 111.181 172.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -74.61 57.59 0.74 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.756 1.222 . . . . 0.0 113.923 -171.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 t -78.78 62.52 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 O-C-N 120.429 -1.419 . . . . 0.0 111.28 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.07 -177.96 4.32 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.138 2.175 . . . . 0.0 112.603 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.33 165.88 24.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.749 0.82 . . . . 0.0 112.801 166.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.4 t -106.4 171.93 7.09 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.567 1.147 . . . . 0.0 112.172 171.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.06 -53.68 1.4 Allowed Glycine 0 CA--C 1.546 1.975 0 O-C-N 120.928 -1.108 . . . . 0.0 111.821 -159.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -58.89 147.44 33.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.809 1.243 . . . . 0.0 113.502 157.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.6 p -108.44 -128.4 0.27 Allowed 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -173.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m 179.86 55.88 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 128.2 2.6 . . . . 0.0 111.73 -162.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -124.03 147.47 47.8 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 126.345 1.858 . . . . 0.0 115.215 -159.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.3 m -44.68 110.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 127.459 2.304 . . . . 0.0 116.439 -170.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.83 -49.67 2.21 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.15 1.38 . . . . 0.0 114.378 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -153.45 163.51 23.47 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 125.626 1.57 . . . . 0.0 112.325 -169.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.96 48.77 2.07 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.74 2.96 . . . . 0.0 113.94 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -155.51 -46.16 0.08 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.511 2.724 . . . . 0.0 108.826 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.43 113.46 17.54 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 127.669 2.387 . . . . 0.0 114.015 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -59.08 122.78 14.6 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.36 117.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -139.58 148.3 42.34 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.14 1.376 . . . . 0.0 113.276 -145.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 m -65.35 91.09 0.11 Allowed 'General case' 0 CA--C 1.555 1.168 0 O-C-N 120.687 -1.258 . . . . 0.0 113.574 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.129 1.372 . . . . 0.0 110.208 154.999 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 CA--C 1.55 0.952 0 N-CA-C 110.86 -0.052 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -90.59 176.79 6.55 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -173.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -49.45 140.71 10.1 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.652 1.581 . . . . 0.0 112.932 -174.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 69.48 -20.34 0.17 Allowed 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -44.94 141.31 3.97 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 116.722 1.449 . . . . 0.0 116.722 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -70.22 138.41 51.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.911 2.084 . . . . 0.0 115.182 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 p -150.26 63.71 0.96 Allowed 'General case' 0 CA--C 1.553 1.075 0 O-C-N 121.078 -1.014 . . . . 0.0 111.851 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.2 -155.23 26.26 Favored Glycine 0 CA--C 1.55 2.278 0 C-N-CA 126.163 1.839 . . . . 0.0 115.071 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.95 -144.94 5.82 Favored Glycine 0 CA--C 1.547 2.063 0 C-N-CA 126.368 1.937 . . . . 0.0 117.446 172.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -55.28 107.01 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 O-C-N 120.887 -1.36 . . . . 0.0 112.424 174.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.74 -44.16 2.57 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 116.93 1.532 . . . . 0.0 116.93 159.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -73.93 69.21 1.4 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 119.407 1.603 . . . . 0.0 114.906 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.5 m -80.06 73.89 6.85 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.017 -1.052 . . . . 0.0 109.102 151.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.78 -170.03 12.62 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 -162.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.13 83.56 0.15 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.618 2.879 . . . . 0.0 114.332 -174.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 p -62.45 15.24 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.05 62.46 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 O-C-N 120.088 -1.632 . . . . 0.0 112.385 -162.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.6 t -57.83 162.6 3.1 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 127.282 2.233 . . . . 0.0 113.968 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.22 69.86 0.09 Allowed 'General case' 0 CA--C 1.555 1.158 0 O-C-N 120.155 -1.591 . . . . 0.0 113.781 172.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.4 t -14.28 80.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 129.06 2.944 . . . . 0.0 116.29 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.16 -55.08 0.47 Allowed Glycine 0 CA--C 1.537 1.432 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -158.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.4 p -81.59 158.18 24.47 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 120.704 0.288 . . . . 0.0 110.481 145.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.4 p -122.94 -115.58 0.3 Allowed 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -154.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.9 t 179.9 74.67 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 128.904 2.881 . . . . 0.0 110.631 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.95 131.06 55.4 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 128.233 2.613 . . . . 0.0 113.797 -162.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.6 t -63.85 103.79 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 125.405 1.482 . . . . 0.0 113.836 -173.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 mt -111.77 -51.77 2.83 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -148.05 158.38 41.89 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -161.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -51.57 -18.26 5.68 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 124.009 3.139 . . . . 0.0 117.106 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -90.0 -45.49 9.15 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.916 -1.115 . . . . 0.0 113.209 168.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.3 119.64 34.61 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.047 1.339 . . . . 0.0 114.101 -170.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -68.41 132.7 47.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 117.144 -1.822 . . . . 0.0 108.933 114.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -131.67 136.45 47.7 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -149.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.3 t -68.18 64.51 0.1 Allowed 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.723 1.209 . . . . 0.0 112.279 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.251 1.153 0 C-N-CA 126.311 1.844 . . . . 0.0 111.856 167.103 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 CA--C 1.558 1.273 0 CA-C-O 120.451 0.167 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.6 t -121.88 -145.35 0.35 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.345 1.458 . . . . 0.0 111.725 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -50.38 134.37 23.37 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.878 1.271 . . . . 0.0 113.896 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 57.99 25.1 11.84 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 126.612 1.965 . . . . 0.0 115.987 -171.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.36 134.29 20.94 Favored Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.306 1.282 . . . . 0.0 116.306 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -72.95 130.97 41.56 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.271 1.428 . . . . 0.0 113.48 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.78 66.84 1.41 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 127.96 2.504 . . . . 0.0 109.234 160.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.96 170.93 33.22 Favored Glycine 0 CA--C 1.543 1.801 0 C-N-CA 126.479 1.99 . . . . 0.0 113.427 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.75 -54.58 27.4 Favored Glycine 0 CA--C 1.545 1.965 0 N-CA-C 119.325 2.49 . . . . 0.0 119.325 -159.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 mt -53.97 114.58 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 O-C-N 121.229 -1.159 . . . . 0.0 113.784 -165.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.76 36.02 70.33 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 125.84 1.686 . . . . 0.0 115.698 -176.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.07 175.12 9.89 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -160.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 m -158.04 -44.73 0.06 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.337 2.255 . . . . 0.0 111.866 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.18 68.31 1.21 Allowed Glycine 0 CA--C 1.547 2.056 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 164.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -61.37 66.64 0.1 OUTLIER 'Trans proline' 0 CA--C 1.551 1.325 0 C-N-CA 123.432 2.755 . . . . 0.0 111.977 152.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 p -141.57 49.99 1.59 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -157.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.97 91.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 O-C-N 121.174 -0.954 . . . . 0.0 109.307 155.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 171.18 5.46 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -166.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.69 78.95 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.9 t -36.21 123.37 0.75 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.407 1.883 . . . . 0.0 114.588 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.2 -45.73 1.25 Allowed Glycine 0 CA--C 1.543 1.801 0 C-N-CA 124.727 1.156 . . . . 0.0 110.585 -149.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.5 p -103.83 148.87 25.62 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.163 2.185 . . . . 0.0 111.771 161.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.4 p -134.75 113.27 11.48 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.413 1.485 . . . . 0.0 114.653 -158.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.0 t -63.58 88.44 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 126.041 1.736 . . . . 0.0 114.622 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -122.59 146.14 47.7 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.76 114.85 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.8 mt -125.04 -58.81 1.45 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.484 1.514 . . . . 0.0 114.97 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -135.94 162.03 59.15 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 124.222 1.009 . . . . 0.0 112.928 -155.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.66 32.95 0.29 Allowed 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.198 2.598 . . . . 0.0 114.963 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -133.74 -48.59 0.81 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.039 2.136 . . . . 0.0 110.649 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.05 135.31 51.61 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 127.746 2.418 . . . . 0.0 114.742 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.4 t -72.43 124.34 24.96 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.483 127.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -122.1 130.19 53.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.787 1.635 . . . . 0.0 112.641 -151.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.8 m -66.24 92.04 0.18 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 C--O 1.246 0.909 0 C-N-CA 124.11 0.964 . . . . 0.0 111.471 165.298 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? . . . . . 0 CA--C 1.556 1.209 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.1 t -116.5 -91.44 0.54 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 119.318 0.963 . . . . 0.0 113.173 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -72.14 120.28 17.52 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.545 1.538 . . . . 0.0 112.837 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 90.56 50.44 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 127.548 2.339 . . . . 0.0 116.406 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.06 132.49 10.71 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 125.732 1.634 . . . . 0.0 114.715 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -68.73 132.51 46.95 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 119.101 1.45 . . . . 0.0 113.658 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.9 m -123.43 0.76 8.91 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.68 1.992 . . . . 0.0 115.097 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.62 -146.19 6.71 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.611 1.577 . . . . 0.0 111.719 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.56 -164.52 20.45 Favored Glycine 0 CA--C 1.545 1.945 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -54.18 134.4 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 O-C-N 121.155 -1.203 . . . . 0.0 114.141 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.64 -42.73 3.13 Favored Glycine 0 CA--C 1.543 1.823 0 C-N-CA 124.927 1.251 . . . . 0.0 115.033 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -67.18 171.48 5.68 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 126.167 1.787 . . . . 0.0 114.681 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.0 p -59.47 156.45 13.09 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 130.856 3.662 . . . . 0.0 116.664 6.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.5 -163.67 26.71 Favored Glycine 0 CA--C 1.549 2.159 0 O-C-N 121.351 -0.843 . . . . 0.0 114.968 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.46 82.32 2.11 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 123.69 2.927 . . . . 0.0 113.977 -168.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.8 p -67.73 56.98 0.06 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 126.242 1.817 . . . . 0.0 114.259 172.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.92 52.38 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 O-C-N 119.88 -1.763 . . . . 0.0 112.132 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.75 157.31 17.04 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 128.105 2.562 . . . . 0.0 113.936 -170.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -101.19 127.22 47.86 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.207 1.803 . . . . 0.0 112.299 172.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.0 t -65.44 122.11 16.41 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 171.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.21 -66.99 0.29 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.488 1.994 . . . . 0.0 109.139 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.4 p -60.53 151.58 28.19 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.559 0.743 . . . . 0.0 111.583 137.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.9 p -93.96 -105.86 0.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -169.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 167.98 3.42 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 128.41 2.684 . . . . 0.0 116.184 -170.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -90.73 172.81 8.39 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 -157.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.0 m -54.05 123.25 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 127.469 2.307 . . . . 0.0 116.602 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -163.54 -55.97 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 157.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -84.52 140.48 38.57 Favored Pre-proline 0 CA--C 1.561 1.4 0 O-C-N 119.604 -1.935 . . . . 0.0 112.333 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -39.32 -52.37 2.42 Favored 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 125.264 3.976 . . . . 0.0 115.93 171.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -69.89 -42.9 72.81 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.83 -1.169 . . . . 0.0 113.079 169.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.04 104.98 9.56 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -168.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t -55.23 116.39 2.79 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.648 124.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -129.87 146.79 51.59 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -155.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.0 m -64.17 80.39 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 O-C-N 120.95 -1.094 . . . . 0.0 112.515 166.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 124.256 1.022 . . . . 0.0 110.138 151.598 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 . . . . . 0 CA--C 1.552 1.031 0 CA-C-O 122.032 0.92 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 t -75.0 -143.54 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.661 -0.649 . . . . 0.0 111.088 160.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -44.7 103.59 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.356 1.463 . . . . 0.0 113.583 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 87.08 84.62 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 129.563 3.145 . . . . 0.0 114.255 -171.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.53 117.26 1.25 Allowed Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.315 1.436 . . . . 0.0 114.732 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -65.42 122.13 16.46 Favored 'General case' 0 CA--C 1.556 1.195 0 O-C-N 119.751 -2.029 . . . . 0.0 112.49 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.4 m -104.9 -52.53 2.84 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.919 1.288 . . . . 0.0 114.387 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.16 132.55 3.58 Favored Glycine 0 CA--C 1.543 1.837 0 C-N-CA 124.185 0.898 . . . . 0.0 114.26 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.27 -157.97 27.46 Favored Glycine 0 CA--C 1.546 2.017 0 C-N-CA 126.424 1.964 . . . . 0.0 113.029 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.0 mt -40.83 110.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 119.333 1.566 . . . . 0.0 112.764 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.37 -33.39 3.2 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 116.296 1.279 . . . . 0.0 116.296 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -82.01 55.56 2.83 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -156.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.2 t -74.53 71.56 1.85 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.357 -1.464 . . . . 0.0 108.612 147.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.0 -172.68 14.88 Favored Glycine 0 CA--C 1.546 2.008 0 N-CA-C 117.82 1.888 . . . . 0.0 117.82 -154.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.41 80.21 2.79 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.152 3.235 . . . . 0.0 112.45 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.5 p -68.9 51.12 0.08 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.856 1.662 . . . . 0.0 114.868 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -78.45 52.54 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 O-C-N 119.728 -1.857 . . . . 0.0 111.704 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 44.5 t -85.59 166.07 16.53 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.915 2.486 . . . . 0.0 115.269 -165.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.28 83.61 1.8 Allowed 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 t -43.29 109.91 0.17 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.834 1.253 . . . . 0.0 113.686 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.98 -52.37 0.79 Allowed Glycine 0 CA--C 1.539 1.584 0 C-N-CA 125.614 1.578 . . . . 0.0 110.158 -160.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.4 p -76.91 163.98 26.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.079 0.552 . . . . 0.0 109.958 140.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.7 p -114.26 -124.19 0.29 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -163.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 m -173.69 32.76 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 128.957 2.903 . . . . 0.0 111.808 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -65.08 141.98 58.54 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 119.867 -1.771 . . . . 0.0 114.676 -162.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 m -64.58 93.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.18 1.392 . . . . 0.0 113.905 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.2 mt -96.59 -48.01 5.7 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -162.86 176.14 2.52 Favored Pre-proline 0 CA--C 1.559 1.326 0 O-C-N 120.832 -1.168 . . . . 0.0 113.94 -165.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.95 -39.15 92.06 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.482 2.788 . . . . 0.0 115.106 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -67.3 -39.55 85.94 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.61 116.73 8.93 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 117.768 2.507 . . . . 0.0 117.768 -164.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.11 125.58 19.54 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.59 111.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -144.04 127.32 16.73 Favored 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -154.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.0 m -63.46 78.58 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.66 1.584 . . . . 0.0 113.043 174.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.6 mt . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.187 151.273 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -74.92 61.11 1.01 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.841 1.657 . . . . 0.0 111.704 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.8 m -59.71 -55.65 31.73 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -171.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -115.17 140.77 48.8 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.939 1.296 . . . . 0.0 114.028 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 62.9 41.92 8.16 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 125.564 1.546 . . . . 0.0 113.17 -171.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.09 109.91 3.68 Favored Glycine 0 CA--C 1.54 1.64 0 C-N-CA 126.113 1.815 . . . . 0.0 114.588 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -52.41 124.36 13.23 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.362 1.465 . . . . 0.0 114.09 176.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 m -118.51 -0.37 11.41 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.58 114.64 0.33 Allowed Glycine 0 CA--C 1.546 2.005 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -175.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.63 -160.28 30.15 Favored Glycine 0 CA--C 1.552 2.384 0 C-N-CA 126.391 1.948 . . . . 0.0 115.023 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -45.64 124.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.7 -13.13 49.43 Favored Glycine 0 CA--C 1.544 1.894 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -89.69 167.43 12.91 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 119.08 1.44 . . . . 0.0 114.856 -172.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 94.2 p -131.49 -92.42 0.4 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.635 1.574 . . . . 0.0 110.881 166.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.2 38.61 0.52 Allowed Glycine 0 CA--C 1.548 2.147 0 N-CA-C 118.294 2.078 . . . . 0.0 118.294 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -76.1 50.58 2.88 Favored 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 123.384 2.723 . . . . 0.0 112.198 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.2 p -77.67 66.6 3.4 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.212 -1.555 . . . . 0.0 113.119 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 t -76.46 51.87 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 O-C-N 120.874 -1.141 . . . . 0.0 112.088 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.1 t -98.59 169.4 9.54 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 129.722 3.209 . . . . 0.0 111.915 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.4 159.37 16.44 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.691 -1.256 . . . . 0.0 112.238 169.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.8 t -72.89 -177.13 2.26 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 161.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.68 -57.02 5.03 Favored Glycine 0 CA--C 1.542 1.742 0 O-C-N 120.857 -1.152 . . . . 0.0 111.688 -165.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.1 p -76.8 177.79 7.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.233 1.013 . . . . 0.0 111.224 153.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -129.11 -128.71 0.21 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -159.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.4 m 179.85 62.51 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 128.645 2.778 . . . . 0.0 111.835 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -128.82 157.83 40.4 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -165.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.39 132.77 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -167.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.1 -113.09 0.16 Allowed 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.745 1.218 . . . . 0.0 112.762 151.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.35 157.45 71.42 Favored Pre-proline 0 CA--C 1.562 1.409 0 O-C-N 119.566 -1.959 . . . . 0.0 114.51 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.79 -17.35 0.71 Allowed 'Trans proline' 0 CA--C 1.554 1.506 0 C-N-CA 124.622 3.548 . . . . 0.0 117.969 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -74.15 -25.52 59.79 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.96 105.31 2.73 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -154.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -71.78 117.3 13.19 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 121.465 -0.772 . . . . 0.0 109.422 130.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -138.97 151.32 46.77 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -160.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.7 m -57.97 76.33 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.527 1.931 . . . . 0.0 113.028 169.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 C--O 1.257 1.483 0 C-N-CA 125.161 1.384 . . . . 0.0 111.237 153.593 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 26.9 p . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 118.449 -0.786 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -106.55 156.02 19.01 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 125.974 1.71 . . . . 0.0 112.882 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.8 m -77.01 154.37 33.55 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -168.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -41.13 146.77 0.16 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.134 1.774 . . . . 0.0 114.112 162.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 60.66 12.67 3.8 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.39 140.4 33.67 Favored Glycine 0 CA--C 1.545 1.937 0 O-C-N 119.807 -1.808 . . . . 0.0 115.254 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -64.95 119.31 10.48 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.572 -1.546 . . . . 0.0 112.78 173.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.5 38.28 3.79 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.453 1.479 . . . . 0.0 113.093 166.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.03 159.85 22.76 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 125.088 1.328 . . . . 0.0 114.685 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.87 -49.85 51.7 Favored Glycine 0 CA--C 1.545 1.955 0 N-CA-C 119.066 2.386 . . . . 0.0 119.066 -158.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.3 mt -58.32 119.72 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 O-C-N 120.724 -1.456 . . . . 0.0 112.983 -168.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.23 25.4 75.61 Favored Glycine 0 CA--C 1.543 1.838 0 C-N-CA 124.755 1.169 . . . . 0.0 115.548 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.22 -170.59 3.53 Favored 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 115.734 1.754 . . . . 0.0 115.734 -166.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.8 p -146.34 -69.29 0.26 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.993 2.117 . . . . 0.0 110.702 175.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.1 64.99 0.52 Allowed Glycine 0 CA--C 1.541 1.699 0 N-CA-C 117.584 1.794 . . . . 0.0 117.584 156.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.54 34.73 0.38 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 C-N-CA 122.663 2.242 . . . . 0.0 112.757 166.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.0 p -84.09 66.36 9.21 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 119.814 -1.804 . . . . 0.0 113.393 -170.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 t -65.35 78.45 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.996 0.919 . . . . 0.0 109.762 163.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 174.27 7.68 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 -168.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.54 73.08 0.06 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.329 1.451 . . . . 0.0 113.721 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.8 t -37.8 109.21 0.09 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.549 1.94 . . . . 0.0 114.74 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.78 -55.56 0.72 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.11 1.814 . . . . 0.0 108.69 -158.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.7 p -70.66 168.49 16.39 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.299 -0.451 . . . . 0.0 111.714 141.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -126.03 -114.04 0.28 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.852 1.661 . . . . 0.0 114.616 -166.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.0 m 162.3 65.35 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.806 0 C-N-CA 131.448 3.899 . . . . 0.0 111.504 -169.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -135.79 165.28 25.97 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 -171.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -68.1 136.52 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 118.178 2.659 . . . . 0.0 118.178 -159.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.39 -46.37 0.51 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.321 1.449 . . . . 0.0 114.532 155.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -130.22 161.18 61.77 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.996 1.319 . . . . 0.0 112.914 -176.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.81 50.05 2.01 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 123.43 2.753 . . . . 0.0 113.865 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -152.82 -49.49 0.1 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.467 2.307 . . . . 0.0 110.437 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.35 100.86 9.39 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.387 2.275 . . . . 0.0 113.374 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.0 t -70.26 88.56 0.63 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 140.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -88.32 148.92 24.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.281 1.832 . . . . 0.0 114.093 -158.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 m -63.81 75.53 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.712 -1.243 . . . . 0.0 112.501 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.208 -1.377 . . . . 0.0 110.806 163.712 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.857 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -80.85 94.19 6.41 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.297 0.953 . . . . 0.0 112.073 -177.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.5 t -66.72 -111.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 157.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -62.99 110.88 1.94 Allowed 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.901 -1.124 . . . . 0.0 112.622 170.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.255 27.4 m-85 89.67 94.26 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 129.424 3.09 . . . . 0.0 115.835 177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.88 129.45 3.08 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 126.532 2.015 . . . . 0.0 113.533 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -71.39 133.97 46.32 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 125.126 1.37 . . . . 0.0 113.561 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 m -140.4 20.11 2.39 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.83 129.69 2.54 Favored Glycine 0 CA--C 1.544 1.854 0 O-C-N 120.406 -1.433 . . . . 0.0 115.178 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.36 -158.12 28.68 Favored Glycine 0 CA--C 1.545 1.965 0 C-N-CA 126.124 1.821 . . . . 0.0 112.437 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.1 mt -43.39 105.63 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-N 119.274 1.537 . . . . 0.0 112.352 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.45 -32.84 2.31 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -73.19 56.49 0.46 Allowed 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -167.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.9 m -73.52 60.78 0.67 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.95 1.3 . . . . 0.0 109.389 155.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.7 -173.45 13.31 Favored Glycine 0 CA--C 1.544 1.903 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 -150.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.35 89.63 1.31 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.955 3.103 . . . . 0.0 112.015 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.5 p -72.61 62.75 0.57 Allowed 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.354 -1.467 . . . . 0.0 113.714 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.69 56.37 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 125.332 1.453 . . . . 0.0 112.254 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.3 t -101.55 151.61 21.77 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.725 2.01 . . . . 0.0 113.933 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.5 90.06 6.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.636 1.574 . . . . 0.0 112.641 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -42.72 115.63 0.75 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.424 1.09 . . . . 0.0 112.946 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.74 -51.84 0.75 Allowed Glycine 0 CA--C 1.539 1.533 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -152.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.5 p -82.98 166.8 18.53 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.634 0.373 . . . . 0.0 111.854 140.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.5 p -99.64 -88.41 0.34 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -158.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.3 m 124.78 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 131.507 3.923 . . . . 0.0 111.508 -163.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -119.12 152.94 35.63 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 126.416 1.887 . . . . 0.0 114.067 -172.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.4 m -57.2 123.91 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -171.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.98 -38.71 3.19 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 156.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -160.86 167.81 12.88 Favored Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -165.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.97 -29.01 25.83 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 124.013 3.142 . . . . 0.0 117.347 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -81.54 -19.8 41.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.231 1.013 . . . . 0.0 113.729 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.28 113.48 3.45 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -165.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 t -67.44 140.86 57.14 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.441 118.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -160.39 135.44 7.83 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -145.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.4 m -67.17 76.64 0.14 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.0 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.463 -1.256 . . . . 0.0 111.264 141.657 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -76.52 100.28 5.23 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 119.696 1.135 . . . . 0.0 112.021 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.0 t -77.93 -102.21 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.257 -0.902 . . . . 0.0 113.034 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.44 127.91 34.69 Favored 'General case' 0 CA--C 1.553 1.091 0 O-C-N 121.034 -1.041 . . . . 0.0 113.459 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.261 37.2 m-85 77.7 47.7 0.05 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 126.931 2.092 . . . . 0.0 115.429 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.62 120.35 6.85 Favored Glycine 0 CA--C 1.545 1.917 0 C-N-CA 125.884 1.707 . . . . 0.0 115.832 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -68.21 103.46 1.58 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.844 1.322 . . . . 0.0 114.312 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -104.04 57.72 0.72 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.944 1.298 . . . . 0.0 110.826 167.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.14 162.81 36.6 Favored Glycine 0 CA--C 1.544 1.881 0 O-C-N 120.467 -1.396 . . . . 0.0 116.472 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.15 -76.21 0.19 Allowed Glycine 0 CA--C 1.544 1.906 0 N-CA-C 119.043 2.377 . . . . 0.0 119.043 -157.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.5 108.25 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 O-C-N 120.981 -1.305 . . . . 0.0 112.075 -164.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.08 -26.97 11.4 Favored Glycine 0 CA--C 1.546 2.025 0 C-N-CA 125.805 1.669 . . . . 0.0 116.446 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -109.73 65.19 0.61 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 -148.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.3 p -70.06 49.39 0.1 Allowed 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.369 -1.457 . . . . 0.0 112.339 162.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.01 156.42 22.15 Favored Glycine 0 CA--C 1.547 2.05 0 N-CA-C 116.33 1.292 . . . . 0.0 116.33 -158.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -82.52 116.93 2.66 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.361 2.708 . . . . 0.0 110.811 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.3 p -71.19 65.66 0.4 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 120.451 -1.406 . . . . 0.0 113.227 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -73.63 61.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 125.248 1.419 . . . . 0.0 112.015 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.2 t -95.06 153.76 17.49 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 127.012 2.125 . . . . 0.0 114.297 -173.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.03 100.37 13.2 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.305 1.042 . . . . 0.0 113.01 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.9 p -49.99 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.954 1.702 . . . . 0.0 114.112 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.83 -48.87 0.32 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.957 1.265 . . . . 0.0 110.235 -159.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.8 p -84.98 158.12 20.59 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 120.873 0.368 . . . . 0.0 111.349 138.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.2 p -101.4 -84.83 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -150.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.5 m 126.03 62.08 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 131.574 3.949 . . . . 0.0 111.049 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -126.91 137.59 53.17 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.3 t -50.52 115.59 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 127.076 2.151 . . . . 0.0 115.101 -170.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.0 mt -101.6 -42.16 6.33 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.907 0.883 . . . . 0.0 113.006 163.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -158.1 166.14 17.16 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 126.905 2.082 . . . . 0.0 110.315 -163.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.93 25.65 0.18 Allowed 'Trans proline' 0 CA--C 1.557 1.65 0 C-N-CA 122.768 2.312 . . . . 0.0 115.005 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -122.29 -66.87 1.0 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.795 2.038 . . . . 0.0 109.902 171.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.43 109.59 22.31 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.549 2.34 . . . . 0.0 113.42 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -76.56 102.35 6.05 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 136.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -97.85 137.91 36.0 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.969 1.708 . . . . 0.0 113.327 -156.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.7 m -64.95 75.84 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.742 -1.224 . . . . 0.0 112.842 166.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.246 0.897 0 C-N-CA 125.41 1.484 . . . . 0.0 111.304 157.878 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -86.45 125.73 33.91 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.686 1.194 . . . . 0.0 110.819 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 t -74.11 178.51 4.99 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -57.68 139.54 53.5 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.035 1.334 . . . . 0.0 114.219 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 73.64 26.65 1.88 Allowed 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 127.6 2.36 . . . . 0.0 115.451 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.43 136.03 12.59 Favored Glycine 0 CA--C 1.549 2.216 0 O-C-N 119.45 -2.031 . . . . 0.0 116.228 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -58.58 126.74 28.88 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 119.747 -2.031 . . . . 0.0 113.732 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.54 45.32 2.06 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 127.317 2.247 . . . . 0.0 110.991 165.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.99 164.32 27.91 Favored Glycine 0 CA--C 1.541 1.694 0 O-C-N 120.615 -1.303 . . . . 0.0 115.06 -169.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.37 -45.4 9.92 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 119.101 2.4 . . . . 0.0 119.101 -149.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.9 mt -53.36 118.48 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 O-C-N 120.693 -1.475 . . . . 0.0 112.919 -170.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.08 33.89 76.68 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 124.645 1.117 . . . . 0.0 115.509 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.1 -179.74 5.96 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -166.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -165.55 -57.21 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.192 2.197 . . . . 0.0 110.59 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 55.15 87.84 0.01 OUTLIER Glycine 0 CA--C 1.548 2.154 0 N-CA-C 118.701 2.241 . . . . 0.0 118.701 155.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -66.92 71.16 0.5 Allowed 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.449 2.766 . . . . 0.0 111.391 166.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -90.08 61.49 5.22 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.672 1.989 . . . . 0.0 113.771 -160.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.26 79.57 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 O-C-N 121.145 -0.972 . . . . 0.0 110.96 171.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.1 t -50.19 153.48 1.44 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.283 2.233 . . . . 0.0 113.907 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.13 74.21 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 O-C-N 120.709 -1.244 . . . . 0.0 113.275 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.9 t -33.45 98.79 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 127.721 2.408 . . . . 0.0 114.804 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.27 -53.97 0.58 Allowed Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.555 1.55 . . . . 0.0 109.396 -156.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.5 p -82.93 166.93 18.47 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.246 0.618 . . . . 0.0 110.78 143.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -117.95 -92.21 0.53 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.161 2.652 . . . . 0.0 118.161 -152.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.3 m 131.14 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 1 C-N-CA 131.797 4.039 . . . . 0.0 113.429 -166.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -134.22 157.72 45.54 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.7 t -54.45 112.52 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -164.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.6 mt -85.85 -55.68 3.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.456 1.102 . . . . 0.0 112.629 153.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -167.55 176.49 1.64 Allowed Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 125.588 1.555 . . . . 0.0 112.185 -159.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.9 -41.81 38.75 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.202 3.268 . . . . 0.0 115.983 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -67.21 -45.06 77.98 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.319 -0.863 . . . . 0.0 113.07 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.58 95.73 4.2 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -151.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -77.28 102.06 6.54 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 144.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -105.21 142.06 35.64 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.114 1.765 . . . . 0.0 113.949 -159.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.4 t -56.31 71.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 127.926 2.49 . . . . 0.0 112.321 167.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 mt . . . . . 0 C--O 1.248 1.0 0 C-N-CA 129.789 3.236 . . . . 0.0 112.838 174.644 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -84.83 163.47 19.03 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 119.276 0.944 . . . . 0.0 112.171 171.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.7 t -112.27 -102.42 0.41 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.546 1.138 . . . . 0.0 112.823 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -68.63 122.17 17.96 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.937 1.295 . . . . 0.0 112.874 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 86.4 61.82 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 128.021 2.529 . . . . 0.0 115.588 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.14 139.49 13.83 Favored Glycine 0 CA--C 1.549 2.184 0 C-N-CA 125.863 1.697 . . . . 0.0 114.48 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -82.39 116.29 21.8 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 118.998 1.399 . . . . 0.0 114.081 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.66 55.59 0.91 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.054 1.742 . . . . 0.0 111.001 171.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.21 163.74 35.1 Favored Glycine 0 CA--C 1.54 1.652 0 O-C-N 120.671 -1.268 . . . . 0.0 114.435 -173.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.99 -64.15 4.31 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 118.697 2.239 . . . . 0.0 118.697 -160.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.3 mt -60.07 116.1 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 O-C-N 120.738 -1.448 . . . . 0.0 112.775 -164.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.01 -12.43 69.54 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 126.153 1.835 . . . . 0.0 116.557 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -111.91 75.21 0.91 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -153.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.2 p -74.42 26.62 0.08 Allowed 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.427 -1.421 . . . . 0.0 113.605 154.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.93 160.35 17.87 Favored Glycine 0 CA--C 1.545 1.939 0 C-N-CA 124.89 1.233 . . . . 0.0 116.008 -165.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.63 124.55 4.08 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 123.292 2.662 . . . . 0.0 111.472 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.7 p -73.84 62.99 0.87 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.964 1.306 . . . . 0.0 113.717 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 t -74.42 53.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 O-C-N 120.184 -1.573 . . . . 0.0 113.477 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.9 t -100.26 159.52 15.05 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 128.161 2.585 . . . . 0.0 114.455 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.35 104.65 16.56 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.616 1.966 . . . . 0.0 113.655 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.0 t -47.15 117.34 1.69 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.181 1.393 . . . . 0.0 112.728 169.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.83 -52.17 0.72 Allowed Glycine 0 CA--C 1.538 1.497 0 C-N-CA 126.144 1.83 . . . . 0.0 109.211 -160.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.9 p -74.42 162.03 29.24 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.198 -0.501 . . . . 0.0 111.11 140.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.0 p -98.57 -90.17 0.29 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -166.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.1 m 125.84 57.26 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 131.628 3.971 . . . . 0.0 110.805 -162.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -118.93 142.23 47.95 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.701 1.601 . . . . 0.0 115.013 -164.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.1 t -51.16 102.04 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 126.449 1.9 . . . . 0.0 114.319 -170.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.3 mt -107.41 -50.12 3.13 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.759 1.224 . . . . 0.0 114.04 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -153.37 166.84 14.71 Favored Pre-proline 0 CA--C 1.557 1.225 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -163.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.51 -35.27 65.84 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.285 2.657 . . . . 0.0 114.982 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -72.17 -54.32 10.04 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.093 1.357 . . . . 0.0 112.513 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.19 120.13 34.32 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.557 1.543 . . . . 0.0 114.354 -166.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -71.97 119.53 16.28 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 126.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -126.43 143.41 51.19 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.115 -0.99 . . . . 0.0 113.393 -151.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.8 m -67.68 81.56 0.18 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.266 -0.896 . . . . 0.0 112.523 171.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 C--O 1.255 1.364 0 CA-C-O 117.286 -1.34 . . . . 0.0 109.645 146.489 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 119.032 -0.508 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -81.07 118.67 22.71 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 119.402 1.001 . . . . 0.0 109.884 168.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.9 t -64.37 168.44 5.7 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -48.52 131.4 17.31 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.904 0.882 . . . . 0.0 112.165 167.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 69.72 74.07 0.23 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.405 1.482 . . . . 0.0 113.338 -173.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.89 145.02 12.7 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 125.128 1.347 . . . . 0.0 114.187 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -70.83 131.63 44.08 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.708 -1.466 . . . . 0.0 114.891 -173.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.17 57.32 1.79 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.263 1.825 . . . . 0.0 110.687 170.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.24 168.59 41.16 Favored Glycine 0 CA--C 1.545 1.963 0 O-C-N 120.47 -1.394 . . . . 0.0 115.502 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.62 -76.1 0.14 Allowed Glycine 0 CA--C 1.545 1.934 0 C-N-CA 127.468 2.461 . . . . 0.0 119.201 -162.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.5 mt -61.24 96.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.055 -1.262 . . . . 0.0 112.564 -164.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.6 13.93 31.2 Favored Glycine 0 CA--C 1.544 1.895 0 C-N-CA 126.279 1.895 . . . . 0.0 116.409 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.05 164.87 28.87 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 120.022 1.911 . . . . 0.0 116.147 -173.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 t -127.08 -65.13 0.96 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.084 2.154 . . . . 0.0 110.406 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.92 75.9 0.07 OUTLIER Glycine 0 CA--C 1.545 1.968 0 N-CA-C 119.407 2.523 . . . . 0.0 119.407 151.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.81 52.55 0.54 Allowed 'Trans proline' 0 CA--C 1.554 1.481 0 C-N-CA 123.514 2.809 . . . . 0.0 112.114 157.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.4 p -73.24 29.75 0.07 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 -162.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.5 t -75.5 66.78 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 O-C-N 119.967 -1.708 . . . . 0.0 111.72 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 52.5 t -59.57 158.88 9.16 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.844 2.057 . . . . 0.0 113.95 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.74 61.77 0.17 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.521 1.529 . . . . 0.0 114.596 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -6.06 75.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 130.12 3.368 . . . . 0.0 116.52 176.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.46 -51.71 0.48 Allowed Glycine 0 CA--C 1.535 1.327 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -158.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.6 p -80.5 160.09 25.34 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.473 0.309 . . . . 0.0 110.393 140.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.1 p -116.21 -84.83 0.63 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -156.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.8 m 127.33 61.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 131.571 3.948 . . . . 0.0 112.102 -167.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -123.54 146.52 48.05 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 125.848 1.659 . . . . 0.0 115.253 -166.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.93 113.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.546 1.939 . . . . 0.0 114.932 -169.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.7 mt -116.45 -46.59 2.77 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -152.63 165.02 18.46 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 120.856 -1.153 . . . . 0.0 113.28 -161.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.79 43.02 0.75 Allowed 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 123.251 2.634 . . . . 0.0 114.204 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -143.41 -54.66 0.38 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.773 2.429 . . . . 0.0 108.552 172.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.26 124.05 48.1 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 128.02 2.528 . . . . 0.0 113.838 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -68.09 134.79 51.18 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.69 120.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -136.82 132.55 34.8 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.977 -1.077 . . . . 0.0 111.618 -144.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.3 t -66.6 67.17 0.06 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.055 1.742 . . . . 0.0 112.293 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--O 1.247 0.974 0 C-N-CA 126.733 2.013 . . . . 0.0 112.242 167.441 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.73 165.27 37.03 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 120.108 1.322 . . . . 0.0 112.771 168.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.5 t -106.31 -162.71 0.87 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.211 1.804 . . . . 0.0 112.037 166.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -52.05 143.49 13.86 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -174.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 57.68 8.87 0.73 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 126.712 2.005 . . . . 0.0 116.051 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.8 150.35 35.65 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.248 -1.533 . . . . 0.0 115.933 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -89.28 114.07 25.4 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.273 1.429 . . . . 0.0 113.285 -171.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.35 62.61 0.77 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.965 1.306 . . . . 0.0 112.927 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.88 -128.69 5.93 Favored Glycine 0 CA--C 1.547 2.048 0 N-CA-C 116.444 1.338 . . . . 0.0 116.444 168.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.5 -150.37 26.27 Favored Glycine 0 CA--C 1.549 2.17 0 O-C-N 120.926 -1.338 . . . . 0.0 115.654 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.0 mt -53.79 110.77 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 O-C-N 120.756 -1.438 . . . . 0.0 113.115 175.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.74 -37.54 3.17 Favored Glycine 0 CA--C 1.546 2.018 0 N-CA-C 117.005 1.562 . . . . 0.0 117.005 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.68 81.83 1.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -158.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.7 p -72.75 5.22 3.31 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 166.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 142.85 35.25 Favored Glycine 0 CA--C 1.552 2.356 0 O-C-N 120.375 -1.453 . . . . 0.0 115.286 -173.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -80.31 66.22 8.83 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.664 2.91 . . . . 0.0 112.574 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.9 p -84.36 48.12 1.45 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 119.797 -1.814 . . . . 0.0 115.311 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -51.94 108.45 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 O-C-N 121.063 -1.023 . . . . 0.0 110.515 162.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.72 -178.69 4.77 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -160.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.69 71.27 0.08 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.68 1.592 . . . . 0.0 112.846 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -37.39 107.21 0.06 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.62 1.968 . . . . 0.0 114.483 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.31 -54.94 0.74 Allowed Glycine 0 CA--C 1.536 1.347 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -158.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.6 p -72.37 170.24 14.62 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.485 0.314 . . . . 0.0 111.484 142.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.3 p -119.74 -113.34 0.33 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -168.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 m 154.13 60.4 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 129.887 3.275 . . . . 0.0 110.474 -166.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -129.69 147.01 51.43 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 126.756 2.023 . . . . 0.0 115.742 -166.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.7 m -51.48 131.8 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -168.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.22 -76.1 0.17 Allowed 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 155.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -81.48 153.24 70.96 Favored Pre-proline 0 CA--C 1.561 1.396 0 O-C-N 120.191 -1.568 . . . . 0.0 112.886 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -58.81 -11.59 12.41 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.458 2.772 . . . . 0.0 116.033 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -91.55 -10.86 39.08 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.993 1.317 . . . . 0.0 113.881 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.96 113.62 5.02 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -166.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -74.21 95.75 2.66 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 137.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -101.21 145.95 28.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.774 1.63 . . . . 0.0 113.816 -154.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.7 m -65.57 75.25 0.07 Allowed 'General case' 0 CA--C 1.551 0.992 0 O-C-N 120.767 -1.208 . . . . 0.0 114.084 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.571 -1.204 . . . . 0.0 112.464 165.45 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.501 2.087 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -72.45 68.5 0.79 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.648 1.179 . . . . 0.0 111.663 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -79.71 -117.1 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.337 1.455 . . . . 0.0 113.009 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -63.66 123.18 18.18 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 121.175 -0.953 . . . . 0.0 112.463 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 79.19 39.75 0.11 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 127.806 2.443 . . . . 0.0 115.11 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.28 122.41 7.56 Favored Glycine 0 CA--C 1.551 2.341 0 N-CA-C 116.607 1.403 . . . . 0.0 116.607 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -66.98 112.12 4.17 Favored 'General case' 0 CA--C 1.556 1.21 0 O-C-N 119.872 -1.957 . . . . 0.0 115.773 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -109.77 50.16 0.81 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.849 1.66 . . . . 0.0 111.588 164.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.37 158.55 29.04 Favored Glycine 0 CA--C 1.54 1.617 0 O-C-N 120.202 -1.561 . . . . 0.0 116.353 -171.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.88 -68.14 1.52 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 119.024 2.369 . . . . 0.0 119.024 -161.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.8 mt -60.68 101.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 120.988 -1.301 . . . . 0.0 112.401 -165.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.19 -28.28 10.58 Favored Glycine 0 CA--C 1.546 1.992 0 C-N-CA 126.242 1.877 . . . . 0.0 115.7 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -106.07 62.27 0.66 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -150.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.2 p -68.69 58.77 0.09 Allowed 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.235 -1.541 . . . . 0.0 111.64 159.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.52 161.56 27.98 Favored Glycine 0 CA--C 1.547 2.042 0 N-CA-C 116.214 1.245 . . . . 0.0 116.214 -158.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -83.88 130.15 4.91 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.092 3.195 . . . . 0.0 112.225 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.5 p -79.56 69.34 5.83 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.302 -1.499 . . . . 0.0 112.31 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.3 t -77.19 57.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.983 1.313 . . . . 0.0 112.525 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.1 t -105.53 149.5 26.18 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.829 2.052 . . . . 0.0 115.121 -158.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.07 62.87 6.82 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -171.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -19.76 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.567 2.347 . . . . 0.0 115.397 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.88 -54.38 0.55 Allowed Glycine 0 CA--C 1.54 1.637 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -151.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.7 p -70.79 154.3 41.97 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 122.807 -0.231 . . . . 0.0 111.319 137.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.7 p -101.08 -117.75 0.17 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -162.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.3 m 162.51 51.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 131.058 3.743 . . . . 0.0 111.102 -172.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -121.47 149.88 42.4 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 119.99 -1.694 . . . . 0.0 115.314 -167.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 m -57.4 137.62 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -171.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -152.73 -59.84 0.15 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.859 1.264 . . . . 0.0 113.675 161.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -92.3 150.66 40.53 Favored Pre-proline 0 CA--C 1.561 1.371 0 O-C-N 120.554 -1.341 . . . . 0.0 112.777 168.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.88 -26.32 57.26 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.702 2.935 . . . . 0.0 115.101 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -45.04 70.53 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.217 -0.927 . . . . 0.0 112.989 175.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.21 113.47 19.51 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.413 1.885 . . . . 0.0 114.106 -167.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.7 t -70.36 113.85 7.92 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 136.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -127.2 137.03 52.83 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -147.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -59.82 79.9 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.415 1.086 . . . . 0.0 112.749 167.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.105 146.903 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.7 p . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -72.02 131.61 43.14 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.339 1.456 . . . . 0.0 110.33 165.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -85.74 175.68 8.57 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -49.85 135.76 19.12 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.681 1.193 . . . . 0.0 112.658 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 69.15 -2.28 1.86 Allowed 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -169.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.73 144.88 49.7 Favored Glycine 0 CA--C 1.549 2.178 0 O-C-N 119.906 -1.746 . . . . 0.0 115.185 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.77 136.51 36.76 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -167.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.67 35.54 4.82 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 126.316 1.846 . . . . 0.0 113.241 161.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.26 168.96 21.32 Favored Glycine 0 CA--C 1.54 1.632 0 O-C-N 120.472 -1.392 . . . . 0.0 114.712 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.97 -45.41 83.39 Favored Glycine 0 CA--C 1.544 1.896 0 N-CA-C 117.855 1.902 . . . . 0.0 117.855 -158.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.7 mm -56.92 109.22 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 O-C-N 121.175 -1.191 . . . . 0.0 113.113 -170.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.46 39.11 96.61 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 125.758 1.647 . . . . 0.0 115.418 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.1 178.98 6.78 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 -168.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 91.3 p -136.73 -84.92 0.34 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.805 1.642 . . . . 0.0 111.046 172.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.5 53.04 0.05 OUTLIER Glycine 0 CA--C 1.545 1.95 0 N-CA-C 117.979 1.952 . . . . 0.0 117.979 169.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.1 46.57 1.14 Allowed 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 123.39 2.727 . . . . 0.0 112.674 169.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.3 p -70.94 23.38 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -164.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 t -77.34 63.28 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 O-C-N 119.798 -1.814 . . . . 0.0 112.181 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.1 t -55.43 154.93 5.73 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.564 1.545 . . . . 0.0 114.682 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.17 73.35 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 O-C-N 120.608 -1.308 . . . . 0.0 112.621 165.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.1 t -38.3 109.16 0.09 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.344 1.858 . . . . 0.0 114.687 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.82 -53.24 0.71 Allowed Glycine 0 CA--C 1.537 1.469 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -156.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.3 p -82.05 163.4 22.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.299 0.64 . . . . 0.0 110.736 146.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 33.8 p -113.44 -120.17 0.3 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -161.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' THR . 47.4 t 171.42 51.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 127.79 2.436 . . . . 0.0 111.315 -169.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -129.54 146.67 51.33 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.676 1.59 . . . . 0.0 115.197 -154.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 m -51.12 127.84 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.3 0.0 OUTLIER -148.76 -99.56 0.08 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 125.112 1.365 . . . . 0.0 113.64 158.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -53.64 146.38 25.85 Favored Pre-proline 0 CA--C 1.565 1.535 0 O-C-N 119.553 -1.967 . . . . 0.0 113.994 169.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -58.23 -28.68 85.14 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.808 3.005 . . . . 0.0 115.045 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -66.22 -33.26 75.34 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 121.035 -1.04 . . . . 0.0 113.77 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.58 115.9 9.97 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.621 1.568 . . . . 0.0 114.917 -166.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -66.43 121.24 14.86 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.842 -1.161 . . . . 0.0 108.525 136.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -129.97 142.8 50.59 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -149.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.7 t -69.19 66.51 0.16 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.832 2.053 . . . . 0.0 112.744 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.9 2.08 . . . . 0.0 112.846 170.872 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.5 2.054 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -106.36 146.97 29.78 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.185 1.394 . . . . 0.0 112.0 169.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -89.53 -166.86 1.7 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 125.072 1.349 . . . . 0.0 114.504 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -59.44 149.96 27.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.282 1.433 . . . . 0.0 114.829 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 61.36 5.12 1.07 Allowed 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.17 130.97 51.79 Favored Glycine 0 CA--C 1.546 1.987 0 O-C-N 119.494 -2.004 . . . . 0.0 115.019 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -66.63 125.7 26.62 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 120.693 -1.475 . . . . 0.0 111.965 175.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -119.32 40.58 3.31 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 125.424 1.489 . . . . 0.0 110.971 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.03 158.77 27.84 Favored Glycine 0 CA--C 1.544 1.904 0 C-N-CA 125.181 1.372 . . . . 0.0 115.195 -170.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.67 -58.77 11.92 Favored Glycine 0 CA--C 1.549 2.187 0 N-CA-C 120.324 2.89 . . . . 0.0 120.324 -158.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.9 mt -57.08 107.34 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 O-C-N 120.643 -1.504 . . . . 0.0 113.22 -165.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.04 19.47 62.87 Favored Glycine 0 CA--C 1.544 1.866 0 C-N-CA 126.254 1.883 . . . . 0.0 115.786 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -140.92 117.02 10.55 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.6 p -120.26 42.85 2.86 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.165 1.386 . . . . 0.0 112.466 163.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.52 122.84 7.17 Favored Glycine 0 CA--C 1.547 2.084 0 C-N-CA 125.083 1.325 . . . . 0.0 114.745 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.46 63.11 7.16 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.588 2.859 . . . . 0.0 111.823 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.8 p -77.56 66.3 3.25 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.273 -1.517 . . . . 0.0 114.28 -176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.26 89.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.905 0.882 . . . . 0.0 109.365 155.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.28 177.44 7.26 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -166.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.43 68.92 0.14 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.878 1.271 . . . . 0.0 113.782 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.2 t -28.75 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 127.156 2.182 . . . . 0.0 114.535 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.63 -54.45 0.62 Allowed Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.283 1.42 . . . . 0.0 109.638 -155.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -77.24 176.3 8.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.287 0.635 . . . . 0.0 111.16 142.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 p -127.92 -124.06 0.23 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.367 1.467 . . . . 0.0 114.582 -167.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 m 167.85 55.08 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 128.867 2.867 . . . . 0.0 111.383 -168.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . 0.266 2.8 pp0? -139.25 169.2 18.2 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -168.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.79 139.88 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -148.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.32 -67.97 0.12 Allowed 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 160.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -88.98 147.64 39.24 Favored Pre-proline 0 CA--C 1.555 1.139 0 O-C-N 120.395 -1.44 . . . . 0.0 112.705 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -54.82 -28.63 58.96 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.531 2.821 . . . . 0.0 115.026 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.85 -44.7 72.85 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 121.077 -1.015 . . . . 0.0 112.698 174.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.21 109.7 15.28 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.042 1.737 . . . . 0.0 115.27 -167.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -64.37 103.59 0.66 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 134.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -111.05 148.8 31.81 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.672 1.589 . . . . 0.0 114.192 -155.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.0 m -68.21 70.58 0.16 Allowed 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.254 1.294 0 CA-C-O 117.65 -1.167 . . . . 0.0 111.304 157.875 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.497 1.895 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -84.98 178.73 7.48 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.558 1.143 . . . . 0.0 111.505 161.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.4 t -86.85 -117.47 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.875 0.87 . . . . 0.0 111.347 167.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -47.83 159.99 0.15 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 172.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 73.38 58.43 0.1 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.303 1.841 . . . . 0.0 115.392 162.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.24 135.86 7.74 Favored Glycine 0 CA--C 1.545 1.958 0 C-N-CA 126.168 1.842 . . . . 0.0 112.653 171.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -76.21 128.85 35.75 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.009 -1.289 . . . . 0.0 113.933 -173.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -111.78 57.66 0.64 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 126.59 1.956 . . . . 0.0 110.892 170.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.12 156.39 27.47 Favored Glycine 0 CA--C 1.544 1.85 0 O-C-N 120.889 -1.132 . . . . 0.0 115.333 -169.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.96 -48.75 5.94 Favored Glycine 0 CA--C 1.546 2.024 0 N-CA-C 118.147 2.019 . . . . 0.0 118.147 -159.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.66 122.97 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.595 -1.533 . . . . 0.0 112.828 -171.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.41 34.96 91.32 Favored Glycine 0 CA--C 1.544 1.855 0 C-N-CA 124.85 1.214 . . . . 0.0 115.089 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.38 -172.6 3.99 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -166.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.1 p -160.52 -87.75 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.659 1.984 . . . . 0.0 110.416 168.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.76 36.66 1.6 Allowed Glycine 0 CA--C 1.552 2.386 0 N-CA-C 119.773 2.669 . . . . 0.0 119.773 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -62.9 37.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.637 0 CA-C-N 122.145 2.972 . . . . 0.0 116.809 165.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.5 p -75.43 57.93 0.96 Allowed 'General case' 0 N--CA 1.481 1.083 0 O-C-N 119.432 -2.043 . . . . 0.0 113.575 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 18' ' ' VAL . 39.0 t -73.51 28.8 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.44 0 O-C-N 119.922 -1.736 . . . . 0.0 114.347 -176.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.2 t -95.75 157.68 15.79 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 129.303 3.041 . . . . 0.0 113.549 -173.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.43 108.06 19.38 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.254 1.422 . . . . 0.0 112.766 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -56.11 150.67 13.53 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.31 -47.69 1.02 Allowed Glycine 0 CA--C 1.541 1.703 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -145.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.1 p -77.16 171.21 15.19 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.945 0.898 . . . . 0.0 111.991 147.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 p -107.99 -146.32 0.4 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.886 1.674 . . . . 0.0 114.08 -168.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 m -162.24 68.61 0.26 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 127.459 2.304 . . . . 0.0 109.787 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -124.29 148.58 47.31 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 126.138 1.775 . . . . 0.0 115.668 -158.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.1 m -57.83 118.98 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -168.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.38 -48.88 3.71 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.109 1.363 . . . . 0.0 113.091 162.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -150.82 168.65 10.6 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 127.831 2.452 . . . . 0.0 110.748 -170.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -55.5 -15.77 12.71 Favored 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.095 2.53 . . . . 0.0 117.741 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.76 -45.36 9.35 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.934 1.243 . . . . 0.0 111.942 173.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.77 94.32 5.01 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.474 1.91 . . . . 0.0 112.84 -157.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 t -89.31 99.28 12.31 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 151.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.87 156.36 38.01 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.875 2.07 . . . . 0.0 113.872 -154.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.5 m -64.91 82.66 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 127.192 2.197 . . . . 0.0 112.967 157.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.34 64.67 0.1 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.296 2.238 . . . . 0.0 112.261 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 m -85.18 -89.28 0.11 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.255 1.022 . . . . 0.0 112.241 -161.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -73.57 92.24 1.9 Allowed 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.456 -0.778 . . . . 0.0 109.623 168.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.254 13.6 m-85 98.93 106.46 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 130.22 3.408 . . . . 0.0 112.442 -174.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.83 109.32 0.39 Allowed Glycine 0 CA--C 1.541 1.671 0 C-N-CA 127.184 2.326 . . . . 0.0 111.625 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -72.62 119.39 16.78 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.748 1.219 . . . . 0.0 112.895 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 p -137.29 56.93 1.76 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.948 1.699 . . . . 0.0 111.189 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.5 34.81 1.47 Allowed Glycine 0 CA--C 1.545 1.915 0 N-CA-C 117.607 1.803 . . . . 0.0 117.607 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.23 -70.66 1.55 Allowed Glycine 0 CA--C 1.545 1.911 0 N-CA-C 117.046 1.578 . . . . 0.0 117.046 165.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.9 mt -54.4 112.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 119.015 1.408 . . . . 0.0 113.841 -168.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.18 -11.55 48.86 Favored Glycine 0 CA--C 1.548 2.145 0 C-N-CA 125.651 1.596 . . . . 0.0 115.332 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -110.85 62.62 0.61 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -155.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 t -70.11 64.09 0.23 Allowed 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.701 -1.25 . . . . 0.0 111.039 156.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.74 176.14 20.12 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 -164.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.16 143.48 25.58 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.615 3.543 . . . . 0.0 112.45 -174.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.8 p -123.94 41.33 3.51 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.992 1.317 . . . . 0.0 113.265 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 t -79.35 51.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 O-C-N 120.323 -1.485 . . . . 0.0 112.335 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.6 t -82.4 164.02 21.29 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 128.73 2.812 . . . . 0.0 113.122 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.58 93.71 4.09 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 t -36.84 111.04 0.13 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.838 1.655 . . . . 0.0 114.218 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.74 -50.3 0.89 Allowed Glycine 0 CA--C 1.541 1.704 0 C-N-CA 125.844 1.688 . . . . 0.0 109.536 -158.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.6 p -82.62 152.87 25.72 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.661 1.185 . . . . 0.0 110.695 143.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.1 p -101.44 -107.25 0.24 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -159.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t 146.09 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 131.547 3.939 . . . . 0.0 110.206 -170.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -118.31 127.12 53.4 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 127.536 2.334 . . . . 0.0 114.214 -157.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.9 t -65.17 86.86 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 C-N-CA 125.431 1.492 . . . . 0.0 114.586 -170.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.69 -44.73 8.4 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -152.91 160.21 31.3 Favored Pre-proline 0 CA--C 1.557 1.246 0 O-C-N 121.029 -1.044 . . . . 0.0 113.497 -164.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.67 53.64 3.25 Favored 'Trans proline' 0 CA--C 1.554 1.48 0 C-N-CA 124.268 3.312 . . . . 0.0 113.58 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -159.75 -53.76 0.06 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 129.534 3.133 . . . . 0.0 109.084 176.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.91 119.16 36.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.028 2.131 . . . . 0.0 113.175 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 t -66.55 123.41 19.98 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 120.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -113.67 129.22 56.6 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.94 1.696 . . . . 0.0 111.38 -160.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.0 m -64.43 83.88 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.357 -0.84 . . . . 0.0 111.909 165.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 C--O 1.256 1.432 0 CA-C-O 116.694 -1.622 . . . . 0.0 109.678 153.385 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -67.51 72.52 0.14 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.127 1.771 . . . . 0.0 111.159 171.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 m -82.79 -131.65 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.499 1.52 . . . . 0.0 113.243 -166.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -47.7 121.32 3.96 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.998 1.319 . . . . 0.0 113.682 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 72.48 50.02 0.19 Allowed 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 127.377 2.271 . . . . 0.0 114.336 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.01 133.76 10.11 Favored Glycine 0 CA--C 1.547 2.038 0 C-N-CA 126.111 1.815 . . . . 0.0 115.317 -174.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -73.66 130.39 39.91 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 120.221 2.011 . . . . 0.0 115.023 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.3 m -112.01 -47.28 3.14 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.588 1.555 . . . . 0.0 111.88 166.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 165.49 10.08 Favored Glycine 0 CA--C 1.548 2.107 0 N-CA-C 117.239 1.656 . . . . 0.0 117.239 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.57 -52.64 24.64 Favored Glycine 0 CA--C 1.548 2.113 0 N-CA-C 119.471 2.549 . . . . 0.0 119.471 -157.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.6 114.35 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 120.094 -1.827 . . . . 0.0 112.033 -166.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.67 -16.83 60.44 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 126.031 1.777 . . . . 0.0 116.391 -172.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -111.37 76.22 0.96 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -153.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 p -72.28 24.27 0.05 Allowed 'General case' 0 CA--C 1.554 1.123 0 O-C-N 120.138 -1.601 . . . . 0.0 114.297 158.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.76 157.73 22.38 Favored Glycine 0 CA--C 1.546 1.984 0 O-C-N 120.735 -1.228 . . . . 0.0 116.036 -168.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -83.68 122.47 3.1 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.336 2.69 . . . . 0.0 110.614 172.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -73.76 60.55 0.71 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.638 -1.288 . . . . 0.0 113.853 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 t -72.39 57.21 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 O-C-N 120.168 -1.583 . . . . 0.0 112.045 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.9 t -93.04 154.59 18.03 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.94 2.096 . . . . 0.0 113.726 -171.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.39 83.78 7.38 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.765 -1.209 . . . . 0.0 112.339 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.3 t -44.24 109.71 0.17 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.785 1.234 . . . . 0.0 113.213 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.26 -50.79 0.81 Allowed Glycine 0 CA--C 1.537 1.455 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -156.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.1 p -74.45 155.09 38.4 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.6 0.36 . . . . 0.0 110.892 139.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.3 p -98.59 -106.46 0.2 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -163.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 m 158.42 30.76 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 130.994 3.718 . . . . 0.0 112.584 -172.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -95.02 151.32 19.28 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.361 -2.087 . . . . 0.0 116.369 -164.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.4 t -55.89 115.2 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 126.481 1.912 . . . . 0.0 114.427 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -122.58 -49.51 2.01 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -139.65 162.1 52.93 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.856 1.263 . . . . 0.0 112.558 -167.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.97 49.99 1.7 Allowed 'Trans proline' 0 CA--C 1.551 1.371 0 C-N-CA 123.833 3.022 . . . . 0.0 113.471 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -154.17 -67.75 0.14 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 129.626 3.17 . . . . 0.0 107.746 172.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.87 111.24 23.69 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 127.046 2.138 . . . . 0.0 113.049 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.1 p -58.79 124.14 18.78 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.573 115.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -138.65 140.56 38.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.085 1.354 . . . . 0.0 114.444 -147.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.1 m -67.75 83.07 0.19 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.794 1.238 . . . . 0.0 112.7 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt . . . . . 0 C--O 1.254 1.312 0 CA-C-O 117.405 -1.283 . . . . 0.0 110.467 152.359 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -82.52 156.62 23.93 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.435 1.016 . . . . 0.0 112.913 170.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.0 t -98.38 -145.46 0.32 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.83 1.252 . . . . 0.0 110.46 164.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -47.84 144.7 3.28 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 169.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 81.34 4.19 1.45 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.146 2.178 . . . . 0.0 116.391 172.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.07 153.78 41.49 Favored Glycine 0 CA--C 1.55 2.268 0 O-C-N 120.426 -1.421 . . . . 0.0 115.285 173.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -84.2 135.78 34.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.605 1.562 . . . . 0.0 113.563 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.5 m -131.54 -6.91 3.7 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.24 111.44 0.3 Allowed Glycine 0 CA--C 1.546 1.975 0 CA-C-N 119.975 1.261 . . . . 0.0 115.237 -177.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.55 24.23 0.06 OUTLIER Glycine 0 CA--C 1.541 1.718 0 O-C-N 118.952 -2.499 . . . . 0.0 117.477 -6.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.9 mt -64.12 129.44 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 120.345 2.073 . . . . 0.0 110.683 169.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.5 -39.43 0.74 Allowed Glycine 0 CA--C 1.547 2.084 0 C-N-CA 124.589 1.09 . . . . 0.0 115.648 -174.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -64.93 178.43 0.82 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 126.858 2.063 . . . . 0.0 115.217 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.6 p -134.39 -86.0 0.41 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.916 1.287 . . . . 0.0 110.953 165.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.95 38.56 0.5 Allowed Glycine 0 CA--C 1.546 2.005 0 N-CA-C 118.103 2.001 . . . . 0.0 118.103 169.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -77.82 58.55 6.51 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 CA-C-N 121.086 2.443 . . . . 0.0 111.181 172.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -74.61 57.59 0.74 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.756 1.222 . . . . 0.0 113.923 -171.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 t -78.78 62.52 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 O-C-N 120.429 -1.419 . . . . 0.0 111.28 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.07 -177.96 4.32 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.138 2.175 . . . . 0.0 112.603 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.33 165.88 24.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.749 0.82 . . . . 0.0 112.801 166.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.4 t -106.4 171.93 7.09 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.567 1.147 . . . . 0.0 112.172 171.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.06 -53.68 1.4 Allowed Glycine 0 CA--C 1.546 1.975 0 O-C-N 120.928 -1.108 . . . . 0.0 111.821 -159.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -58.89 147.44 33.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.809 1.243 . . . . 0.0 113.502 157.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.6 p -108.44 -128.4 0.27 Allowed 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -173.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m 179.86 55.88 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 128.2 2.6 . . . . 0.0 111.73 -162.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -124.03 147.47 47.8 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 126.345 1.858 . . . . 0.0 115.215 -159.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.3 m -44.68 110.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 127.459 2.304 . . . . 0.0 116.439 -170.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.83 -49.67 2.21 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.15 1.38 . . . . 0.0 114.378 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -153.45 163.51 23.47 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 125.626 1.57 . . . . 0.0 112.325 -169.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.96 48.77 2.07 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.74 2.96 . . . . 0.0 113.94 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -155.51 -46.16 0.08 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.511 2.724 . . . . 0.0 108.826 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.43 113.46 17.54 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 127.669 2.387 . . . . 0.0 114.015 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -59.08 122.78 14.6 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.36 117.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -139.58 148.3 42.34 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.14 1.376 . . . . 0.0 113.276 -145.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 m -65.35 91.09 0.11 Allowed 'General case' 0 CA--C 1.555 1.168 0 O-C-N 120.687 -1.258 . . . . 0.0 113.574 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.129 1.372 . . . . 0.0 110.208 154.999 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 68.8 p . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -88.41 131.87 34.68 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.936 2.094 . . . . 0.0 110.86 167.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -90.59 176.79 6.55 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -173.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -49.45 140.71 10.1 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.652 1.581 . . . . 0.0 112.932 -174.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 69.48 -20.34 0.17 Allowed 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -44.94 141.31 3.97 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 116.722 1.449 . . . . 0.0 116.722 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -70.22 138.41 51.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.911 2.084 . . . . 0.0 115.182 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 p -150.26 63.71 0.96 Allowed 'General case' 0 CA--C 1.553 1.075 0 O-C-N 121.078 -1.014 . . . . 0.0 111.851 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.2 -155.23 26.26 Favored Glycine 0 CA--C 1.55 2.278 0 C-N-CA 126.163 1.839 . . . . 0.0 115.071 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.95 -144.94 5.82 Favored Glycine 0 CA--C 1.547 2.063 0 C-N-CA 126.368 1.937 . . . . 0.0 117.446 172.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -55.28 107.01 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 O-C-N 120.887 -1.36 . . . . 0.0 112.424 174.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.74 -44.16 2.57 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 116.93 1.532 . . . . 0.0 116.93 159.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -73.93 69.21 1.4 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 119.407 1.603 . . . . 0.0 114.906 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.5 m -80.06 73.89 6.85 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.017 -1.052 . . . . 0.0 109.102 151.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.78 -170.03 12.62 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 -162.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.13 83.56 0.15 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.618 2.879 . . . . 0.0 114.332 -174.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 p -62.45 15.24 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.05 62.46 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 O-C-N 120.088 -1.632 . . . . 0.0 112.385 -162.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.6 t -57.83 162.6 3.1 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 127.282 2.233 . . . . 0.0 113.968 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.22 69.86 0.09 Allowed 'General case' 0 CA--C 1.555 1.158 0 O-C-N 120.155 -1.591 . . . . 0.0 113.781 172.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.4 t -14.28 80.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 129.06 2.944 . . . . 0.0 116.29 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.16 -55.08 0.47 Allowed Glycine 0 CA--C 1.537 1.432 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -158.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.4 p -81.59 158.18 24.47 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 120.704 0.288 . . . . 0.0 110.481 145.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.4 p -122.94 -115.58 0.3 Allowed 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -154.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.9 t 179.9 74.67 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 128.904 2.881 . . . . 0.0 110.631 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.95 131.06 55.4 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 128.233 2.613 . . . . 0.0 113.797 -162.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.6 t -63.85 103.79 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 125.405 1.482 . . . . 0.0 113.836 -173.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 mt -111.77 -51.77 2.83 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -148.05 158.38 41.89 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -161.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -51.57 -18.26 5.68 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 124.009 3.139 . . . . 0.0 117.106 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -90.0 -45.49 9.15 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.916 -1.115 . . . . 0.0 113.209 168.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.3 119.64 34.61 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.047 1.339 . . . . 0.0 114.101 -170.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -68.41 132.7 47.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 117.144 -1.822 . . . . 0.0 108.933 114.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -131.67 136.45 47.7 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -149.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.3 t -68.18 64.51 0.1 Allowed 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.723 1.209 . . . . 0.0 112.279 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.251 1.153 0 C-N-CA 126.311 1.844 . . . . 0.0 111.856 167.103 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -133.75 173.07 11.93 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 126.842 2.057 . . . . 0.0 111.446 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.6 t -121.88 -145.35 0.35 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.345 1.458 . . . . 0.0 111.725 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -50.38 134.37 23.37 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.878 1.271 . . . . 0.0 113.896 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 57.99 25.1 11.84 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 126.612 1.965 . . . . 0.0 115.987 -171.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.36 134.29 20.94 Favored Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.306 1.282 . . . . 0.0 116.306 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -72.95 130.97 41.56 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.271 1.428 . . . . 0.0 113.48 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.78 66.84 1.41 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 127.96 2.504 . . . . 0.0 109.234 160.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.96 170.93 33.22 Favored Glycine 0 CA--C 1.543 1.801 0 C-N-CA 126.479 1.99 . . . . 0.0 113.427 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.75 -54.58 27.4 Favored Glycine 0 CA--C 1.545 1.965 0 N-CA-C 119.325 2.49 . . . . 0.0 119.325 -159.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 mt -53.97 114.58 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 O-C-N 121.229 -1.159 . . . . 0.0 113.784 -165.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.76 36.02 70.33 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 125.84 1.686 . . . . 0.0 115.698 -176.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.07 175.12 9.89 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -160.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 m -158.04 -44.73 0.06 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.337 2.255 . . . . 0.0 111.866 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.18 68.31 1.21 Allowed Glycine 0 CA--C 1.547 2.056 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 164.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -61.37 66.64 0.1 OUTLIER 'Trans proline' 0 CA--C 1.551 1.325 0 C-N-CA 123.432 2.755 . . . . 0.0 111.977 152.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 p -141.57 49.99 1.59 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -157.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.97 91.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 O-C-N 121.174 -0.954 . . . . 0.0 109.307 155.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 171.18 5.46 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -166.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.69 78.95 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.9 t -36.21 123.37 0.75 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.407 1.883 . . . . 0.0 114.588 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.2 -45.73 1.25 Allowed Glycine 0 CA--C 1.543 1.801 0 C-N-CA 124.727 1.156 . . . . 0.0 110.585 -149.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.5 p -103.83 148.87 25.62 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.163 2.185 . . . . 0.0 111.771 161.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.4 p -134.75 113.27 11.48 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.413 1.485 . . . . 0.0 114.653 -158.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.0 t -63.58 88.44 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 126.041 1.736 . . . . 0.0 114.622 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -122.59 146.14 47.7 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.76 114.85 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.8 mt -125.04 -58.81 1.45 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.484 1.514 . . . . 0.0 114.97 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -135.94 162.03 59.15 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 124.222 1.009 . . . . 0.0 112.928 -155.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.66 32.95 0.29 Allowed 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.198 2.598 . . . . 0.0 114.963 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -133.74 -48.59 0.81 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.039 2.136 . . . . 0.0 110.649 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.05 135.31 51.61 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 127.746 2.418 . . . . 0.0 114.742 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.4 t -72.43 124.34 24.96 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.483 127.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -122.1 130.19 53.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.787 1.635 . . . . 0.0 112.641 -151.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.8 m -66.24 92.04 0.18 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 C--O 1.246 0.909 0 C-N-CA 124.11 0.964 . . . . 0.0 111.471 165.298 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.499 1.98 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -88.77 170.7 10.54 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.171 0.988 . . . . 0.0 112.282 171.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.1 t -116.5 -91.44 0.54 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 119.318 0.963 . . . . 0.0 113.173 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -72.14 120.28 17.52 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.545 1.538 . . . . 0.0 112.837 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 90.56 50.44 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 127.548 2.339 . . . . 0.0 116.406 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.06 132.49 10.71 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 125.732 1.634 . . . . 0.0 114.715 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -68.73 132.51 46.95 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 119.101 1.45 . . . . 0.0 113.658 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.9 m -123.43 0.76 8.91 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.68 1.992 . . . . 0.0 115.097 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.62 -146.19 6.71 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.611 1.577 . . . . 0.0 111.719 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.56 -164.52 20.45 Favored Glycine 0 CA--C 1.545 1.945 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -54.18 134.4 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 O-C-N 121.155 -1.203 . . . . 0.0 114.141 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.64 -42.73 3.13 Favored Glycine 0 CA--C 1.543 1.823 0 C-N-CA 124.927 1.251 . . . . 0.0 115.033 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -67.18 171.48 5.68 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 126.167 1.787 . . . . 0.0 114.681 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.0 p -59.47 156.45 13.09 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 130.856 3.662 . . . . 0.0 116.664 6.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.5 -163.67 26.71 Favored Glycine 0 CA--C 1.549 2.159 0 O-C-N 121.351 -0.843 . . . . 0.0 114.968 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.46 82.32 2.11 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 123.69 2.927 . . . . 0.0 113.977 -168.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.8 p -67.73 56.98 0.06 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 126.242 1.817 . . . . 0.0 114.259 172.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.92 52.38 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 O-C-N 119.88 -1.763 . . . . 0.0 112.132 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.75 157.31 17.04 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 128.105 2.562 . . . . 0.0 113.936 -170.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -101.19 127.22 47.86 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.207 1.803 . . . . 0.0 112.299 172.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.0 t -65.44 122.11 16.41 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 171.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.21 -66.99 0.29 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.488 1.994 . . . . 0.0 109.139 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.4 p -60.53 151.58 28.19 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.559 0.743 . . . . 0.0 111.583 137.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.9 p -93.96 -105.86 0.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -169.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 167.98 3.42 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 128.41 2.684 . . . . 0.0 116.184 -170.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -90.73 172.81 8.39 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 -157.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.0 m -54.05 123.25 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 127.469 2.307 . . . . 0.0 116.602 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -163.54 -55.97 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 157.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -84.52 140.48 38.57 Favored Pre-proline 0 CA--C 1.561 1.4 0 O-C-N 119.604 -1.935 . . . . 0.0 112.333 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -39.32 -52.37 2.42 Favored 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 125.264 3.976 . . . . 0.0 115.93 171.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -69.89 -42.9 72.81 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.83 -1.169 . . . . 0.0 113.079 169.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.04 104.98 9.56 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -168.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t -55.23 116.39 2.79 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.648 124.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -129.87 146.79 51.59 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -155.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.0 m -64.17 80.39 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 O-C-N 120.95 -1.094 . . . . 0.0 112.515 166.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 124.256 1.022 . . . . 0.0 110.138 151.598 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.497 1.908 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -64.17 73.85 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.01 1.324 . . . . 0.0 111.897 169.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 t -75.0 -143.54 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.661 -0.649 . . . . 0.0 111.088 160.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -44.7 103.59 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.356 1.463 . . . . 0.0 113.583 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 87.08 84.62 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 129.563 3.145 . . . . 0.0 114.255 -171.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.53 117.26 1.25 Allowed Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.315 1.436 . . . . 0.0 114.732 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -65.42 122.13 16.46 Favored 'General case' 0 CA--C 1.556 1.195 0 O-C-N 119.751 -2.029 . . . . 0.0 112.49 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.4 m -104.9 -52.53 2.84 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.919 1.288 . . . . 0.0 114.387 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.16 132.55 3.58 Favored Glycine 0 CA--C 1.543 1.837 0 C-N-CA 124.185 0.898 . . . . 0.0 114.26 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.27 -157.97 27.46 Favored Glycine 0 CA--C 1.546 2.017 0 C-N-CA 126.424 1.964 . . . . 0.0 113.029 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.0 mt -40.83 110.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 119.333 1.566 . . . . 0.0 112.764 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.37 -33.39 3.2 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 116.296 1.279 . . . . 0.0 116.296 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -82.01 55.56 2.83 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -156.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.2 t -74.53 71.56 1.85 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.357 -1.464 . . . . 0.0 108.612 147.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.0 -172.68 14.88 Favored Glycine 0 CA--C 1.546 2.008 0 N-CA-C 117.82 1.888 . . . . 0.0 117.82 -154.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.41 80.21 2.79 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.152 3.235 . . . . 0.0 112.45 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.5 p -68.9 51.12 0.08 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.856 1.662 . . . . 0.0 114.868 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -78.45 52.54 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 O-C-N 119.728 -1.857 . . . . 0.0 111.704 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 44.5 t -85.59 166.07 16.53 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.915 2.486 . . . . 0.0 115.269 -165.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.28 83.61 1.8 Allowed 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 t -43.29 109.91 0.17 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.834 1.253 . . . . 0.0 113.686 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.98 -52.37 0.79 Allowed Glycine 0 CA--C 1.539 1.584 0 C-N-CA 125.614 1.578 . . . . 0.0 110.158 -160.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.4 p -76.91 163.98 26.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.079 0.552 . . . . 0.0 109.958 140.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.7 p -114.26 -124.19 0.29 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -163.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.3 m -173.69 32.76 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 128.957 2.903 . . . . 0.0 111.808 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -65.08 141.98 58.54 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 119.867 -1.771 . . . . 0.0 114.676 -162.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 m -64.58 93.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.18 1.392 . . . . 0.0 113.905 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.2 mt -96.59 -48.01 5.7 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -162.86 176.14 2.52 Favored Pre-proline 0 CA--C 1.559 1.326 0 O-C-N 120.832 -1.168 . . . . 0.0 113.94 -165.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.95 -39.15 92.06 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.482 2.788 . . . . 0.0 115.106 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -67.3 -39.55 85.94 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.61 116.73 8.93 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 117.768 2.507 . . . . 0.0 117.768 -164.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.11 125.58 19.54 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.59 111.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -144.04 127.32 16.73 Favored 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -154.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.0 m -63.46 78.58 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.66 1.584 . . . . 0.0 113.043 174.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.6 mt . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.187 151.273 . . . . . . . . 0 0 . 1 stop_ save_